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THESIS ABSTRACT 
 
 
Julia Elizabeth Rager 
 
A Systems Biology Approach to Investigate Human Lung Cell Response to Air Pollutants 
 
(Under the direction of Dr. Rebecca C. Fry) 
 
 
 
Exposure to air pollution is associated with many diseases, such as asthma, bronchitis, and 
lung cancer. Despite these adverse health effects, the cellular mechanisms underlying air 
pollution-associated diseases remain largely unknown. In this study we set out to investigate 
the genome-wide responses of human lung cells exposed to multiple air pollutant conditions. 
We first employ a toxicogenomic approach to compare transcripts and molecular networks 
modulated upon exposure to freshly emitted air pollutants and photochemically altered 
pollutant mixtures, containing secondary pollutants. The results demonstrate that secondary 
pollutants initiate a more robust genomic response. After identifying this trend, we 
investigate potential mechanisms underlying responses to individual secondary pollutants. 
Here, we evaluate global microRNA expression modifications resulting from formaldehyde 
exposure. Our analysis reveals that formaldehyde induces significant changes in microRNA 
levels, which may in turn, regulate genes associated with inflammation and cancer. Together, 
these investigations reveal novel mechanisms potentially underlying air pollutant-induced 
disease. 
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PREFACE 
 
 
Toxicology studies analyzing the health effects of air pollutant exposure are becoming 
increasingly important, as the number of epidemiology studies showing strong associations 
between air pollution exposure and adverse health effects are rapidly growing (Brunekreef 
and Holgate, 2002;  Burnett et al., 2001;  Cohen et al., 2005;  Götschi et al., 2008). Some air 
pollution health effects may occur over time due to chronic exposure, as with chronic 
bronchitis and lung cancer (Brunekreef and Holgate, 2002;  Nyberg et al., 2000). Other 
health effects occur more abruptly, as with increased hospital admissions, acute respiratory 
symptoms, cardiovascular events, and decreased lung function (Brunekreef et al., 1995;  Dab 
et al., 1996). Despite these serious health effects, the cellular mechanisms underlying air 
pollutant-induced disease remain largely unknown.  
 
Our study set out to investigate lung cell responses to multiple air pollutant exposure 
conditions on a genome-wide scale. We perform our studies using a systems level approach, 
where pollutant-induced lung cell responses are identified and related molecular networks are 
constructed. Our goal is to increase the mechanistic understanding of air pollutant-related 
diseases, particularly in response to multiple components of air pollution present in urban 
atmospheres. 
 
Thesis Organization 
This report is organized into two chapters. Chapter One evaluates the genome-wide response 
of human lung cells exposed to gaseous pollutant mixtures found in urban atmospheres. 
Specifically, cellular response, at the gene-transcript level, is evaluated by identifying genes 
and molecular pathways modulated upon exposure to freshly emitted air pollutants. These 
response mechanisms are then compared against genes and networks modulated upon 
exposure to photochemically altered pollutant mixtures, containing secondary pollutants. 
This study reveals that secondary pollutants produced from primary pollutants irradiating 
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throughout the day cause a much more robust cellular response than primary pollutants. After 
identifying this trend, we focus on the potential mechanisms underlying lung cell response 
from exposure to individual secondary pollutants.  
 
As detailed in Chapter Two, we focus our analysis on formaldehyde, a secondary pollutant 
found in both indoor and outdoor air pollution. Here, we investigate human lung cell 
response to formaldehyde exposure by measuring microRNA expression profiles across the 
genome. We reveal that formaldehyde induces significant changes in microRNA expression 
patterns, which may in turn, regulate genes associated with inflammation and cancer. These 
two chapters, combined, reveal novel mechanisms potentially underlying air pollutant-
induced disease. 
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CHAPTER 1 
A Toxicogenomic Comparison of Primary and Photochemically Altered 
Air Pollutants in Human Lung Cells 
ABSTRACT 
Background: Outdoor air pollution contributes significantly to global increases in mortality, 
particularly within urban environments. Studies have investigated cellular responses in lung 
cells caused by single pollutants, such as individual gases or particulate matter. There is, 
however, limited knowledge of the mechanisms underlying health effects resulting from 
exposure to pollutant mixtures. Toxicogenomic analyses can increase our mechanistic 
understanding of exposure effects through observations of gene expression alterations and 
their associated molecular pathways.  
 
Objectives: We set out to compare the cellular responses of lung cells exposed to primary 
pollutants relative to photochemically altered (PCA) pollutant mixtures found in urban 
atmospheres. We hypothesized that lung cells exposed to PCA pollutants will show increased 
modulation of inflammatory-associated genes and pathways relative to primary  pollutants.  
 
Methods: Human lung epithelial cells were exposed to either primary or PCA mixtures. 
Transcription changes were assessed using microarrays and confirmed using RT-PCR on a 
subset of genes.  
 
Results: There was a large difference in cell response with primary air pollutants altering the 
expression levels of 19 genes, while PCA pollutants altered 709 genes. Functional and 
molecular analyses of the altered genes showed that pollutant exposure modifies the 
signaling of pathways associated with cancer and inflammation. To confirm the altered 
inflammatory response, interleukin-8 were measured at significantly increased levels.  
 
Conclusions: Our study shows for the first time that exposure to PCA pollutants results in 
robust gene expression changes relative to primary components of air pollution. These 
transcription changes may, in part, explain the health effects related to air pollutant exposure.
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1.1 INTRODUCTION 
 
Outdoor air pollution contributes significantly to global increases in morbidity and mortality, 
particularly within urban environments (Burnett et al., 2000;  Cao et al., 2009). Some air 
pollution health effects may occur over time due to chronic exposure, as with chronic 
bronchitis and lung cancer (Brunekreef and Holgate, 2002;  Nyberg, et al., 2000). Other 
health effects occur more abruptly, as with increased hospital admissions, acute respiratory 
symptoms, cardiovascular events, and decreased lung function (Brunekreef, et al., 1995;  
Dab et al., 1996). Despite these adverse health outcomes, the underlying molecular 
mechanisms associating air pollutant mixtures with disease remain largely unknown. 
 
1.1.1 Toxicogenomic Analyses of Air Pollution Health Effects 
Toxicogenomic analyses can increase our understanding of the molecular mechanisms that 
associate exposure to air pollution with disease. Specifically, transcriptional studies can be 
used to assess alterations in mRNA levels providing information on the genes and regulatory 
pathways that are modified through environmental exposures (McHale et al., 2010). 
Knowledge of signaling pathways altered by air pollution mixtures is currently limited, with 
primarily exposures to diesel exhaust and particulate matter mixtures studied. For example, 
exposure to diesel exhaust and/or particulate matter alters the signaling of cyclooxygenase-2 
(COX-2), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) as well 
as signal transducer and activator of transcription 3 (STAT3) (Becker et al., 2005;  Cao et al., 
2007). Individual gas-phase pollutant exposures have also been studied. For example, 
exposure to ozone or sulfur dioxide results in the altered signaling of cytokines, such as IL-6 
and IL-8, as well as activator protein-1 (AP-1) and nuclear factor kappa beta (NFκB) 
(Damera et al., 2009;  Jaspers et al., 1997;  Thompson et al., 2009). However, studies 
evaluating responses to gaseous pollutant mixtures are limited. Furthermore, to our 
knowledge, no studies have evaluated the genome-wide transcriptional response of lungs 
cells exposed to gaseous primary emitted pollutant mixtures relative to photochemically 
altered (PCA) air mixtures. 
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1.1.2 Air Pollution Chemistry 
In order to link air pollution exposure to health outcomes, it is important to accurately 
characterize exposure conditions by understanding air pollution chemistry. Within urban air 
environments, primary pollutants emitted into the atmosphere undergo photochemical 
reactions in sunlight and form various secondary pollutants giving rise to photochemical 
smog. The main primary pollutants emitted are nitrogen oxides (NOx) and volatile organic 
compounds (VOCs). These primary pollutants then photochemically react during daylight to 
generate secondary products, including ozone, peroxyacetyl nitrate, formaldehyde, and other 
various carbonyls (EPA, 2006). This complex chemistry between primary emitted air 
pollutants and sunlight has created an environment where almost 175.3 million (58%) 
Americans currently live in areas with unhealthy levels of pollution (ALA, 2010). 
 
1.1.3 Study Objectives 
In this study, we set out to investigate the toxicogenomic response of lung cells exposed to 
gaseous mixtures that mimic urban atmospheric conditions. Specifically, we analyze the 
transcriptomic response of lung cells exposed to common air pollutants reacting 
photochemically with sunlight. Through the use of an environmental irradiation chamber, we 
compare gene expression patterns and inflammatory responses in cells exposed to primary 
pollutants with cells exposed to PCA pollutant mixtures. 
 
 
 
 
1.2 MATERIALS AND METHODS 
 
1.2.1 Generation of Pollutant Mixtures 
An outdoor environmental irradiation chamber (120 m
3
 volume) was used to prepare air 
exposure conditions. Outdoor environmental irradiation chambers are photochemical reactors 
that utilize natural sunlight to initiate the natural photochemical transformation chemistry of 
air pollutants (Jeffries et al., 1976;  Jeffries, 1995;  Sexton et al., 2004;  Yu et al., 1997). 
Synthetic Urban Mix, a volatile organic carbon (VOC) mixture, was used as the starting 
material for the test atmosphere. This mixture contains 55 different hydrocarbons at specific 
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ratios representing chemicals present in urban atmospheres (Jeffries and Sexton, 1995). On 
the morning of the exposure day, the volatile organics of Synthetic Urban Mix were drawn 
from a gas cylinder into the environmental irradiation chamber, while a liquid mixture 
containing the less volatile organics was injected into the chamber. In addition, oxides of 
nitrogen (NOx) were drawn from a gas cylinder (Reference # 8857085) into the chamber to 
establish a test atmosphere containing 2 ppmC Synthetic Urban Mix and 0.2 ppm NOx. This 
test atmosphere remained inside the environmental irradiation chamber throughout the day 
where sunlight induced photochemical reactions between the mixture's compounds, and 
secondary chemical products were generated. 
 
1.2.2 Cell Culture 
Human A549 type II lung epithelial cells, derived from a human lung adenocarcinoma, were 
cultured according to standard protocol (ATCC). Cells were grown in growth media 
containing F-12K plus 10% FBS plus 1% penicillin and streptomycin. Cells were plated onto 
24 mm diameter collagen-coated membranes with 0.4 μm pores (Trans-CLR; Costar, 
Cambridge, MA). Upon confluence, cells were cultured in phenol red-free F-12K nutrient 
mixture without FBS. Immediately prior to exposure, apical media was removed in order to 
create direct air-liquid interface culture conditions. The media beneath each membrane 
remained to supply nourishment for cells throughout the exposure. 
 
1.2.3 Exposure to Pollutant Mixtures 
A coupled chamber-in vitro exposure system was used for this study (Sexton, et al., 2004). 
Sample lines directly linked the environmental irradiation chamber’s mixture to a cellular 
exposure chamber (Billups-Rothenberg, Modular Incubator Chamber, Del Mar, CA), where 
air exposures were continuously drawn through at 1.0 L/min. The cellular exposure chamber 
was positioned within an incubator (set at 37°C), where CO2 was added to the exposure 
source stream at 0.05 L/min and a small water dish provided proper humidification. 
 
The first exposure was in the morning, representing the primary pollutant mixture exposure. 
Lung cells were exposed for four hours, while mock-treated control cells were exposed to 
humidified air under similar conditions. The second exposure was in the evening, 
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representing the PCA pollutant mixture, which contained primary pollutants and secondary 
products of irradiation chemistry. For this treatment, prepared lung cells were exposed for 
four hours, while another set of mock-treated control cells were exposed to humidified air. 
For each exposure period, four exposed sample wells and four unexposed sample wells were 
used, resulting in a total of 16 total samples. Cells were incubated for nine hours after each 
respective exposure period. Cells were then scraped and stored at -80°C in TRIzol® Reagent 
(Invitrogen Life Technologies), and basolateral supernatants were aspirated and stored at -
80°C. 
 
1.2.4 Chemical Analysis of Atmospheric Mixtures 
Gas measurement methods were used to assess the chemical constituents within the chamber 
during the experiment. Volatile organic hydrocarbon levels were measured five times during 
the experiment using a Varian STAR 3400 capillary gas chromatograph - flame ionization 
detection with a Varian Saturn 2000 ion trap mass spectrometer. Ozone was measured every 
minute using an EPA equivalent method (EQOA-0193-091) based on chemiluminescence 
with a Teledyne Monitor Labs Model 9811 monitor (Englewood, CO). NO and NO2 levels 
were measured every minute using an EPA standard reference method (RFNA-1292-090) 
based on chemiluminescence with a Teledyne Monitor Labs Model 9841. Formaldehyde 
concentrations were measured continuously using a Dasgupta-diffusion-tube sampler 
(Dasgupta et al., 1988). Peroxyacetyl nitrate levels were measured every 30 minutes using a 
Varian CP-3800 gas chromatograph. 
 
1.2.5 Analysis of Cytotoxicity 
To measure cytotoxicity, the enzyme lactate dehydrogenase (LDH) was measured within the 
supernatant of each sample. LDH levels were assessed using a coupled enzymatic assay, 
according to the supplier’s instructions (Clontech Laboratories, Inc., Mountain View, CA). 
For each exposure period, four unexposed and four exposed sample wells were analyzed in 
technical triplicate for a total of 24 measurements. Scanned absorbance reading outliers were 
identified through the Grubbs’ test where outliers were identified as those with less than a 
5% probability of occurring as an outlier by chance alone, relative to a normal distribution 
(Grubbs, 1969). Fold increase was calculated as µLDH exposed / µLDH unexposed, where µ 
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represents the mean LDH levels. Statistical significance of the exposed versus unexposed 
LDH levels was calculated using an unpaired t-test with Welch’s correction (Welch, 1938). 
1.2.6 Microarray Processing 
Total RNA was isolated from unexposed cells and cells exposed to either primary or PCA air 
pollutants using Qiagen’s RNeasy® Kit according to the manufacturer’s protocol (Valencia, 
CA). RNA was quantified with the NanoDrop™ 1000 Spectrophotometer (Thermo 
Scientific, Waltham, MA) and its integrity was verified with an Agilent Technologies 2100 
Bioanalyzer (Santa Clara, CA). RNA was biotin-labeled according to the Affymetrix 
protocol and hybridized to Affymetrix GeneChip® Human Gene 1.0 ST arrays, which probe 
for 28,869 genes. Samples were assessed in biological duplicate for each exposure condition: 
primary pollutant exposure and time-matched unexposed control, PCA pollutant exposure 
and time-matched unexposed control, for a total of eight microarray samples. 
 
1.2.7 Microarray Analysis 
Microarray data were first normalized using Robust Multi-Chip Average (RMA) (Irizarry et 
al., 2003) and filtered for expression levels above background noise (> abs[30]) which 
resulted in a reduction of probesets from 28,869 to 24,652 for primary mixture conditions 
and 24,830 for PCA mixture conditions. Differential gene expression was defined as a 
significant difference in mRNA levels between exposed versus unexposed samples, where 
the following three statistical requirements were set: (1) fold change of ≥ 1.5 or ≤ - 1.5 
(exposed versus unexposed); (2) p-value < 0.05 (ANOVA); and (3) a false discovery rate 
corrected q-value < 0.05. Analysis of variance (ANOVA) p-values were calculated using 
Partek
®
 Genomics Suite
TM
 software (St. Louis, MO). To control the rate of false positives, q-
values were calculated as the minimum “positive false discovery rate” that can occur when 
identifying significant hypotheses (Storey, 2003). Microarray data have been submitted to 
NCBI's Gene Expression Omnibus (GEO) repository (http://www.ncbi.nlm.nih.gov/geo/) and 
are available under accession number GSE23735 (Edgar et al., 2002). 
 
1.2.8 Enriched Biological Functions and Network Analysis 
Biological functions and molecular networks associated with air pollutant exposure were 
identified using the Ingenuity database (Ingenuity Systems, www.ingenuity.com, Redwood 
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City, CA). The Ingenuity database provides a collection of gene to phenotype associations, 
molecular interactions, regulatory events, and chemical knowledge accumulated to develop a 
global molecular network. The lists of differentially expressed genes were overlaid onto this 
global molecular network, where related networks were algorithmically constructed based on 
connectivity. Functional analysis was carried out to identify biological functions and disease 
signatures most significantly associated with the differentially expressed genes. Statistical 
significance of each biological function or disease was calculated using a Fischer's exact test. 
Functions with p-values ≤ 3.0 x 10-6 were evaluated. 
 
1.2.9 Transcription Factor Binding Site Analysis 
Transcription factor binding site analysis was performed using the EXPANDER Software, 
version 5.1 (acgt.cs.tau.ac.il/expander/). For this analysis, Affymetrix probesets were linked 
to sequence data in regions 1,000 base pairs upstream and 200 base pairs downstream of the 
transcription start sites. These sequence data were then analyzed for significant enrichment of 
transcription factor binding site sequences. P-values of significance represent the probability 
of obtaining an equal or greater number of matched binding site sequences using a randomly 
drawn sample of the same size as the input sequence set. 
 
1.2.10 Inflammatory Cytokine Release 
The protein levels of the inflammatory cytokine interleukin-8 (IL-8) were measured using the 
basolateral supernatant samples. A BD OptEIA
TM
 human IL-8 enzyme-linked 
immunosorbent assay (ELISA) was performed and analyzed according to the manufacturers’ 
protocol (BD Biosciences, San Jose, California). Scanned absorbance reading outliers were 
identified, and statistical significance was calculated using the same method as the LDH 
analysis. IL-8 fold increase was calculated as µIL-8 exposed / µIL-8 unexposed, where µ represents 
mean IL-8 levels.  
 
1.2.11 Quantitative RT-PCR Verification of mRNA Expression 
Expression levels of selected genes were validated using quantitative real-time PCR (qRT-
PCR). QuantiTect Primer Assays for glutamine-fructose-6-phosphate transaminase 2 
(GFPT2) (Cat No. QT00007854), 2’,5’-oligoadenylate synthetase 1 (OAS1) (Cat No. 
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00099134), and ATPase, class I, type 8B, member 1 (ATP8B1) (Cat No. QT00038094) were 
used with the Qiagen QuantiTect SYBR
®
 Green PCR kit and Roche Lightcycler 480. Fold 
changes between exposed and unexposed samples were calculated based on cycle time values 
and normalized against a β-actin housekeeping gene. Statistical significance of the exposed 
versus unexposed transcript levels was calculated using an unpaired Student’s t-test. 
 
 
 
 
1.3 RESULTS 
 
1.3.1 Chemical Analysis of Exposure Conditions 
Human lung cells were exposed to either a primary air pollutant mixture or a PCA air 
pollutant mixture, containing secondary chemical products (see Materials and Methods). In 
order to assess the gas composition the cells were being exposed to, chemical concentrations 
were measured within the environmental irradiation chamber throughout the day (see 
Materials and Methods). Average nitrogen dioxide (NO2), nitric oxide (NO), and ozone (O3) 
concentrations for the primary pollutant exposure were measured at 0.21, 0.14, and 0.02 
ppm, respectively (Fig. 1A). Average NO2, NO, and O3 concentrations for the PCA pollutant 
exposure were 0.12 , 0.01, and 0.14 ppm, respectively (Figure 1). Most hydrocarbon levels 
decreased throughout the exposure day (Figure 1), such as the aromatic compound, toluene 
(Additional File 1). More stable hydrocarbons, including n-hexane and benzene, remained at 
stable levels across the day (Additional File 1). Formaldehyde levels increased to 0.03 ppm 
by the end of the afternoon exposure period, while peroxyacetyl nitrate levels increased to 
0.1 ppm (Figure 1). 
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Figure 1: Chemical component analysis of exposure conditions. Figure (A) shows the concentrations for 
nitric oxide (NO), nitrogen dioxide (NO2), ozone (O3), formaldehyde (HCHO), and peroxyacetylnitrate (PAN) 
in parts per million (ppm). Exposure periods are shaded for the primary and photochemically altered air 
pollutant exposures. The decay of hydrocarbons throughout the day, in ppm carbon (ppmC) is shown (B), where 
chemicals are grouped according to species. EDT refers to Eastern Standard Time. 
 
1.3.2 Cytotoxicity Measurements 
After the exposures, lung cells were measured for cellular lactate dehydrogenase (LDH) 
release (see Materials and Methods). Investigation of the enzyme LDH showed that human 
lung cells experience more cell death after exposure to PCA pollutants (fold increase = 9, p-
value < 0.001) than to primary pollutants (fold increase = 1.6, p-value = 0.07) (Figure 2). 
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Figure 2: Levels of lactate dehydrogenase (LDH). LDH 
levels are shown for cells exposed to either primary or 
photochemically altered (PCA) pollutant mixtures relative to 
unexposed (control) cells. Results are displayed as fold increase 
over control +/- S.E.M. The (*) symbol indicates statistical 
significance (p-value < 0.05). 
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1.3.3 Gene Expression Analysis 
Human lung cells were exposed to two different gaseous conditions: primary air pollutants in 
the morning, and PCA pollutants in the afternoon. Each exposure condition was performed 
alongside untreated, control samples. After exposure, mRNA was extracted and relative 
transcript abundance was assessed using Affymetrix Human Gene 1.0 ST microarrays (see 
Materials and Methods).  
 
Lung cells exposed to the primary pollutant mixture showed differential expression in 19 
genes, 15 of which showed increased expression levels and 4 of which showed decreased 
levels (Figure 3, Additional File 2). The PCA pollutant exposure resulted in changes in the 
expression levels of 709 genes. Of these, 190 showed increased expression levels and 519 
showed decreased levels (Figure 3, Additional File 2). Among these two lists, 14 genes were 
identified as significantly differentially expressed in response to both pollutant mixtures 
(Table 1). Of this common set, 13 out of the 14 overlapping genes had higher expression fold 
change magnitudes due to PCA pollutant exposure when compared to the primary pollutant 
exposure.  
Figure 3: Heat map showing the average gene expression 
fold changes across 714 total genes modulated by 
primary and/or PCA pollutant mixture exposures. Red 
represents relative increase in expression, and blue 
represents relative decrease in expression. 
Primary Pollutants
Fold Change
PCA Pollutants
Fold Change
+ FC- FC
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Table 1: 14 overlapping genes with significantly (p-value < 0.05, q-value < 0.05) modified expression 
levels upon exposure to primary pollutants and photochemically altered (PCA) pollutant mixtures. 
Gene Symbol Primary Pollutants Fold 
Change (Exposed/Unexposed) 
PCA Pollutants Fold Change 
(Exposed/Unexposed) 
ACSM3 -1.50 -2.33 
ACTA2 -1.58 -1.99 
ATP8B1 -1.51 -2.95 
CCL2 1.78 1.97 
GCOM1 1.51 1.52 
GFPT2 1.60 2.78 
NFKBIA 1.51 1.53 
OAS1 1.62 2.43 
OR4A47 1.73 1.57 
PAQR5 1.58 2.19 
SLC5A3 1.75 1.80 
TXNIP -1.61 -2.42 
USP17 1.53 1.57 
USP17L2 1.53 1.53 
 
 
 
 
1.3.4 Network Analysis and Biological Functions 
In order to identify potential biological pathways in the lung cells that are affected by air 
pollutant exposure, the lists of differentially expressed genes were overlaid onto molecular 
network maps (see Materials and Methods). Networks containing the identified genes were 
algorithmically constructed based on connectivity and known relationships among proteins. 
The 19 genes with altered expression due to primary pollutant exposure generated one 
significant (p-value < 10
-25
) network (Figure 4A). This network consists of 35 total proteins, 
nine of which are encoded by differentially expressed genes following primary pollutant 
exposure (Additional File 3). Within this network, there are gene products related to cancer, 
respiratory disease, and inflammation, such as chemokine (C-C motif) ligand 2 (CCL2).  
 
The 709 genes altered in response to PCA pollutant mixture exposure generated 25 
significant networks (p-values ranging from 10
-12 
to 10
-52
) (Additional File 3). These 25 
networks consist of 838 total proteins, 458 of which are encoded by differentially expressed 
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genes following PCA pollutant exposure (Additional File 3). Interestingly, a large interacting 
protein network (i.e. interactome) was identified containing 23 of the 25 networks modulated 
by PCA pollutants (p-value < 10
-12
). This interactome illustrates multiple networks 
associated with air pollution interacting together (Figure 4B). Within this interactome, a 
highly significant (p-value < 10
-52
) smaller network was identified (Figure 4C) containing 
proteins related to cancer, inflammation, and respiratory disease. Another network identified 
within the interactome shows a significant enrichment of proteins involved in inflammation 
linked to IL-8 and activator protein-1 (AP-1) signaling (p-value < 10
-27
) (Figure 4D). This 
network also contains proteins related to cancer, inflammation, and respiratory disease. 
 
To identify biological processes that may be influenced upon exposure to air pollutant 
mixtures, the constructed networks were queried for biological processes and disease 
signatures (see Materials and Methods). The network associated with primary pollutant 
exposure showed significant association with one disease signature, which was cancer (p-
value = 3 x 10
-6
) (Figure 5). PCA pollutant exposure, on the other hand, modified the 
expression of genes with protein products significantly (p-value < 3.0 x 10
-6
) associated with 
ten different biological processes (Figure 5). These biological processes and signatures 
included cancer (p-value < 1.9 x 10
-12
) and cellular growth and proliferation (p-value < 4.2 x 
10
-7
). 
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Figure 4: Molecular networks modulated by exposure to air pollution. Protein networks display (A) the 
network identified as associated with primary pollutant mixture exposure. A large interactome (B) displays 
multiple interacting networks associated with PCA pollutant exposure. Smaller, more focused networks of this 
interactome are shown for (C) a highly significant network, and (D) a significant network showing possible 
inflammatory response through IL-8 and AP-1 signaling. P-values are shown in the top right corners of each 
network. Networks are displayed with symbols representing protein products of genes that are up-regulated (red 
symbols), down-regulated (green symbols), or associated with the differentially expressed genes (clear 
symbols). 
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1.3.5 Predicted Transcription Factors 
Transcription factor binding site analysis was performed to predict regulatory mechanisms 
that potentially underlie the gene expression modifications associated with the air pollution 
exposures (see Materials and Methods). For the primary pollutant mixture, analysis of the 
promoter regions of the 19 differentially expressed genes identified significant (p-value < 
0.05) enrichment for binding sites of 17 transcription factors (Additional File 4). In the PCA 
pollutant mixture gene set, 53 total transcription factors with significantly (p-value < 0.05) 
enriched binding sites were predicted (Additional File 4). Comparison of the transcription 
factors predicted to control the responses to primary and PCA pollutant exposure revealed six 
common, overlapping transcription factors predicted to regulate pathway response to both 
exposure conditions (Table 2). All six of these transcription factors were associated with 
genes down-regulated by air pollutant exposure. The transcription factors with the most 
significant p-values, averaged across both exposure results, are hepatocyte nuclear factor 1 
(HNF-1) (p-value = 0.003), nuclear transcription factor Y (NF-Y) (p-value = 0.005), and 
POU class 2 homeobox 1 (Oct-1) (p-value = 0.014). Networked genes associated with air 
pollution exposure that were identified as predicted targets of the these three transcription 
factors are shown in Figure 4, and all predicted targets are detailed in Additional File 4. 
Figure 5: Biological functions significantly associated with primary 
and PCA pollutant exposure. 
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Table 2: Transcription factors predicted to regulate genes modified by exposure to primary pollutants 
and genes modified by exposure to photochemically altered pollutant mixtures. 
Transcription Factor TRANSFAC Accession 
Number 
Average p-value 
HNF-1 M00132 0.003 
NF-Y M00287 0.005 
Oct-1 M00137 0.014 
GATA-1 M00127 0.017 
FOXO4 M00472 0.022 
Evi-1 M00078 0.039 
 
 
1.3.6 Inflammatory Cytokine IL-8 Release 
After exposure to the gaseous pollutant mixtures, the release of inflammatory response 
protein interleukin-8 (IL-8) was assessed in human lung cells (see Materials and Methods). 
Analysis revealed that lung cells exposed to primary pollutants released an insignificant (p-
value = 0.50) change in IL-8 levels, with an average fold increase of 1.14 compared to 
unexposed cells. Cells exposed to PCA pollutants showed a significant (p-value < 0.001) 
increase in IL-8 levels, with an average fold increase of 3.79 (Figure 6). 
Figure 6: Levels of interkeukin-8 (IL-8) release. Levels of IL-8 are 
shown for cells exposed to either primary or photochemically altered 
(PCA) pollutant mixtures relative to unexposed (control) cells. 
Results are displayed as fold increase over control +/- S.E.M. The star 
symbol (*) indicates statistical significance (p-value < 0.05). 
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1.3.7 Validation of Expression Changes through qRT-PCR 
Quantitative real-time RT-PCR (qRT-PCR) was used to validate the expression levels of 
three genes across both exposures. From microarray analysis, GFPT2 and OAS1 were 
significantly up-regulated in expression, while ATP8B1 was significantly down-regulated due 
to both primary and PCA pollutant exposures (Table 1). PCR analysis confirmed significant 
(p-value < 0.05) up-regulation due to air pollutant exposure in GFPT2 (Fold Change (FC) 
1.85 primary pollutants, FC 4.52 PCA pollutants) and OAS1 (FC 1.95 primary, FC 3.54 
PCA) (Figure 7). PCR analysis also confirmed significant (p-value < 0.05) down-regulation 
of ATP8B1 (FC -1.46 primary, FC -3.12 PCA). Furthermore, PCR analysis confirmed that 
these genes show higher magnitudes of expression fold changes after exposure to PCA 
pollutants in comparison to primary pollutants (Figure 7). 
 
 
 
 
  
Figure 7: Quantitative real-time PCR results. Results are 
displayed as fold change in transcript level +/- S.E.M. The star 
symbol (*) indicates statistical significance (p-value < 0.05). 
17 
 
1.4 DISCUSSION 
 
In this study, we compared the genome-wide response of human lung epithelial cells exposed 
to either primary air pollutant mixtures or PCA pollutant mixtures. The primary pollutant 
mixture includes compounds humans inhale during the morning, while the PCA pollutant 
mixture contains compounds humans are exposed to during the afternoon in outdoor urban 
environments (Jeffries and Sexton, 1995;  Sexton, et al., 2004). This study simulates real-life 
conditions using an in vitro exposure system that physically mimics in vivo human lung gas 
exposures (Bakand et al., 2005). Furthermore, chemical component analysis verifies that the 
pollution chemistry analyzed within the outdoor environmental irradiation chamber is similar 
to urban air photochemistry and exposure conditions for humans living in cities (Jeffries and 
Sexton, 1995). More specifically, primary air pollutants, including oxides of nitrogen (NOx) 
and multiple volatile organic compounds (VOCs), showed decreasing concentrations 
throughout the experiment day. At the same time, chemical reactions between NOx, VOCs, 
and sunlight generated secondary products, including ozone, formaldehyde, and peroxyacetyl 
nitrate.  
 
We find through microarray analysis that exposure to primary pollutants alters the expression 
of only 19 genes, while exposure to PCA pollutants significantly alters the expression of 709 
genes. While there was differential cell survival between the two exposures, the changes in 
gene expression are unlikely to be the result of cytotoxicity (Jelinsky et al., 2000). Further 
validating this claim, a study using human lung A549 cells shows that the difference in the 
number of genes differentially expressed upon exposure to air mixtures, at varying dilutions, 
is not proportional to changes in cell viability (Tsukue et al., 2010). 
 
To identify molecular pathways that may be influenced by exposure to air pollutants, the 
differentially expressed genes were integrated with their protein products and queried for 
known interactions to construct associated molecular networks. Again, a significant 
difference was seen between the number of altered networks associated with primary and 
PCA pollutant exposure. Specifically, exposure to the primary pollutant mixture was 
associated with the modulation of one molecular network, whereas PCA pollutant exposure 
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resulted in the modification of a massive interactome containing multiple overlapping 
networks. Altogether, 25 networks were identified as associated with PCA pollutant 
exposure. These results suggest that exposure to secondary products created through 
photochemical reactions involving VOCs and NOx induce more substantial changes in lung 
cell signaling than primary emitted air pollutants. 
 
As revealed through network analysis, genes associated with inflammatory response 
pathways showed modulation in human lung cells exposed to air pollution. For example, 
CCL2, IL-8, and AP-1 expression levels were all increased, illustrating potential increases in 
molecular signaling within their associated pathways. Interestingly, CCL2 gene products can 
signal for the accumulation of monocytes and dendritic cells, which promote the build-up of 
inflammatory microenvironments that can lead to possible tumor progression (Mantovani et 
al., 2008). To note, increased IL-8 expression is a biomarker of air pollutant-induced lung 
inflammation (Damera, et al., 2009;  Jaspers, et al., 1997). Here the up-regulation of IL-8 
was verified at the protein level, where IL-8 protein abundance also showed significantly 
increased levels due to PCA exposure. A similar study also shows increased IL-8 levels in 
lung cells exposed to air pollutants undergoing chemical reactions under sunlight (Sexton, et 
al., 2004). AP-1 is shown through network analysis as possibly regulating the altered IL-8 
inflammatory response pathway. This finding coincides with a previous study showing that 
AP-1 activation increases IL-8 transcription in human A549 lung epithelial cells (Adam et 
al., 2006). Furthermore, ozone, one of the secondary products within the PCA pollutant 
mixture, has been shown to activate AP-1 in A549 lung cells, which potentially regulates 
ozone-induced IL-8 release (Jaspers, et al., 1997). From our results, we show that air 
pollution exposures, such as those in urban environments, may influence lung cell function 
by altering the levels of gene transcripts and proteins associated with inflammatory response 
pathways. 
 
Using a biological process enrichment analysis, the networks identified as modulated by air 
pollutant exposure were queried for known involvement with biological processes and 
disease signatures. Here, the primary pollutant exposure modified the expression levels of 
genes that encode protein products significantly related to one function, cancer. On the other 
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hand, exposure to PCA pollutants significantly modified the expression levels of genes that 
encode protein products associated with a large number of biological processes. Specifically, 
ten biological processes were identified as modified in lung cells exposed to PCA pollutants. 
These processes include cancer and cellular growth/ profileration. The increased number of 
biological processes affected by PCA pollutants further confirms our finding that PCA 
pollutants induce a more robust response in gene expression patterns and their associated 
biological functions than primary pollutants. 
 
In order to analyze potential regulatory mechanisms underlying changes in gene expression 
resulting from air pollutant exposures, putative mediating transcription factors were 
computationally predicted. Six common transcription factors were identified as potential 
regulators of the observed gene expression changes in response to both primary and PCA 
pollutant mixture exposures. These transcription factors include Oct-1, FOXO4, and HNF-1, 
which were all predicted to regulate genes with decreased expression after exposure. Oct-1 is 
a transcription factor associated with cancer malignancy, and loss of Oct-1 can cause cells to 
become hypersensitive to genotoxic and oxidative stress agents (Kang et al., 2009). Another 
transcription factor, FOXO4, is related to tumorigenesis with a role in apoptosis (Myatt and 
Lam, 2007). The most significant of these six transcription factors, HNF-1, has been 
primarily studies for mutations which are linked to diabetes susceptibility (Ellard and 
Colclough, 2006), hepatocellular carinoma (Bluteau et al., 2002), and inflammatory 
pathways underlying coronary heart disease (Armendariz and Krauss, 2009). HNF-1 is also 
known to control HNF-4α transcription (Hatzis and Talianidis, 2001). HNF-4α is one of the 
highlighted molecules present in the networks constructed using the proteins encoded by 
genes with altered expression in primary and PCA pollutant-exposed lung cells. This finding 
connects our transcription factor binding site analysis with the network analysis. 
Interestingly, there is limited knowledge on how HNF-1 is specifically involved in lung cell 
function. With our results, we show that promoter sites of genes associated with air pollutant 
exposures are potentially enriched for transcription factors involved in cell cycle regulation, 
cancer, and cellular stress. 
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Two exposure atmospheres were used in our study, where each atmosphere contained a very 
large number of chemical compounds. When inhaled, these compounds are known to 
influence lung function (e.g. ozone) (EPA, 2006) and cause cancer (e.g. benzene, 
formaldehyde, 1,3-butadiene) (IARC, 2010). Due to the complexity of our exposure 
atmospheres, it is difficult to extrapolate which chemicals within the air mixtures are 
contributing the most to the observed changes in gene expression and molecular pathways. 
Future research will investigate the effects of individual air pollutants on lung cells, and 
compare these responses against air mixtures.  
 
 
1.5 CONCLUSION 
 
In conclusion, our study reveals potential mechanisms that may underlie health effects 
induced by primary emitted air pollutants and PCA pollutant mixtures. In this genome-wide 
comparison study, we find there is a significantly more robust response in lung cells exposed 
to PCA pollutants in comparison to primary pollutants. Specifically, there were 37-fold more 
genes dysregulated by exposure to PCA pollutants. Mapping the genes affected by pollutant 
exposure to their encoded protein products and analyzing their biological functions reveals 
the association of air pollution exposure to cellular stress, inflammation, and cancer pathways 
in human lung cells. Future research will investigate the differences between lung cell 
response to air pollutant mixtures and individual components within air mixtures. 
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CHAPTER 2 
Epigenetic Changes Induced by Air Toxics: Formaldehyde Exposure 
Alters miRNA Expression Profiles in Human Lung Cells 
ABSTRACT 
Background: Exposure to formaldehyde, a known air toxic, is associated with cancer and 
lung disease. Despite its adverse health effects, the mechanisms underlying formaldehyde-
induced disease remain largely unknown. Research investigations have uncovered 
microRNAs (miRNAs) as key post-transcriptional regulators of gene expression that may 
influence cellular disease state. While studies have compared different miRNA expression 
patterns between diseased and healthy tissue, this is the first study to examine perturbations 
in global miRNA levels resulting from formaldehyde exposure. 
 
Objectives: We set out to investigate whether cellular miRNA expression profiles are 
modified by formaldehyde exposure in human lung cells. We hypothesized that 
formaldehyde exposure disrupts miRNA expression levels within lung cells, representing  a 
novel epigenetic mechanism through which formaldehyde may induce disease. 
 
Methods: Human lung cells were grown at air-liquid interface and exposed to gaseous 
formaldehyde at 1 ppm for 4 hours. Small RNAs and protein were collected and analyzed for 
miRNA expression using microarray analysis or IL-8 protein levels by ELISA, respectively. 
 
Results: Gaseous formaldehyde exposure altered the miRNA expression profiles in human 
lung cells. Specifically, 89 miRNAs were significantly down-regulated in formaldehyde 
exposed samples versus controls. Functional and molecular network analysis of the predicted 
miRNA transcript targets revealed that formaldehyde exposure potentially alters signaling 
pathways associated with cancer, inflammatory response, and endocrine system regulation. 
IL-8 release was increased in cells exposed to formaldehyde, and results were confirmed  by 
Real Time PCR. 
 
Conclusions: Formaldehyde alters miRNA patterns which regulate gene expression, 
potentially leading to the initiation of a variety of diseases.
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2.1 INTRODUCTION 
 
Current indoor and outdoor air quality contributes significantly to global increases in 
morbidity and mortality (Brunekreef and Holgate, 2002;  Burnett, et al., 2001;  Smith and 
Mehta, 2003). Epidemiological studies have shown that formaldehyde, a known air toxic, 
causes increased risk of childhood and adult asthma (Rumchev et al., 2002;  Wieslander et 
al., 1997), acute respiratory tract illness (Smith et al., 2000;  Tuthill, 1984), nasopharyngeal 
cancer (Vaughan et al., 2000), and possibly leukemia (Zhang et al., 2009). In animal studies, 
strong links have been made between formaldehyde exposure and nasal carcinoma (Kerns et 
al., 1983). Furthermore, the International Agency for Research on Cancer (IARC) has 
classified formaldehyde as a known human carcinogen (IARC, 2006). 
 
2.1.1 Formaldehyde Exposure Sources 
In outdoor environments, formaldehyde is present due to direct emissions from 
anthropogenic and biogenic sources, and is also formed as a secondary chemical product 
through hydrocarbon atmospheric chemistry (WHO, 2001). Anthropogenic sources of 
formaldehyde include automobile exhaust, power plants, manufacturing facilities, and 
incinerators (EPA, 2007;  WHO, 2001). Ambient air is estimated to contain formaldehyde at 
levels between 0.0008 and 0.02 ppm
 
(WHO, 2001). Higher formaldehyde exposure occurs 
within indoor environments, where humans inhale levels estimated between 0.02 and 0.3 
ppm, depending on the presence of tobacco smoke (WHO, 2001). The highest formaldehyde 
levels are found in certain occupational environments, such as industries related to resin, 
plastics, wood, paper, insulation, textile, and chemical productions, as well as medical 
institutions using disinfectants and embalming products. In these high exposure cases, 
occupational workers are exposed to, on average, approximately 0.74 ppm (WHO, 2001).  
 
2.1.2 Formaldehyde Dosimetry 
As formaldehyde is highly reactive and water soluble, more than 95% of inhaled 
formaldehyde is predicted to be absorbed within the human respiratory tract (Overton et al., 
2001). While most inhaled formaldehyde is absorbed in the nasal and upper airways 
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(Overton, et al., 2001), much remains uncertain about the dosimetry and mechanisms 
underlying pulmonary responses to formaldehyde (Thompson et al., 2008). As a result, it is 
important to study the effects of gas exposure to the lower respiratory region. This has been 
studied recently where the effects of formaldehyde exposure on the DNA-damage protection 
of human A549 alveolar epithelial cells were established (Speit et al., 2010). 
 
2.1.3 Gene-Transcript Regulation through miRNAs 
Previous research has shown that altered gene expression patterns exist in nasal and lung 
cells exposed to formaldehyde (Kim et al., 2002;  Li et al., 2007). These changes in gene 
transcript profiles, which likely translate to changes in protein levels, could arise from altered 
microRNA expression. MicroRNAs (miRNAs) are an abundant class of regulatory molecules 
that have received scientific attention for their ability to alter mRNA abundance. miRNAs are 
non-coding single stranded RNA molecules approximately 22 nucleotides in length (Bartel, 
2004). One of the more established functions of miRNAs is translational inhibition of target 
messenger RNA (mRNA) molecules. Translational inhibition occurs when miRNAs base 
pair with 3’-untranslated regions (UTRs) of mRNAs causing decreases in protein production 
(Filipowicz et al., 2008). Once paired with mRNAs, miRNAs can destabilize mRNAs and 
target their degradation through deadenylation (Filipowicz, et al., 2008;  O'Hara et al., 2009). 
The study of the dysregulation and modification of miRNA abundance has revealed 
miRNAs’ important roles in many diseases, including heart failure, hematological 
malignancies, and neurodegenerative disease (Divakaran and Mann, 2008;  Fabbri et al., 
2008;  Hébert and De Strooper, 2009). In addition, studies have shown that miRNA 
expression profiling in tumor cells can aid in classifying cancer type, cancer state, and 
cellular response to treatment (Calin and Croce, 2006;  Lu et al., 2005;  Ma et al., 2007).  
 
Mammalian miRNAs are estimated to regulate 30% of all protein-coding genes through post-
transcriptional modification (Filipowicz, et al., 2008). Because miRNAs play such a pivotal 
role in human cellular gene regulation, more research is needed to understand the effects of 
environmental exposures on miRNA levels. To our knowledge, only one other study has 
investigated the effects of environmental air pollution on cellular miRNA abundance. In that 
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study, diesel exhaust particles were shown to affect miRNA expression related to 
inflammatory response pathways and tumorigenesis (Jardim et al., 2009). 
 
2.1.4 Study Objectives 
In this study, we hypothesized that formaldehyde exposure can disrupt miRNA levels within 
lung cells. We tested this hypothesis by exposing human lung epithelial cells to 
formaldehyde using a direct air-liquid interface that physically mimics the human respiratory 
tract. Using microarray analysis, we assessed the expression levels of more than 500 known 
miRNAs. We demonstrate that formaldehyde significantly alters the expression profiles of 89 
miRNAs which are predicted to target mRNAs associated with numerous biological 
pathways related to cancer, inflammatory response, and endocrine system regulation. 
Confirming one of the most dysregulated inflammation-associated pathways, IL-8 showed 
significantly increased protein expression levels in formaldehyde exposed cells. Taken 
together, this research suggests a novel epigenetic mechanism by which formaldehyde may 
induce disease. 
 
 
 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Cell Culture 
Human A549 type II lung epithelial cells derived from a human lung adenocarcinoma were 
cultured according to standard protocol (ATCC). Cells were grown in growth media 
containing F-12K plus 10% FBS plus 1% penicillin and streptomycin. Cells were plated onto 
24 mm diameter collagen-coated membranes with 0.4 μM pores (Trans-CLR; Costar, 
Cambridge, MA). Upon confluence, cells were cultured in phenol red-free F-12K nutrient 
mixture without FBS. Immediately prior to exposure, media above each membrane was 
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aspirated in order to create direct air-liquid interface culture conditions. The media beneath 
each membrane remained to supply nourishment for cells throughout the exposure. 
 
2.2.2 Formaldehyde Treatment 
Gaseous formaldehyde was generated by heating 143 mg paraformaldehyde (Aldrich 
Chemical Company, Inc., Milwaukee Wi, lot no. 05910EI) in an air-flushed “U-tube” until 
the powder was completely vaporized within a dark un-irradiated 120 m
3
 environmental 
chamber. The walls of the chamber are made of chemically non-reactive film, as detailed 
previously (Sexton, et al., 2004). The chamber was naturally humidified from pre-flushing 
with HEPA filtered ambient air during cloudy conditions. This resulted in a formaldehyde 
concentration of 1 ppm (1.2 mg/m
3
) which was then drawn through a cellular exposure 
chamber (Billups-Rothenberg, Modular Incubator Chamber, Del Mar, CA) at 1.0 L/min. The 
exposure chamber was positioned within an incubator where CO2 was added to the 
formaldehyde exposure source stream at 0.05 L/min and a small water dish provided proper 
humidification. Prepared lung cells were exposed to 1 ppm formaldehyde for 4 hours, while 
mock-treated control cells were exposed to humidified air under similar conditions. 
Experiments were carried out with six technical replicates for each exposure condition, 
generating a total of 12 samples. After nine hours, cells were scraped and stored at -80°C in 
TRIzol
®
 Reagent (Invitrogen Life Technologies), and basolateral supernatants were aspirated 
and stored at -80°C.  
 
2.2.3 Cytotoxicity Analysis 
To measure formaldehyde exposure’s cytotoxicity, the enzyme lactate dehydrogenase (LDH) 
was measured within the supernatant of each sample. Measurements were acquired using a 
coupled enzymatic assay (Takara), according to the supplier’s instructions (Takara Bio Inc., 
Japan). LDH fold increase was calculated as μLDH, FE / μLDH C, where μ represents the mean 
LDH activity, FE represents formaldehyde exposed samples, and C represents controls. 
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2.2.4 Microarray Processing 
RNA molecules of at least 18 nucleotides in length were isolated using Qiagen’s miRNeasy® 
Kit according to the manufacturer’s protocol (Qiagen, Valencia CA). RNA was quantified 
with the NanoDrop™ 1000 Spectrophotometer (Thermo Scientific, Waltham MA) and its 
integrity was verified with an Agilent Technologies 2100 Bioanalyzer (Santa Clara, CA). 
RNA was labeled and hybridized to the human miRNA microarray (version 1) manufactured 
by Agilent Technologies (Santa Clara, CA). This microarray measures expression levels of 
534 human miRNAs. Three of the six total samples from each exposure condition, three 
formaldehyde-exposed and three mock-treated samples, were hybridized using 400 ng of 
input RNA per sample. RNA labeling and hybridization were performed according to the 
manufacturer’s protocol, and microarray results were extracted using Agilent Feature 
Extraction Software. Data were submitted to NCBI's Gene Expression Omnibus (GEO) 
database (http://www.ncbi.nlm.nih.gov/geo/) and are available under accession #GSE22365 
(Edgar, et al., 2002).  
 
2.2.5 Microarray Analysis 
The resulting expression levels for each of the miRNAs measured by the microarrays were 
calculated and used to filter for miRNAs expressed above a background level (background 
was set at 30, approximating the median signal per array). This resulted in a reduction of 
probesets from 12033 to 4900 records. Differential miRNA expression was defined as a 
significant difference in miRNA expression levels between treated samples and untreated 
samples, where the following three statistical requirements were set: (1) fold change of ≥ 1.5 
or ≤ - 1.5 (treated versus untreated); (2) p-value < 0.005; and (3) false discovery rate (FDR) < 
0.005. P-values and FDRs were generated using the Comparative Marker Selection tool in 
GenePattern (www.broadinstitute.org/cancer/software/genepattern/) (Reich et al., 2006). 
Here, 2000 permutation tests were carried out using the signal-to-noise (SNR) ratio analysis 
and smoothed p-values were determined for each miRNA. SNR is defined by the equation 
SNR = (μA – μB) / (σA + σB), where μ represents average sample intensity and σ represents 
standard deviation (Golub et al., 1999). SNRs have been shown to provide one of the most 
accurate classification prediction methods (Cho and Ryu, 2002). False discovery rates 
(FDRs) were calculated as the expected fraction of false positives among probesets reported 
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as significant using the Benjamini and Hochberg procedure (Benjamini and Hochberg, 1995). 
Targets for the most differentially expressed miRNAs were identified using miRDB 
(www.mirdb.org) (Wang, 2008;  Wang and El Naqa, 2008) where targets with a score of >70 
were investigated. 
 
2.2.6 Enriched Biological Functions and Network Analysis 
Enriched biological functions and molecular network analyses were performed using the 
Ingenuity database (Ingenuity Systems, www.ingenuity.com, Redwood City, CA). The 
Ingenuity database provides a collection of gene to phenotype associations, molecular 
interactions, regulatory events, and chemical knowledge accumulated to develop a global 
molecular network. The lists of putative targets for each miRNA were overlaid onto this 
global molecular network, where protein networks significantly associated with the targets 
were algorithmically constructed based on connectivity. Associated enriched canonical 
pathways within these networks were also identified. Functional analysis was carried out to 
identify biological functions and disease signatures most significantly associated with the 
input targets. Statistical significance of each biological function or disease was calculated 
using a Fischer’s exact test. This test generated a p-value signifying the probability that each 
function or disease was associated with the miRNA targets by chance alone. Only enriched 
functions with p-values < 0.005 were assessed. 
 
2.2.7 Quantitative RT-PCR Verification of miRNA Expression 
Expression levels of the five most significantly modified miRNAs were also tested using 
quantitative real-time PCR. The TaqMan® MicroRNA Primer Assays for hsa-miR-33 (ID 
002135), hsa-miR-450 (ID 2303), hsa-miR-330 (ID 000544), hsa-miR-181a (ID 000516), 
and hsa-miR-10b (ID 002218) were used in conjunction with the TaqMan® Small RNA 
Assays PCR kit (Applied Biosystems). The Bio-Rad MyCycler Thermal Cyler was used for 
the reverse transcription step, and the Roche Lightcycler 480 was used for the real-time step. 
The same three control and three formaldehyde exposed samples from the microarray were 
used for qRT-PCR, which was performed in technical duplicate. Statistical significance was 
evaluated using a t-test. 
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2.2.8 Interleukin-8 Measurement 
The protein abundance of the cytokine interleukin-8 (IL-8) was measured using the 
basolateral supernatant from all 12 samples. A BD OptEIA
TM
 human IL-8 enzyme-linked 
immunosorbent assay (ELISA) was performed and analyzed according to the manufacturers’ 
protocol (BD Biosciences, San Jose, California). Experiments were carried out with 12 
technical replicates for each exposure condition. Scanned absorbance reading outliers were 
identified through the Grubbs’ test (www.graphpad.com) where outliers were identified as 
those with less than a 5% probability of occurring as an outlier by chance alone, as based off 
a normal distribution (Grubbs, 1969). IL-8 fold increase was calculated as μIL-8 FE / μIL-8 C, 
where μ represents the mean, FE represents formaldehyde exposed samples, and C represents 
controls. Statistical significance of the treated versus untreated IL-8 levels was calculated 
using a t-test with Welch’s correction. 
 
 
 
 
2.3 RESULTS 
 
2.3.1 Formaldehyde Exposure Modulates miRNAs in Human Lung Cells  
In this study, we set out to identify whether formaldehyde exposure alters the expression 
levels of miRNAs in lung cells. Human lung epithelial cells (A549) were exposed to gaseous 
formaldehyde drawn directly from an un-irradiated (dark) environmental chamber into an 
exposure chamber or were mock-treated (see Materials and Methods). This exposure resulted 
in a 6.68 fold increase in LDH release in the formaldehyde treated cells. After exposure, 
small RNAs were collected and their relative abundance measured using microarrays. A total 
of 343 unique miRNAs were detectable above background in these cells. The 343 miRNAs 
were further assessed for formaldehyde-induced changes in expression level (see Materials 
and Methods). A total of 89 miRNAs showed a significant decrease in expression in the 
formaldehyde exposed lung samples compared to control samples (Figure 8, Additional File 
5). There were no miRNAs identified with significantly increased expression levels in 
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response to formaldehyde. The five most significantly differentially expressed miRNAs, as 
determined through microarray analysis, were miR-33 (FC -5.48), miR-450 (FC -3.57), miR-
330 (FC -2.43), miR-181a (FC -2.11), and miR-10b (FC -2.11). 
 
 
Figure 8: Heat map of 89 formaldehyde-modulated miRNAs. Data were mean standardized and hierarchical 
clustering was performed. Blue indicates relative low expression while red indicates relative high expression. 
Formaldehyde-treated samples are abbreviated as FA.  
 
 
2.3.2 MicroRNA Expression Changes are Validated through qRT-PCR 
Quantitative real-time RT-PCR was used to confirm the findings of the array-based results. 
The qRT-PCR validated the findings of the decreased miRNA expression induced by 
formaldehyde exposure. Specifically, miR-330 showed a fold change (FC) of -1.32, and miR-
Control 1 Control 2 Control 3 FA 1 FA 2 FA 3
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181a showed a FC of -7.39 (Figure 9). Likewise, miR-33 displayed a FC of -1.2 and miR-10b 
displayed a FC of -1.48. miR-450 showed minimal expression changes with a FC of -1.04. 
Because it could not be validated, further analysis on miR-450 was not performed. To assess 
the similarity of the array-based quantification of the miRNA expression changes and the 
qRT-PCR, the relative miRNA abundances were compared against the raw microarray 
expression data. This analysis shows a high correlation (0.8) between miRNA abundance 
measured with both qRT-PCR and microarray (Figure 9). More specifically, these analyses 
support that the direction of differential expression of the miRNAs induced by exposure to 
formaldehyde was consistent between the qRT-PCR and microarray analyses. It is important 
to note, however, that there is a difference in the magnitude of expression change with the 
microarray results generally greater than those obtained with the qRT-PCR.  
 
 
Figure 9: Comparison of Microarray and qRT-PCR Results. miRNA microarray results (A) are displayed 
as miRNA abundance obtained from raw microarray data. miRNA qRT-PCR results (B) are displayed in terms 
of miRNA abundance relative to 40, the maximum cycle threshold. Star symbols represent significance, where 
one star represents p-value < 0.1, and two stars represent p-value < 0.05. Each column represents either control 
samples (CT) or treated samples (Trt). Average fold changes (FC) are shown, and error bars represent S.E.M. 
Correlation (C) between miRNA abundance measured by microarrays and RT-PCR is illustrated. 
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2.3.3 miRNA Targets are Integrated into Biological Networks 
In order to identify potential biological pathways affected by formaldehyde exposure, the 89 
miRNAs that showed significant changes in expression levels were ranked according to their 
fold-changes, p-values, and qRT-PCR results (Additional File 5). Here, the four miRNAs 
with the most significant formaldehyde-induced changes in expression were further 
investigated: miR-33, miR-330, miR-181a, and miR-10b. For each of these four miRNAs, we 
identified their putative mRNA targets (see Materials and Methods). Using a stringent cutoff 
of a match score between each miRNA and its mRNA targets followed by analysis for 
unique mRNAs per target list (see Materials and Methods), we identified a total of 67 targets 
of miR-33, 217 targets of miR-330, 334 targets of miR-181a, and 25 targets of miR-10b 
(Additional File 6). Among this list of 647 mRNAs, there are 42 that are common to at least 
two of the modulated miRNAs (Additional File 6). 
 
Once the predicted mRNA targets were identified for the most significant miRNAs, they 
were overlaid onto molecular pathway maps enabled through the Ingenuity Pathways’ 
Knowledge Base (see Materials and Methods). Networks containing miRNA targets were 
algorithmically constructed based on connectivity and the known relationships among 
proteins. The predicted targets of the four modulated miRNAs (miR-33, miR-330, miR-181a, 
and miR-10b) resulted in the generation of a total of 40 networks (  
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Additional File 7). For each of the miRNA gene targets, the most significant (p-values range 
from 10
-23
 to 10
-43
) network has been highlighted for further evaluation (Figure 10). The 
proteins identified within these networks were queried for their enrichment for various 
canonical pathways (see Materials and Methods). A comparison of the canonical pathways 
highlighted the conservation of a cancer-associated pathway common to all four miRNA-
generated networks (Additional File 8). Overlaying the pathway information onto the most 
significant networks resulted in the identification of enrichment for the nuclear factor kappa 
beta (NFκB) pathway and the interleukin-8 (IL-8) signaling pathway, among others (Figure 
10, Additional File 8). 
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Figure 10: Most significant molecular networks of modulated miRNAs affected by formaldehyde 
exposure. Protein networks display interactions using the mRNA targets of (A) miR-33, (B) miR-330, (C)  
miR-181a, and (D) miR-10b. P-values representing the probability of these interactions occurring by chance are 
shown in the top right corners of each network. Networks are displayed with symbols representing predicted 
miRNA targets (red symbols) or proteins associated with the predicted targets (clear symbols). 
 
Using a biological process enrichment analysis, the 40 networks encoded by the mRNA 
targets for each miRNA were queried for biological processes that were most significantly 
modulated by formaldehyde exposure. A total of 71 unique biological processes were found 
(Additional File 9). Across the mRNA targets, common enrichment was found for 13 
different cellular biological processes. These processes included inflammatory response (p-
value < 0.0029) and endocrine system development/function (p-value < 0.0018) which were 
enriched within the targets of all four miRNAs (Table 3). 
 
 
Table 3: Biological functions significantly associated with all predicted target sets of miR-33, miR-330, 
miR-181a, and miR-10b. 
Enriched Functions Average p-value 
Cellular Development 0.0011 
Small Molecule Biochemistry 0.0015 
Nervous System Development and Function 0.0016 
Cell-To-Cell Signaling and Interaction 0.0017 
Cell Morphology 0.0017 
Tissue Development 0.0017 
Cellular Function and Maintenance 0.0017 
Cellular Movement 0.0017 
Endocrine System Development and Function 0.0018 
Gene Expression 0.0018 
Cellular Growth and Proliferation 0.0021 
Inflammatory Response 0.0029 
Hematological System Development and Function 0.0033 
 
 
2.3.4 Conservation of Predicted and Observed mRNA Targets 
In our analysis, we used a stringent computational metric to match miRNAs to their predicted 
mRNA targets to better understand the biological implications of formaldehyde exposure. As 
34 
 
these mRNA targets were computationally predicted, we also compared our results with 
those of an existing genomic database established from a study that analyzed human tracheal 
fibroblast cells exposed to formaldehyde (Li, et al., 2007). In this comparison, we found 
overlap between the predicted mRNA targets of the formaldehyde-modulated miRNAs and 
the tested formaldehyde-responsive genes identified (Li, et al., 2007). Specifically, brain-
derived neurotrophic factor (BDNF), bone morphogenetic protein receptor, type II 
(serine/threonine kinase) (BMPR2), calcium channel voltage-dependent L type, alpha 1C 
subunit (CACNA1C), casein kinase 1 delta (CSNK1D), high mobility group AT-hook 2 
(HMGA2), heat shock transcription factor 2 (HSF2), heat shock 105kDa/110kDa protein 1 
(HSPH1), and Pim-1 oncogene (PIM1), are found within the four most significant networks 
associated with the identified miRNA targets (Figure 10). 
 
We expanded our comparison by performing network analysis on the formaldehyde-
associated genes identified by Li et. al (2007). Here, networks were constructed and related 
biological functions were identified, as done with the miRNA predicted target network 
analysis (see Materials and Methods). Networks related to cancer (p-value = 1.9 x 10
-19
), 
inflammation (p-value = 1.1 x 10
-8
), and endocrine system disorders (p-value = 3.15 x 10
-4
) 
were generated (Additional File 10). 
 
2.3.5 Inflammatory Cytokine IL-8 is Released in Response to Formaldehyde 
Based on our findings from the canonical pathway and biological process enrichment 
analyses that showed the IL-8 pathway as potentially dysregulated by formaldehyde 
exposure, we set out to confirm whether IL-8 protein levels may be influenced by such 
exposure. After cells were exposed to formaldehyde, IL-8 protein release was assessed (see 
Materials and Methods). The investigation of the inflammatory response protein interleukin-
8 (IL-8) showed that human lung cells activate an inflammatory response after exposure to 
formaldehyde. Specifically, an average 16.9 fold increase (p-value < 0.05) in cytokine release 
was observed in formaldehyde exposed cells relative to control samples (Figure 11). 
 
35 
 
 
Figure 11: Interleukin-8 levels in formaldehyde-treated samples compared to untreated samples. Results 
are displayed as fold increase over control +/- S.E.M. The star symbol (*) indicates statistical significance 
compared to the control (p-value < 0.05). 
 
2.4 DISCUSSION 
 
In this study, we exposed human A549 lung epithelial cells to formaldehyde using an in vitro 
exposure system that physically replicates in vivo human lung gas exposures (Bakand, et al., 
2005). A549 cells are routinely used to study the effects of environmental air exposures 
(Jaspers, et al., 1997;  Sexton, et al., 2004;  Speit, et al., 2010), and they have been proposed 
as a standardized model to study the lung epithelium (Foster et al., 1998). Moreover, when 
exposed to gases at an air-liquid interface, A549 cells secrete enough surfactant to mimic 
airway surface tension (Blank et al., 2006).  
 
Our microarray analysis revealed that formaldehyde exposure resulted in the down-regulation 
of 89 miRNAs. It was interesting that all of the modulated miRNAs were down-regulated by 
formaldehyde exposure. This general trend of miRNA down-regulation has been observed in 
rat lung cells exposed to cigarette smoke (Izzotti et al., 2009), as well as in multiple tumor 
cell types, including lung cancer, breast cancer, and leukemia (Lu, et al., 2005) 
 
We focused a detailed analysis on the four most significantly down-regulated miRNAs, as 
determined through microarray analysis and qRT-PCR: miR-33, miR-330, miR-181a, and 
miR-10b. These miRNAs have been studied, to some extent, and knowledge about their 
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regulation and association to disease is growing. For example, miR-33 shows decreased 
expression levels in tissues from patients with lung carcinomas (Yanaihara et al., 2006). 
Also, miR-330 expression levels have been measured at significantly lower levels in human 
prostate cancer cells when compared against nontumorigenic prostate cells (Lee et al., 2009). 
Furthermore, miR-330 has been suggested to act as a tumor suppressor by regulating 
apoptosis of cancer cells (Lee, et al., 2009). In addition, miR-10b shows altered expression 
levels within breast cancer tissue, and is one of the most consistently dysregulated miRNAs 
able to predict tumor classification (Iorio et al., 2005;  Ma, et al., 2007). These findings 
suggest that miR-33, miR-330, and miR-10b may influence cellular disease state, specifically 
related to cancer.  
 
Formaldehyde exposure also altered the expression level of miR-181a, which has known 
associations with leukemogenesis (Marcucci et al., 2009). The specific link between 
formaldehyde exposure and leukemia is currently debated, as numerous epidemiological 
studies show evidence for possible association to this disease (Pinkerton et al., 2004;  Zhang 
et al., 2010), as well as against it (Bachand et al., 2010;  Marsh and Youk, 2004). However, it 
is important to note that our study evaluates miRNA expression in lung cells, which likely 
differ from leukemia target cells’ responses to formaldehyde exposure, or exposure to 
formaldehyde’s metabolic products. Nevertheless, it is worth highlighting the observation of 
the dysregulation of miR-181a upon exposure to formaldehyde. 
 
To expand our analysis, we used a systems biology approach to understand the potential 
biological implications of the miRNA expression changes induced by acute formaldehyde 
exposure. For this analysis, we used a stringent computational matching approach to identify 
predicted mRNA targets for miR-33, miR-330, miR-181a, and miR-10b. The identified 
mRNA targets were used to construct associated molecular networks and were analyzed for 
their known involvement in signaling pathways and biological functions. The identified 
networks showed enrichment for various canonical pathways including nuclear factor kappa 
beta (NFκB) and interleukin-8 (IL-8) signaling. Although very few predicted targets 
overlapped between the four miRNAs, proteins involved with cancer mechanisms including 
that of the NFκB pathway were found within the miRNA target networks. Importantly, NFκB 
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has clear links to inflammation and cancer development (Karin and Greten, 2005;  Schmid 
and Birbach, 2008). Also related to inflammation, IL-8 signaling was present in the miRNA 
target networks. Previous studies have shown IL-8 release in lungs cells representing 
inflammatory response after exposure to other air pollutants (Jaspers, et al., 1997;  Sexton, et 
al., 2004). In addition, investigations have shown increased IL-8 levels in lungs of patients 
with diseases such as acute lung injury (McClintock et al., 2008), adult respiratory distress 
syndrome (Jorens et al., 1992), and asthma (Bloemen et al., 2007). Inflammation is a 
recognized formaldehyde-induced response, as formaldehyde is known to irritate the 
respiratory system (Smith, et al., 2000) and increase asthmatic response (Rumchev, et al., 
2002;  Wieslander, et al., 1997). Our findings suggest that the canonical pathways associated 
with formaldehyde-induced miRNA profile changes may affect the regulation of biological 
pathways associated with various disease states, including cancer and inflammation. 
 
As a method to further verify our results, we compared the protein levels of cytokine 
interkeukin-8 (IL-8) in formaldehyde-exposed cells versus mock-treated controls. We found 
that, indeed, IL-8 showed significantly increased protein expression levels in the 
formaldehyde-exposed cells. These results support our findings that IL-8 signaling is altered 
in lung cells exposed to formaldehyde. Our network analyses suggest that cytokine signaling 
may be altered through changes in miRNA expression levels. Supporting this is a recent 
study that shows microRNAs can repress inflammatory response signaling by promoting the 
decay of related Interleukin transcripts (Anderson, 2010). Future research will test whether 
miRNA expression changes are directly associated with IL-8 signaling. 
 
In an effort to gain further understanding of formaldehyde’s effects on gene expression, we 
compared our results with those of an existing genomics database (e.g. mRNA) from a study 
that evaluated human lung cells exposed to formaldehyde (Li, et al., 2007). Using the 
predicted targets in our most significant miRNA networks, we found the following genes 
overlap with the existing database: BDNF, BMPR2, CACNA1C, CSNK1D, HMGA2, HSF2, 
HSPH1, and PIM1. These genes have been shown to play a role in various diseases. For 
example, BDNF, or brain-derived neurotrophic factor, modulates neurogenesis after injury to 
the central nervous system (Ming and Song, 2005). CSNK1D, or casein kinase 1 delta, has 
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been identified as up-regulated in breast cancer tissue (Abba et al., 2007). HMGA2, or high 
mobility group AT-hook 2, is oncogenic in many tumor cells, including lung carcinoma cells, 
and is regulated by the tumor-suppressive miRNA let-7 (Lee and Dutta, 2007). Lastly, PIM1, 
or Pim-1 oncogene, is found at increased levels within prostate cancer tissue (Dhanasekaran 
et al., 2001). Network analysis of all formaldehyde-responsive genes identified through the 
Li et. al. (2007) study revealed significant associations with cancer, inflammation, and 
endocrine system regulation, which also overlap with our findings. These genes are therefore 
linked with formaldehyde-induced changes in miRNA abundance as well as mRNA 
alterations, and they are related to a diverse range of cellular responses including 
tumorigenesis. 
2.5 CONCLUSIONS 
 
Our study provides evidence of a potential mechanism that may underlie the cellular effects 
induced by formaldehyde, namely the modification of miRNA expression. We identify a set 
of 89 miRNAs that are dysregulated in human lung cells exposed to formaldehyde. Mapping 
the most significantly changed miRNAs to their predicted mRNA targets and their network 
interactomes within the cell reveals the association of formaldehyde exposure to 
inflammatory response pathways. We also validate our findings by: (1) performing qRT-
PCR; (2) integrating our predicted networks with known formaldehyde-induced mRNA 
expression changes; and (3) examining protein expression changes of a key inflammatory 
response mediator, IL-8. Future research will investigate whether the expression levels of 
these miRNAs may serve as potential biomarkers of formaldehyde exposure in humans. Such 
biomarkers can be utilized to better monitor human exposure to environmental toxicants and 
relate them to health effects. Based on our findings, we believe that miRNAs likely play an 
important role in regulating formaldehyde-induced gene expression and may represent a 
possible link between exposure and disease. 
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3 THESIS CONCLUSION 
 
Together, our two studies reveal novel biological mechanisms that may influence lung cell disease 
state after exposure to common air pollutants. We first investigate gene-transcript responses of lung 
cells exposed to air pollutant mixtures found in urban atmospheres. After discovering that secondary 
pollutants induce a significantly more robust response in lung cells in comparison to primary 
pollutants, we focus on lung cell response to formaldehyde, a common secondary pollutant. Here, we 
identify microRNAs at altered expression levels due to formaldehyde exposure. Mapping these 
miRNAs to their predicted transcript targets and associated pathways reveals networks and biological 
functions possibly affected by the formaldehyde-associated miRNAs. Some pathways identified as 
associated with air pollution exposure confirm findings from previous studies, such as air pollutant-
induced IL-8 release through pathways potentially involving NFκB and AP-1 regulation. Other 
mechanisms are more novel, and have yet to be strongly associated with air pollution effects. These 
proposed mechanisms include, for example, HNF-1 and HNF-4 transcriptional regulation. Both 
studies identify genes that are influenced by air pollution exposure in human lung cells. We propose 
that these genes can potentially be used as biomarkers of air pollutant exposure, upon further 
validation. Such biomarkers can be utilized to effectively monitor human exposure to environmental 
toxicants and link them to health effects. Altogether, our research shows that air  pollution heavily 
influences multiple signaling pathways within lung cells, potentially initiating a variety of diseases. 
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4 ADDITIONAL FILES 
 
Additional File 1: Volatile organic compounds detected through gas chromatography 
throughout the experiment day. 
 
Dashes (-) represent flame ionization detection peaks that were below detection limits. 
Concentration is abbreviated as Conc. 
---------------------------------------------------------------------------------------------------------------- 
Compound 
Chemical 
Group 
Conc at 8:45 
AM (ppmC) 
Conc at 9:59 
AM (ppmC) 
Conc at 12:40 
PM (ppmC) 
Conc at 4:42 
PM (ppmC) 
Conc at 5:57 
PM (ppmC) 
butane alkane 0.147 0.109 0.078 0.079 0.028 
cyclohexane alkane 0.017 0.016 0.012 0.006 0.006 
isobutane alkane 0.066 0.034 - 0.022 0.027 
isopentane alkane 0.173 0.146 0.071 0.056 0.036 
methylcyclohexane alkane 0.010 0.009 0.007 0.006 0.003 
methylcyclopentane alkane 0.023 0.018 0.013 - - 
n-decane alkane 0.031 0.029 0.023 0.015 0.009 
n-heptane alkane 0.038 0.033 0.026 0.018 0.017 
n-hexane alkane 0.015 0.015 0.017 0.016 0.015 
n-nonane alkane 0.036 0.029 0.022 0.012 0.012 
n-octane alkane 0.024 0.021 0.018 0.012 0.010 
n-pentane alkane 0.092 0.097 0.056 0.057 0.013 
propane/propene 
85% alkane, 
15% alkene 
0.109 0.105 0.083 0.048 0.057 
2,2,4-trimethylpentane alkane 0.033 0.028 0.025 0.018 0.019 
2,3,4-trimethylpentane alkane 0.020 0.018 0.015 0.010 0.009 
2,3-dimethyl-pentane alkane 0.034 0.026 0.023 0.017 0.016 
2,5-dimethylhexane alkane 0.023 0.020 0.016 0.011 0.009 
2-methylpentane alkane 0.044 0.031 0.023 0.019 0.020 
3-methylhexane alkane 0.070 0.068 0.055 0.041 0.034 
3-methylpentane alkane 0.034 0.024 0.011 0.009 0.010 
4-methylnonane alkane 0.042 0.031 0.023 0.015 0.012 
a-pinene alkene 0.010 0.006 - - - 
c-2-pentene alkene 0.015 - - - - 
1-nonene alkene 0.012 0.011 0.005 - - 
1-octene alkene 0.017 0.010 0.005 - - 
2,3,3-trimethyl-1-
butene 
alkene 0.049 0.030 0.008 - - 
benzene aromatic 0.044 0.042 0.008 0.033 0.030 
ethylbenzene aromatic 0.024 0.022 0.017 0.014 0.010 
m-ethyltoluene aromatic 0.016 0.013 0.009 0.004 - 
m-xylene aromatic 0.074 0.059 0.038 0.022 0.016 
n-propylbenzene aromatic 0.022 0.019 0.015 0.009 0.008 
o-xylene aromatic 0.025 0.023 0.017 0.010 0.009 
p-ethyltoluene aromatic 0.025 0.022 0.016 0.009 0.010 
sec-butylbenzene aromatic 0.018 0.018 0.015 0.008 0.006 
toluene aromatic 0.138 0.121 0.101 0.078 0.072 
1,2,3,5-
tetramethylbenzene 
aromatic 0.007 0.007 - - - 
1,2,4-trimethylbenzene aromatic 0.113 0.094 0.052 0.023 0.018 
1,3-diethylbenzene aromatic 0.034 0.029 0.018 0.010 0.007 
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Additional File 2: Genes identified as significantly* differentially expressed due to primary 
or photochemically altered (PCA) pollutant exposure. 
 
Dashes (-) indicate insignificant changes in expression. 
* Fold change ≥ 1.5 or ≤ - 1.5, p-value < 0.05, q-value < 0.05 
---------------------------------------------------------------------------------------------------------------- 
Gene Symbol 
Primary Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
A1CF - - -1.81 0.00276 
ABCA1 - - -1.56 0.00494 
ABCA12 - - -1.60 0.00261 
ABCA5 - - -1.90 0.00149 
ABCB6 - - -1.70 0.00001 
ABCC4 - - -1.59 0.00002 
ABCG2 - - -1.57 0.00124 
ACAD10 - - -1.78 0.00075 
ACAD11 - - -1.55 0.00078 
ACSM3 -1.50 0.00606 -2.33 0.00038 
ACSS2 - - -1.54 0.00001 
ACTA2 -1.58 0.01055 -2.00 0.00239 
ADD3 - - -1.98 0.00022 
ADH1C - - -1.71 0.04174 
ADH6 - - -2.12 0.00168 
ADHFE1 - - -1.51 0.01654 
AHCYL1 - - -1.60 0.00109 
AK3L1 - - -1.99 0.00053 
AK7 - - -2.18 0.00040 
AKAP12 - - 1.67 0.00192 
AKAP9 - - -1.73 0.00219 
AKR1B1 - - 1.55 0.00102 
ALDH5A1 - - -1.51 0.00686 
ALDH6A1 - - -2.50 0.00005 
ALPK1 - - -1.82 0.00084 
ALS2CR8 - - -1.55 0.03130 
AMPD1 - - 1.49 0.00723 
ANG - - -1.92 0.00069 
ANKRA2 - - -1.82 0.00414 
ANKRD1 - - 1.68 0.01161 
ANKRD18A - - -1.51 0.01560 
ANKRD22 - - 2.88 0.00045 
ANKRD30A - - -1.87 0.00110 
ANKS4B - - -1.65 0.00036 
ANO5 - - -1.52 0.00979 
ANXA10 - - 1.69 0.00491 
ANXA13 - - -1.68 0.00414 
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Gene Symbol 
Primary Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
ANXA3 - - 1.91 0.00053 
ANXA4 - - -1.64 0.00035 
ANXA9 - - -1.70 0.00337 
AP1S3 - - 1.80 0.00005 
APAF1 - - -1.52 0.00074 
APH1B - - -1.52 0.00342 
APOBEC3C - - -1.52 0.00212 
APOH - - -1.56 0.00202 
AQP3 - - 1.79 0.00023 
AR - - -1.79 0.00008 
AREG - - 3.22 0.00010 
ARFGAP2 - - -1.55 0.00108 
ARHGAP1 - - -1.54 0.00038 
ARID4A - - -1.67 0.00244 
ARID4B - - -1.53 0.00671 
ARID5B - - -1.60 0.00007 
ARL15 - - -1.69 0.00037 
ARMCX3 - - -1.58 0.00332 
ARRB1 - - -1.63 0.00000 
ARSD - - -1.60 0.00019 
ARSE - - -1.93 0.00001 
AS3MT - - -1.76 0.00281 
ASAM - - 1.91 0.00731 
ASPM - - -1.83 0.00018 
ATF6B - - -1.52 0.00112 
ATG2B - - -1.58 0.00018 
ATP8B1 -1.52 0.02013 -2.95 0.00063 
ATP9A - - -1.80 0.00014 
AXL - - 1.72 0.00217 
BAMBI - - -1.72 0.00027 
BBS9 - - -1.59 0.01465 
BCAS3 - - -1.71 0.00032 
BCL2L11 - - -2.10 0.00011 
BCL2L15 - - -1.85 0.01002 
BCMO1 - - -2.49 0.00009 
BDH2 - - -1.58 0.00797 
BDKRB1 - - -1.57 0.00003 
BDKRB2 - - -1.67 0.00396 
BLMH - - -1.51 0.00475 
BMPR2 - - -1.82 0.00290 
BNIP3L - - -1.55 0.00010 
BTBD11 - - -1.76 0.00003 
BTN3A1 - - -1.73 0.00562 
BTN3A3 - - -1.58 0.00015 
43 
 
Gene Symbol 
Primary Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
C10orf114 - - 1.61 0.00440 
C10orf57 - - -1.70 0.00847 
C12orf27 - - -1.91 0.00166 
C14orf106 - - -1.55 0.02065 
C15orf51 - - -1.57 0.01539 
C18orf58 - - -1.61 0.00275 
C1orf63 - - -1.64 0.00036 
C1RL - - -2.01 0.00000 
C1S - - -1.59 0.00003 
C20orf19 - - -1.60 0.00380 
C20orf194 - - -1.75 0.00203 
C20orf74 - - -1.87 0.00071 
C4orf18 - - -2.25 0.00219 
C4orf34 - - -1.61 0.00130 
C5 - - -2.07 0.00044 
C5orf26 - - -1.50 0.00269 
C5orf42 - - -1.64 0.00225 
C6orf130 - - -1.54 0.00364 
C6orf191 - - 1.58 0.00075 
C7orf11 - - 1.63 0.00256 
C7orf68 - - -1.53 0.00114 
C9orf3 - - -2.13 0.00103 
CA12 - - -1.52 0.00010 
CABYR - - -1.67 0.00169 
CACNA1D - - -1.87 0.00156 
CACNA2D1 - - -1.52 0.00198 
CALB1 - - 1.62 0.02927 
CALCOCO1 - - -1.54 0.00013 
CAMK2D - - -1.82 0.00122 
CASP4 - - -1.63 0.00331 
CASP6 - - -1.60 0.00474 
CCBE1 - - 1.95 0.00131 
CCBL2 - - -1.74 0.00035 
CCDC144A - - -1.55 0.00054 
CCDC28A - - -1.56 0.00767 
CCDC34 - - -1.59 0.00058 
CCDC80 - - -1.64 0.00112 
CCDC99 - - 1.60 0.00285 
CCL2 1.79 0.00249 1.96 0.00143 
CCNG1 - - -1.52 0.00018 
CCNG2 - - -1.98 0.00375 
CCPG1 - - -1.58 0.00182 
CD177 - - 1.95 0.03989 
CD209 - - 1.50 0.02235 
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Primary Pollutant Fold Change 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
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CD55 - - 1.79 0.00225 
CD99L2 - - -1.61 0.00007 
CDC14B - - -1.52 0.01131 
CDC25C - - -1.53 0.00153 
CDCA7L - - -1.54 0.00104 
CDCP1 - - 1.90 0.00178 
CDH1 - - -2.16 0.00002 
CDK5RAP3 - - -1.67 0.00070 
CDRT1 1.59 0.01225 - - 
CEACAM1 - - -1.84 0.00148 
CEACAM5 - - 1.52 0.00019 
CENPF - - -1.55 0.00048 
CEP152 - - -1.55 0.00683 
CEP70 - - -1.75 0.00426 
CFH - - -1.71 0.00089 
CFHR1 - - -2.19 0.02652 
CFHR3 - - -1.85 0.00017 
CFI - - -1.66 0.00250 
CIR1 - - -1.55 0.00185 
CIRBP - - -1.88 0.00006 
CLDN1 - - 1.65 0.00159 
CLMN - - -1.66 0.00034 
CNNM2 - - -1.53 0.00028 
CORO2A - - -1.72 0.00068 
COTL1 - - 1.51 0.00228 
CPA4 - - 1.59 0.00746 
CPB2 - - -1.69 0.01898 
CPN1 - - -2.02 0.00108 
CRBN - - -1.52 0.00023 
CSGALNACT2 - - 1.59 0.00058 
CSRP1 - - 1.70 0.00046 
CST1 - - 1.77 0.01150 
CTDSP2 - - -1.76 0.00009 
CTNND1 - - -1.56 0.00021 
CTPS - - 1.80 0.00187 
CTTNBP2 - - -1.57 0.00047 
CXCL5 - - 2.43 0.00092 
CYB5A - - -1.55 0.00014 
CYBRD1 - - -1.54 0.00007 
CYFIP2 - - -1.66 0.00007 
CYHR1 - - -1.91 0.00028 
CYP2D6 1.63 0.04999 - - 
CYP4F11 - - -1.66 0.00038 
CYP4F12 - - -1.54 0.00544 
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Primary Pollutant Fold Change 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
CYP4F3 - - -1.75 0.00058 
DAB2 - - -1.70 0.00070 
DAPK1 - - -1.77 0.00001 
DCDC2 - - -1.56 0.00069 
DCDC5 - - -1.76 0.00020 
DCLK1 - - 1.90 0.00068 
DEPDC4 - - -1.53 0.03365 
DEPDC6 - - -2.18 0.00003 
DET1 - - -1.58 0.00028 
DGCR6 - - 1.52 0.02151 
DHCR24 - - -1.51 0.00004 
DHFR - - 1.81 0.01212 
DHRS3 - - -3.69 0.00017 
DHRS9 - - 1.56 0.02798 
DHX37 - - 1.60 0.00006 
DIAPH2 - - -1.53 0.00949 
DMXL2 - - -1.71 0.00070 
DNAJB4 - - -1.55 0.01249 
DND1 - - 1.52 0.02165 
DPT - - 1.53 0.02035 
DPYD - - -1.53 0.00512 
DTX3L - - -1.86 0.00046 
DUSP1 - - 1.65 0.00089 
DUSP4 - - 1.52 0.00138 
DUSP5 - - 1.79 0.00028 
DYNC2H1 - - -1.63 0.00337 
DZIP3 - - -1.55 0.01019 
ECE1 - - -1.59 0.00002 
EFHC1 - - -1.55 0.00639 
EFNA1 - - -1.79 0.00405 
EFNB2 - - 1.61 0.00046 
EHHADH - - -1.61 0.00032 
EIF2C4 - - -1.52 0.00280 
EIF4B - - -1.68 0.00510 
ELF3 - - -1.77 0.00003 
ELMO1 - - -1.94 0.00006 
ELOVL6 - - -1.56 0.00533 
ELP4 - - -1.52 0.00125 
EML4 - - -1.52 0.00001 
EMP1 - - 1.84 0.00096 
ENTPD5 - - -1.62 0.00211 
EPB41 - - -1.51 0.00242 
EPB41L4A - - -1.80 0.00023 
EPHA2 - - 1.60 0.00280 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
EPHX2 - - -1.90 0.00134 
ERAP1 - - -1.53 0.00020 
ERBB2 - - -1.77 0.00002 
ERBB3 - - -2.33 0.00023 
EREG - - 2.83 0.00013 
ESSPL - - 1.60 0.01585 
FAM105A - - -1.55 0.03236 
FAM111A - - -1.69 0.00133 
FAM149A - - -1.76 0.00333 
FAM149B1 - - -1.52 0.00208 
FAM175A - - -1.55 0.00181 
FAM185A - - -1.56 0.04457 
FAM38B - - -1.88 0.00154 
FAM55C - - -1.55 0.00081 
FAM74A3 - - 1.53 0.00197 
FARP2 - - -1.72 0.00120 
FBXO32 - - -1.84 0.03748 
FBXO40 - - 1.51 0.02732 
FCHSD2 - - -1.66 0.00440 
FGA - - -1.81 0.00031 
FGB - - -1.88 0.00010 
FGFBP1 - - 3.85 0.00009 
FGFR4 - - -1.71 0.00013 
FGG - - -1.80 0.00209 
FHL1 - - 1.66 0.00166 
FKBP5 - - -1.53 0.00162 
FLI1 - - 1.52 0.04567 
FLJ11292 - - 1.52 0.00547 
FLJ35848 - - -1.54 0.03243 
FLJ41484 - - -1.56 0.02264 
FLJ44124 - - -1.55 0.00060 
FLOT1 - - -1.65 0.00036 
FMN1 - - -1.53 0.02740 
FMO5 - - -2.14 0.00015 
FNBP1L - - -1.54 0.00003 
FNIP1 - - -1.84 0.00347 
FOXN3 - - -1.72 0.01025 
FRAS1 - - -1.53 0.00459 
FRK - - -2.00 0.00024 
FRMD3 - - 1.69 0.00082 
FSHB - - 1.51 0.01644 
FSTL5 - - 1.70 0.00515 
FZD7 - - -1.82 0.00001 
GAB1 - - -1.53 0.02435 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
GABARAPL1 - - -1.69 0.00401 
GABPA - - 2.01 0.00008 
GABRA5 - - 1.84 0.00003 
GABRE - - -1.76 0.01005 
GALNT12 - - -1.56 0.00227 
GALNT4 - - -1.65 0.00138 
GATM - - -1.53 0.00008 
GATS - - -1.71 0.00017 
GATSL1 - - -1.68 0.00014 
GCA - - -1.66 0.02017 
GCOM1 1.51 0.01963 1.52 0.01866 
GDF15 - - 1.60 0.01375 
GFPT2 1.60 0.00208 2.78 0.00010 
GIP - - -1.59 0.00122 
GK - - -2.16 0.00005 
GLIPR1 - - 2.20 0.00018 
GLS - - 1.54 0.00035 
GLTSCR2 - - -1.59 0.00000 
GPAM - - 2.35 0.02748 
GPRC5A - - 1.68 0.00057 
GPRC5B - - -2.33 0.00020 
GRAMD1A - - -1.59 0.00031 
GREM2 - - 1.56 0.00011 
GRIP1 - - -1.54 0.00589 
GSTA4 - - -1.54 0.00194 
GSTM4 - - -1.76 0.00138 
GTF2IRD2 - - -1.53 0.00006 
GUCY1B2 - - -1.55 0.02367 
HABP2 - - -1.53 0.00125 
HAO1 - - -1.52 0.01414 
HAS2 - - 2.19 0.00276 
HBEGF - - 1.69 0.00043 
HBP1 - - -1.88 0.00002 
HERC6 - - -1.68 0.00007 
HFE - - -1.93 0.00003 
HGD - - -1.86 0.00098 
HIST1H1C - - -1.54 0.00009 
HIST1H2AB - - -1.63 0.00019 
HIST1H2AC - - -1.57 0.00023 
HIST1H2AG - - -1.56 0.00076 
HIST1H2AI - - -1.65 0.00306 
HIST1H2BM - - -1.51 0.00152 
HIST1H3A - - -1.61 0.00256 
HIST1H3E - - -1.54 0.01168 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
HIST1H3H - - -1.75 0.00148 
HIST1H3J - - -1.68 0.00053 
HIST1H4E - - -1.60 0.00275 
HIST1H4H - - -1.71 0.00050 
HIST2H2AA3 - - -1.52 0.00014 
HIST2H2AB - - -1.62 0.00076 
HIST2H2BF - - -1.52 0.00093 
HIST2H4A - - -1.72 0.00023 
HMGB2 - - -1.58 0.00755 
HMGCL - - -2.08 0.00131 
HNF4A - - -1.71 0.00002 
HNF4G - - -1.66 0.00086 
HOOK1 - - -1.61 0.00180 
HOOK3 - - -1.79 0.00433 
HOXA2 - - -1.56 0.00149 
HP1BP3 - - -1.57 0.00116 
HSD17B11 - - -1.62 0.00054 
HSD17B6 - - -1.50 0.04876 
HSPH1 - - 1.57 0.00072 
HTR1A - - 1.64 0.01235 
HTR3D - - 1.54 0.01543 
ID1 - - -1.55 0.00006 
IER3 - - 1.56 0.01359 
IFI35 - - -1.66 0.00049 
IFIT1 - - -2.12 0.00579 
IFT81 - - -1.62 0.00776 
IGHA1 - - 1.50 0.00025 
IGKC - - 1.69 0.00480 
IL11 - - 1.85 0.01698 
IL8 - - 1.60 0.00007 
INA - - 1.64 0.00039 
INADL - - -1.64 0.00020 
ING4 - - -1.55 0.00015 
IP6K2 - - -1.55 0.00025 
IQGAP2 - - -1.97 0.00035 
ITGA3 - - 1.67 0.00115 
ITGA6 - - 1.61 0.00050 
ITGB8 - - 1.52 0.03105 
ITGBL1 - - 1.56 0.00139 
ITPR2 - - -1.86 0.00137 
JUN - - 1.69 0.00013 
KCNK5 - - -1.53 0.00055 
KCNT2 - - -1.75 0.00295 
KDM3A - - -1.50 0.00034 
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Primary Pollutant Fold Change 
(Exposed / Unexposed) 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
KIAA0922 - - -1.73 0.00115 
KIAA1109 - - -1.59 0.00023 
KIAA1147 - - -1.91 0.00001 
KIAA1161 - - -1.66 0.00119 
KIAA1199 - - 1.66 0.00915 
KIAA1370 - - -2.70 0.00016 
KIAA1377 - - -1.52 0.00437 
KIAA1618 - - -1.53 0.00043 
KIAA1632 - - -1.55 0.00050 
KIAA1712 - - -1.60 0.00490 
KIF13B - - -1.56 0.00016 
KIF20A - - -1.57 0.00062 
KIF20B - - -1.52 0.02541 
KIR2DL5A - - 1.51 0.04814 
KLHDC2 - - -2.08 0.00016 
KLHL24 - - -2.44 0.00010 
KRT38 - - 1.57 0.01687 
KRT80 - - 1.68 0.00320 
LAMC2 - - 2.74 0.00002 
LARGE - - -1.53 0.00001 
LBA1 - - -1.93 0.00099 
LETMD1 - - -1.72 0.00011 
LHX8 - - -1.68 0.00030 
LIMA1 - - -1.70 0.00084 
LIMD1 - - -1.51 0.00395 
LITAF - - -1.60 0.00000 
LMO7 - - 1.61 0.00085 
LOC100130581 - - -1.51 0.01258 
LOC100289668 - - -1.73 0.00711 
LOC162632 - - -1.52 0.00058 
LOC345258 - - 1.59 0.00970 
LOC440518 - - 1.51 0.00644 
LOC644714 1.72 0.03988 - - 
LOC652493 - - 1.66 0.00876 
LOC729724 - - 1.51 0.00076 
LOXL2 - - 1.55 0.00171 
LRBA - - -1.53 0.00005 
LRIG1 - - -1.53 0.00104 
LRP1 - - -1.60 0.00103 
LRRFIP1 - - 1.75 0.00191 
LXN - - -3.17 0.00008 
LYAR - - 1.52 0.01154 
LYRM5 - - -1.64 0.01013 
MAFG - - -1.50 0.00030 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
MANBA - - -1.55 0.00047 
MANSC1 - - -1.76 0.00055 
MAOA - - -2.04 0.00003 
MARCH4 - - 1.61 0.00392 
MARCH8 - - -1.57 0.00542 
MARCKS - - -1.64 0.00055 
MATN2 - - -2.00 0.00034 
MBOAT1 - - -2.24 0.00006 
MCCC1 - - -1.66 0.00242 
MCTP1 - - 1.61 0.00115 
MEIS2 - - -1.80 0.00026 
MGAM - - -1.54 0.00001 
MIA2 - - -2.10 0.00458 
MICAL2 - - 1.54 0.00571 
MIR21 - - -1.56 0.00251 
MLEC - - -1.77 0.00001 
MLF1 - - -1.57 0.01458 
MLLT4 - - -1.55 0.00085 
MR1 - - -1.85 0.00105 
MRAP2 - - -1.58 0.00189 
MSI2 - - -1.56 0.00022 
MST131 - - 2.14 0.00035 
MTMR11 - - -1.56 0.00059 
MUT - - -1.95 0.00019 
MYCNOS - - 1.56 0.00044 
MYEOV - - 1.62 0.00574 
MYO1A - - -1.66 0.00277 
NAGA - - -1.56 0.00399 
NAP1L2 - - -1.57 0.00312 
NAV3 - - 2.05 0.00442 
NBEA - - -1.73 0.00019 
NBEAL1 - - -1.77 0.00311 
NBR1 - - -1.55 0.00122 
NCALD - - -1.51 0.00015 
NCAPD2 - - -1.64 0.00007 
NCEH1 - - 1.52 0.00011 
NCOA2 - - -1.51 0.00336 
NDC80 - - -1.79 0.00277 
NDRG1 - - -1.59 0.00516 
NDRG2 - - -1.51 0.00030 
NEB - - -1.76 0.00001 
NEDD4L - - -1.98 0.00001 
NEK11 - - -1.54 0.00645 
NFIA - - -1.95 0.00006 
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(Exposed / Unexposed) 
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NFKBIA 1.51 0.00016 1.53 0.00014 
NFKBIZ - - -1.56 0.00523 
NID2 - - 1.77 0.00950 
NIPAL3 - - -1.54 0.00599 
NIPSNAP3A - - -1.67 0.00309 
NMNAT2 - - 1.68 0.00052 
NNT - - -1.52 0.00002 
NOSTRIN - - 1.62 0.00233 
NOTCH2 - - -1.68 0.00081 
NOTCH2NL - - -1.57 0.00049 
NPY1R - - -1.74 0.00596 
NR0B1 - - -1.52 0.00120 
NR1D2 - - -1.53 0.00500 
NR4A1 - - 1.69 0.00307 
NR5A2 - - -1.87 0.00024 
NRG1 - - 1.73 0.00057 
NRG4 - - -1.81 0.00017 
NRIP1 - - -1.66 0.00006 
NRM - - -1.57 0.00020 
NUDT7 - - -1.76 0.00017 
NUSAP1 - - -1.59 0.00367 
OAS1 1.62 0.00085 2.43 0.00008 
ODC1 - - 1.66 0.00054 
OPHN1 - - -1.96 0.00109 
OR10G2 1.55 0.01301 - - 
OR2T1 - - 1.55 0.01790 
OR4A47 1.73 0.00898 1.56 0.01815 
OR4C6 - - 1.91 0.00808 
OR4K1 - - 1.53 0.03161 
OR51B4 - - 1.53 0.02610 
OR51D1 1.51 0.01660 - - 
OR51L1 - - 1.54 0.00304 
OR52I2 - - 1.50 0.04879 
OR5AP2 - - 1.58 0.03335 
OR5I1 - - 1.51 0.02120 
OR9A2 - - 1.50 0.04432 
OR9Q2 - - 1.60 0.00867 
OSBPL9 - - -1.70 0.00006 
OTUD1 - - -1.54 0.00205 
OXTR - - 1.68 0.00105 
P2RX4 - - -1.73 0.00037 
P2RY4 - - 1.54 0.01409 
PAIP2B - - -2.02 0.00175 
PAN2 - - -1.61 0.00035 
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(Exposed / Unexposed) 
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PAQR5 1.58 0.00319 2.19 0.00041 
PAR5 - - -1.63 0.02688 
PARP14 - - -1.85 0.00301 
PARP9 - - -2.18 0.00046 
PBLD - - -2.57 0.00011 
PCCA - - -1.52 0.00462 
PCDH9 - - -1.56 0.00041 
PCMTD1 - - -1.66 0.00712 
PCMTD2 - - -1.66 0.01622 
PDCD4 - - -2.83 0.00020 
PDE3A - - -1.59 0.00000 
PDGFC - - -1.62 0.00169 
PDGFRL - - -1.90 0.00023 
PDK2 - - -1.76 0.00028 
PDPR - - -1.52 0.00073 
PDXDC2 - - -1.53 0.03412 
PDZK1 - - -2.25 0.00069 
PECR - - -1.55 0.00431 
PER2 - - -1.55 0.00044 
PFKFB3 - - -1.83 0.00003 
PGAP2 - - -1.56 0.00005 
PHKB - - -1.65 0.00006 
PHLDA1 - - 1.57 0.00787 
PIGN - - -1.57 0.00143 
PIR - - -1.55 0.00011 
PLAU - - 1.75 0.00069 
PLCD4 - - -1.53 0.03026 
PLCH1 - - -1.99 0.00005 
PLD1 - - -1.98 0.00015 
PLEK2 - - 1.75 0.00089 
PLEKHH2 - - -1.64 0.00354 
PMEPA1 - - 1.51 0.00154 
POF1B - - -1.78 0.00037 
POU1F1 - - 1.53 0.01782 
PP13439 - - -1.57 0.01707 
PPFIBP2 - - -1.58 0.00008 
PRKCD - - -1.67 0.00020 
PRKD1 - - -1.51 0.00039 
PSG8 - - 1.67 0.02451 
PTCH2 - - 3.64 0.00156 
PTGR2 - - -1.55 0.00099 
PTPLAD2 - - -1.73 0.01052 
PTRF - - 1.65 0.00203 
RAB3B - - 1.80 0.01271 
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RAP1GAP - - -1.50 0.00055 
RARB - - -2.43 0.00014 
RBKS - - -1.61 0.00033 
RBM14 - - 1.51 0.00420 
RBPMS - - -1.51 0.00151 
REXO1L1 - - 1.50 0.00607 
RFC1 - - 2.82 0.01137 
RFX5 - - -1.60 0.00110 
RHOBTB1 - - -1.72 0.00326 
RHOBTB3 - - -2.60 0.00060 
RMRP - - 1.51 0.00148 
RND1 - - -1.70 0.00000 
RNF182 - - 1.80 0.00674 
RNF213 - - -1.64 0.00071 
RNU11 - - 3.67 0.00002 
RNU1A - - 2.73 0.00053 
ROBO1 - - -1.63 0.00025 
RPPH1 - - 2.27 0.00040 
RPS27L - - -1.54 0.00908 
RPS6KA5 - - -1.61 0.03867 
S100A3 - - 1.82 0.00190 
SAMD7 - - 1.56 0.01411 
SAMD9 - - -1.58 0.00962 
SASH1 - - -1.54 0.00060 
SCAPER - - -1.55 0.00306 
SCARB1 - - -1.59 0.00036 
SCARNA17 - - -1.71 0.00735 
SCARNA9L - - -1.52 0.02066 
SCD - - -1.59 0.00047 
SCMH1 - - -1.88 0.00078 
SCNN1A - - -1.50 0.00613 
SELENBP1 - - -1.64 0.00061 
SEMA3C - - 1.51 0.00066 
SEMA3E - - -1.62 0.00373 
SEPT14 - - -1.57 0.00871 
SERPINA6 - - -1.52 0.00385 
SERPINB1 - - -1.60 0.00030 
SERPINB8 - - 1.53 0.00242 
SERPINE2 - - 2.12 0.00056 
SESN3 - - -2.96 0.00075 
SFRP1 - - 1.98 0.00127 
SFRP4 - - -3.15 0.00197 
SFRS18 - - -1.64 0.00018 
SH3BGRL2 - - -1.51 0.00173 
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Primary Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
SHMT1 - - -1.62 0.00007 
SKAP2 - - -1.68 0.00063 
SLC16A7 - - -1.87 0.01007 
SLC19A3 - - -1.55 0.00100 
SLC22A3 - - -1.63 0.00131 
SLC23A1 - - -1.77 0.00003 
SLC23A2 - - -1.82 0.00014 
SLC25A27 - - -1.63 0.00072 
SLC29A3 - - -1.51 0.00096 
SLC2A12 - - -1.62 0.00055 
SLC35D2 - - -1.57 0.00050 
SLC40A1 - - -1.77 0.00003 
SLC41A2 - - -1.95 0.00481 
SLC44A2 - - -1.64 0.00225 
SLC46A3 - - -2.19 0.00010 
SLC5A3 1.58 0.00021 1.80 0.00050 
SLC7A2 - - -1.55 0.00019 
SLC9A3R1 - - -1.51 0.00002 
SLCO4A1 - - 1.71 0.00150 
SLFN5 - - -1.93 0.00126 
SMOX - - 1.71 0.00078 
SMPD1 - - -1.91 0.00009 
SNORA23 - - 2.06 0.00929 
SNORA3 - - 3.62 0.00002 
SNORA42 - - 6.35 0.00030 
SNORA52 - - 1.56 0.00372 
SNORA56 - - 1.77 0.00060 
SNORA71D - - 1.60 0.00162 
SNORA73A - - 1.92 0.01085 
SNORD113-3 - - 1.55 0.02204 
SNORD114-2 - - 1.52 0.00117 
SNORD115-11 - - 1.64 0.02566 
SOAT1 - - -1.70 0.00056 
SOCS2 - - 1.64 0.00506 
SORL1 - - -1.73 0.00003 
SPANXE - - 1.54 0.00193 
SPATA18 - - -1.57 0.00132 
SPATA7 - - -1.54 0.00089 
SPG11 - - -1.53 0.00373 
SPP1 - - -1.51 0.00065 
SPRR2B - - 1.73 0.04629 
SPTLC3 - - -1.85 0.00091 
SSBP2 - - -1.66 0.00118 
SSFA2 - - 1.55 0.00011 
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Primary Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
ST6GAL1 - - -2.01 0.00014 
ST8SIA4 - - -1.83 0.00152 
STAMBPL1 - - 2.17 0.00034 
STAT4 - - -2.20 0.00111 
STAT6 - - -1.51 0.00003 
STC1 - - 1.69 0.00281 
STEAP2 - - -1.53 0.00016 
STRA6 - - -1.56 0.00983 
STX17 - - -1.50 0.00142 
SULT2B1 - - -1.69 0.00114 
SVEP1 - - -1.85 0.00007 
SYCP2L - - -1.59 0.00681 
SYNE2 - - -2.41 0.00008 
TAF9B - - -1.74 0.00036 
TAS2R5 - - 1.92 0.00015 
TBC1D5 - - -1.56 0.00100 
TBC1D8B - - -1.63 0.00073 
TBCK - - -1.83 0.00024 
TC2N - - -1.96 0.00089 
TCP11L2 - - -2.19 0.00000 
TFDP2 - - -1.79 0.00115 
TFPI2 - - 1.77 0.00075 
TGFA - - 1.53 0.00335 
TGFB2 - - -1.67 0.00049 
THBD - - 1.53 0.00012 
THG1L - - -1.56 0.00083 
TIGD2 - - -1.85 0.00235 
TJP2 - - -1.52 0.00181 
TLR1 - - -2.18 0.00124 
TLR3 - - -1.65 0.04429 
TM4SF20 - - -2.48 0.00007 
TMC5 - - -1.51 0.01022 
TMC7 - - -1.64 0.00134 
TMEM136 - - -1.52 0.00435 
TMEM140 - - -1.56 0.01972 
TMEM144 - - -1.81 0.00091 
TMEM171 - - 1.52 0.00509 
TMEM202 - - 1.59 0.04147 
TMEM37 - - -2.39 0.00015 
TMEM50B - - -1.60 0.01620 
TMEM60 - - -1.59 0.00078 
TMEM74 - - 1.53 0.03446 
TNFRSF12A - - 1.83 0.00138 
TNFSF10 - - -2.26 0.00008 
56 
 
Gene Symbol 
Primary Pollutant Fold Change 
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PCA Pollutant Fold Change 
(Exposed / Unexposed) 
p-value 
TNS4 - - 2.08 0.00110 
TP53 - - -1.59 0.00023 
TP53INP1 - - -2.68 0.00001 
TPCN1 - - -1.86 0.00077 
TRIM31 - - -1.84 0.00213 
TRIM52 - - -1.56 0.02026 
TRIML2 - - 1.60 0.01377 
TSKU - - -1.59 0.00001 
TSPAN15 - - -1.56 0.00043 
TST - - -1.54 0.00005 
TTC28 - - -1.68 0.00006 
TTC39B - - -1.63 0.01453 
TTLL6 - - -1.53 0.00987 
TUBB2C - - 1.51 0.01846 
TXNDC16 - - -1.67 0.00328 
TXNIP -1.61 0.01468 -2.43 0.00160 
TYR - - 1.73 0.03422 
UBASH3B - - 1.82 0.00084 
UGT2B15 - - -1.77 0.00178 
UIMC1 - - 1.93 0.00243 
UNC119B - - -1.58 0.00219 
UNC13B - - -1.59 0.00049 
USP17 1.52 0.04976 1.59 0.03729 
USP17L2 1.52 0.03727 1.53 0.03761 
USP3 - - -1.50 0.00022 
VCAN - - -1.62 0.00012 
VIL1 - - -1.65 0.00193 
VPS13C - - -1.53 0.00114 
VPS39 - - -1.55 0.00068 
VRK2 - - -1.53 0.00264 
VWC2L - - 1.57 0.03979 
WDR19 - - -1.51 0.00064 
WDR69 - - 1.61 0.02320 
WEE1 - - -1.93 0.00169 
WSB1 - - -1.53 0.00269 
WWP1 - - -1.51 0.00065 
XBP1 - - -1.54 0.00334 
XCL1 - - 1.66 0.01526 
XDH - - 1.52 0.00199 
YPEL2 - - -2.04 0.00002 
YPEL5 - - -1.93 0.00001 
ZBTB20 - - -1.86 0.00095 
ZC3H6 - - -1.52 0.01515 
ZFP14 - - -1.51 0.01861 
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(Exposed / Unexposed) 
p-value 
ZFYVE1 - - -1.54 0.00139 
ZKSCAN1 - - -1.58 0.00080 
ZMYM3 - - -1.55 0.00055 
ZNF224 - - -1.53 0.00287 
ZNF234 - - -1.52 0.00360 
ZNF277 - - -1.54 0.00502 
ZNF287 - - -1.65 0.01718 
ZNF292 - - -1.62 0.00032 
ZNF479 - - 1.62 0.01404 
ZNF594 - - -1.57 0.01350 
ZNF608 - - -1.52 0.01259 
ZNF626 - - 1.87 0.03625 
ZNF654 - - -1.69 0.01354 
ZNF704 - - -1.61 0.00041 
ZRSR1 - - 1.51 0.00283 
ZSCAN16 - - -1.52 0.00316 
ZSWIM6 - - -1.59 0.00588 
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Additional File 3: Networks and proteins within networks constructed using genes and 
related gene products associated with exposure to (A) primary or (B) photochemically altered 
(PCA) pollutant mixtures. 
---------------------------------------------------------------------------------------------------------------- 
 
Network 
Number 
Molecules in Network p-value 
(A) Primary Pollutants Network 
1 
1,4-glucan,2' 5' oas,ACTA2,beta-hydroxyisovaleric acid,C13ORF15,C21ORF33,CCL2,CXCL16, 
CYP2D6, EDA2R,GFPT2,HNF4A,Interferon alpha,lymphotoxin-alpha1-beta2,NFkB (complex),NfkB-
Nfkbia,NFKBIA, NKIRAS1,OAS1,PAQR5, PDGF BB,PIF,PNPT1,retinoic acid,RIOK3,SLC5A3,STAT4, 
SUMO4,TNAP, TNFAIP8, TNIP3,TRAPPC9,TXNIP,UBA7,ZFAND6 
1E-25 
(B) PCA Pollutants Networks 
1 
A1CF,BCAS3,CDH1,Ck2,Cyp4f,CYP4F3,CYP4F12,DNAJB4,ELP4,FLJ11292,GLTSCR2,GSTA4,HGD,Histo
ne h3,HNF4A,HNF4G,HOOK3,KIF20A,MYO1A,NMNAT2,PAQR5,PIGN,PPFIBP2,SERPINB8, 
SLC19A3,SLC22A3, SLC5A3,SPP1,STX17,TBCK,TMEM140,TPCN1,ZNF224,ZNF277,ZSCAN16 
1E-52 
2 
ANXA3,APOH,ASPM,C14ORF106,CALCOCO1,CCDC99,CCNG1,CCNG2,CDC14B,CENPF,CYFIP2 
(includes EG:26999),FAM175A,HIST1H1C,Histone H1,HMGB2, HSPH1,ING4,LETMD1,NBR1, 
NCAPD2,NDC80, Nuclear factor 1,NUSAP1,P2RX4,PHLDA1,PMEPA1,Ppp2c,PRKAC,ROBO1,Rsk, 
CMH1,SH3BGRL2,TP53, TP53INP1,UIMC1 
1E-43 
3 
ADH6,ADH1C (includes EG:126),ADHFE1,alcohol dehydrogenase,AQP3,AR, ATP9A,C7ORF68,CA12, 
CCDC80,CDCA7L,CIR1,CTDSP2,DHRS3,DHRS9,EFNB2,FSH,FZD7,GPRC5B,KIF20B,KLHL24,Lh,MAOA,
MIR124,NDRG1,NID2,NPY1R,oxidoreductase,PTGR2,RNA polymeraseII,SELENBP1,SSFA2,STAT4, 
TGFA,Vegf 
1E-41 
4 
APH1B,BLMH,C1S,CASP4,CASP6,DTX3L,ECE1,FGFBP1,GLS,GPRC5A,HABP2,IFI35,IFIT1,IgG,IL1,Immu
noglobulin,Interferon alpha,IRG,MICAL2,Mmp,NFKBIA, NGF,OAS1,PARP,PARP9,PARP14, 
peptidase,PIR,RPS27L (includes EG:51065), S100A3,SERPINE2,SMOX,STAT,STAT6,TNFSF10 
1E-35 
5 
20s proteasome,26s Proteasome,Actin,Alpha tubulin,ARRB1,DIAPH2,DPT,DUSP1,EIF2C4,EIF4B, 
EPB41, ERBB2,ERBB3,GPAM,HIST2H2AB,HTR1A,ID1,INA,Insulin,LRIG1,MAP2K1/2,MARCKS 
(includes EG:4082), MATN2,MCCC1, NDRG2,Notch,NOTCH2,OPHN1,Pkc(s),PP2A,PTCH2,PTRF, 
SFRP1,TCR,XBP1 
1E-35 
6 
ANKRD1,ANXA13,Cbp,CDK5RAP3 (includes EG:80279),CFHR1,CPB2,CPN1,CXCL5,DUSP5, 
Elastase,FGA, FGB,FGG,Fibrin,Fibrinogen,GFPT2,HAS2,IER3,IFN TYPE 1,IGKC,IP6K2,LITAF,NFkB 
(complex),NfkB-RelA, NFKBIZ,PPAR-RXR, Pro-inflammatory Cytokine,RAP1GAP (includes 
EG:5909),SLC2A12,SOAT1, Stat3-Stat3,THBD,Tlr,TNFRSF12A,TXNIP 
1E-32 
7 
ABCC4,AXL,BCMO1,CD209,CEACAM1,CEACAM5 (includes EG:1048),EML4,Estrogen Receptor, 
Ferritin, Gm-csf,Growth hormone,HFE,IL12 (complex), JAK,Ldh,LDL,LRP,MIR1,MIR21 (includes 
EG:406991), NEDD4L,NRG,NRG1, PDCD4,PDE3A,PI3K,PRKD1,SCNN1A,SLC9A3R1,SOCS2,ST6GAL1, 
STAT5a/b,TNS4, WWP1,XCL1,XDH 
1E-29 
8 
14-3-3,AHCYL1,AKAP9,ANKRA2,Calmodulin,CAMK2D,CaMKII,Creb,DET1,DGCR6,EPHX2,FOXN3, 
FRAS1, GABARAPL1,GABPA,GRIP1,hydrolase,ITPR2, JUN,KIF13B,LRRFIP1,MAFG,NCEH1,Nfat 
(family), NIPSNAP3A,PER2,PHKB,Pka,Pka catalytic subunit,Pkg,RFC1,TUBB2C,Tubulin, 
UNC13B,USP3 
1E-29 
9 
Adaptor protein 2,ADD3,AKAP12,Alp,Ap1,BAMBI,BMPR2,CACNA2D1,Clathrin,DAB2,EMP1, 
FHL1,FSHB, Hat,hCG,Histone h4,HOXA2,IFN Beta,IL8,LIMD1, Mapk,MHC Class II (complex),NBEA 
(includes EG:26960),NCALD,NOSTRIN, ODC1,PDGF BB,Pias,PRKCD,SCD,SFRP4,Smad2/3,STC1,Tgf 
beta,TGFB2 
1E-27 
10 
ABCA1,C3-Cfb,CALB1,Cbp/p300,CD55,CFH,CFI,collagen,DUSP4,EHHADH,FRK,GC-GCR dimer, 
GDF15,HDL, ITGB8,JINK1/2,Jnk,KDM3A,LXR ligand-LXR-Retinoic acid-RXR±,N-cor,NCOA2,NR0B1, 
NR4A1,NR5A2, NRIP1,POU1F1, RAB3B,Retinoic acid-RAR-RXR,Rxr,SCARB1,SERPINB1,T3-TR-
RXR,Thyroid hormone receptor,VitaminD3-VDR-RXR,VRK2 
1E-27 
59 
 
Network 
Number 
Molecules in Network p-value 
11 
ACTA2,Alpha catenin,Cadherin,Calpain,CIRBP,Collagen type I,Collagen(s),CPA4,CTNND1,DAPK1, 
DCLK1, ERK1/2,Esr1-Esr1-estrogen-estrogen,Fgf,Fgfr, FGFR4,Focal adhesion kinase,Integrin, 
IntegrinI,ITGA3, ITGA6,LAMC2, Laminin,Laminin1,LARGE,LMO7,LXN,MLLT4,OXTR,PDGFC,SMPD1, 
TFPI2,TSKU,VCAN,Vla-4 
1E-25 
12 
Adaptor protein 1,ALS2CR8,AP1S3 (includes EG:130340),BRF2,CABYR, CDCA7L,CDKN2A,CES2 
(includes EG:8824),CYP4F3,CYP4F11,DDX10,ELF3,FAM111A,FETUB,GABRE,HNF4A,HSD17B11, 
JAK1,LOXL2,MUT, PAN2,PDXDC2,PLEKHA8,retinoic acid,SERPINB8,SLC5A3,STRA6,SUZ12,TBRG1, 
TCF19, TMEM49,TRIM52, USP30,USP36,ZNF133 
1E-23 
13 
APOL1,ATXN1,AZU1,BTN3A3,C20ORF194,CD86,CD209,CFHR3,CNN1,DPYD,DZIP3,EIF4B,EIF4E,EIF4
ENIF1,EMP1,HABP2,heparin,HIVEP1,LAMC2,LHX8,MARCH8,MIR17 (includes EG:406952), 
phosphatidylinositol 3,4-diphosphate, SAA2,SERPINA6,SERPINE2,SVIL,TBC1D5,TNF,TNFRSF18, 
TRAF2,TRIM31,TST,XCL1, ZFYVE1 
1E-23 
14 
ARSA,ARSD,ARSE,Aryl Sulfatase,CCNG1,CHST2,CLEC7A,CYBRD1,DMXL2, ELOVL6,ethanol,GREM2, 
HAMP, HFE2,HIST1H3A,hydrocortisone,IL2,IL13,IL13RA2,iron,MAOA,NCAPH,norepinephrine, 
NPY1R,PHLDA1,PHLDA2,progesterone,SERPINA6,SESN3,SLC40A1,SLC7A2,SUMF1,TC2N,TP53INP1 
1E-20 
15 
ALDH2,ALDH5A1,ARPC2,BDKRB2,C9ORF3,CCDC28A,CCNG2,CLMN,CSRP1,EPHA2,ERCC5,FDXR,FMN
1,FNBP1,HSD17B6,IER3,JAG2,KCNJ4,KIAA1199,LIMK2,LRBA,MIA2,PBLD,PIGF,PLK2,PPP1R13B,RHO
C,RHOD,SHISA5,SHMT1,SLC23A2,SNRPD3,STRAP,TGFB1,TP73 
1E-20 
16 
Alpha actin,AMPK,APAF1,ARID4A,BCL2L11,BNIP3L,Calcineurin protein(s), Caspase,Cdc2,CDC25C, 
Cyclin A,Cyclin B,Cyclin E,Cytochrome c,DHCR24, DHFR,E2f,EFHC1,FBXO32,GIP,Hdac,HIST1H2AB, 
HIST1H2AG, Hsp27,Hsp70,Hsp90,IQGAP2,MEF2,Mek,P38 MAPK,PFKFB3,Rb,RPS6KA5,TFDP2,WEE1 
1E-20 
17 
ACTR5,ACTR8,ANK3,ARID5B,ATF7IP,BAZ1A,ERVK6,FCHSD2,GATS,HOOK1,INO80,INO80B,INO80D,I
NO80E,KIAA1370,KIAA1377,KIAA1632,KIF20B,MARCH4,MGAM,MIR292 (includes EG: 
100049711),MIR30E (includes EG:407034), MTMR11,PEX6,PLCH1,RHOBTB1,RRBP1,RUVBL1, 
SCAPER,SMAD2,SMAD9,SUMO1, SVEP1,ZBTB20,ZMYND11 
1E-18 
18 
Akt,Angiotensin II receptor type 1,AREG,BDKRB1,BDKRB2,CCL2,CDCP1, CHEMOKINE,CLDN1,EGFR 
ligand,ERBB,ERBB4 ligand,EREG,GAB1,Gpcr, HBEGF,IFN alpha/beta,Ifn gamma,Ifnar,Ikb,IKK 
(complex),IL11,IL12 (family), INADL,NfkB1-RelA,NRG4,P2RY4,p70 S6k,Pik3r,Sfk,Shc,TJP2,TLR1, 
TLR3,Tnf 
1E-18 
19 
BBS9,BTN3A1,C1R,CABP7,CORO2A,CYB561,EFCAB6,EGR2,ERAP1,GCA,GIP2,HERC6,Hla-abc,IFI30, 
IFI35, IFI44,IFI47,IFNA2,IFNG,KDM5B,LARGE,MR1,MT1X, NFE2L3,OAS3 (includes EG:4940),PARP9, 
RNF213,SAMD9,SP110,STAMBPL1, TBC1D10A,TMEM50B,TRIM22,ZFP36,ZKSCAN1 
1E-17 
20 
ABCG2,ARG1,BBS1,BCL6,beta-estradiol,BLNK,CEP152,CYB5A,CYP17A1, CYP2C9,DUSP6,EIF3A,ELF1, 
EPB41L2,EPB41L3,FLOT1,FMO5,GSR,HBEGF,HLA-DR,HLA-DRB1,ITGBL1,KIAA0922,MED23,MEIS2, 
Mhc ii (family),MIR200A (includes EG:406983),PBX1,PCDH9,RFX5,SAP30,SHBG,SSBP2,TM4SF20, 
TMEM37 
1E-15 
21 
ARHGAP1,BCR,C5,C1q,COTL1,EFNA1,ELMO1,EPHA2,ERK,F Actin,G protein alpha,G protein alphai, 
G-Actin,G-protein beta,G-protein gamma,Igm,LIMA1, LRP1,p85 (pik3r),Pdgf,Pi3-kinase,PLC,PLC 
gamma, PLCD4,Pld,PLD1,Rac,Rap1, Ras,Ras homolog,RND1,Sapk,SORL1,SYNE2,VIL1 
1E-14 
22 
ADCY10,COPS8,CST1,CTPS,DDAH2,E2F1,FNIP1,GUCY1A2,GUCY1B2,GUCY1B3,GUCY2C,GUCY2D,GU
CY2E,GUCY2F,HIST1H2AC,HIST1H4H (includes EG:8365),HMGCL,HSP90AA1,KRT38,LIMA1,MLEC, 
MLXIP,NAGA, NFKBIL1,PECR,PNN,PRPF19,SFRS18,SLC25A3,SLC2A4,SOD2,Soluble guanylate 
cyclase, SRRM2,TXNL1, YWHAG 
1E-13 
23 
ASF1B,BMP1,BTBD11,COL6A1,collagen,CX3CL1,dihydrotestosterone,ETV1,FGF3,GRAMD1A,HIST1
H3E,HIST1H3J,Histone h4,HOXA9,KITLG,KLK2,MME, MMP2,MSI2,NEB,NNT,PARK7,PDGFRL, 
poly(ADP-ribose), RBM39,RDX, RPS6KB1,SFRP1,SFRS11,SLC16A7,SLC44A2,TERT,UBASH3B,UGCG, 
WSB1 
1E-13 
24 
adenylate kinase,AK1,AK5,AK7,AK3L1,APP,ARL15,C1ORF63,C1RL,CNNM2, CRCT1 (includes 
EG:54544), Cytoplasmic Dynein,DYNC1LI1,DYNC2H1, FAM38B,HP,KLK6,MIR98 (includes 
EG:407054),MIRLET7B (includes EG:406884),NAV3,prostaglandin E2,PROZ,PRSS1 (includes 
EG:5644),PRSS2 (includes EG:25052),PRSS3 (includes EG:5646),PTN,PTPLAD2,REG1A, SERPINE2, 
SLC31A1,TCOF1,Trypsin,YPEL5, ZNF654 
1E-13 
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25 
AHSG,ALB,AMBP,APOC3,ATG2B,CDC45L,CDKN1B,CLCA2 (includes EG:9635), COPS3,CYHR1,HAO1, 
HNF1A,HPX,LGALS3,MIR26A1,MIR291B,MLF1,NFIA,NFIB,NFIC,NFIX,NR1D1,NR1D2,OSBPL9,PLEK2,
PRSS1 (includes EG:5644),PRSS3 (includes EG:5646),SERPING1,SLC25A27,TBC1D8B,Tcf 1/3/4, 
TCF7L2 (includes EG:6934),TMOD2,ZNF292,ZNF608 
1E-12 
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Additional File 4: Transcription factors predicted to regulate genes modified by exposure to 
(A) primary pollutants and  (B) photochemically altered (PCA) pollutant mixtures 
---------------------------------------------------------------------------------------------------------------- 
Transcription 
Factor 
TRANSFAC 
Accession 
Number 
Predicted Gene Targets 
(Targets are Genes Identified as Differentially Expressed) 
Targets' 
Expression 
Direction 
p-value 
(A) Primary Pollutant Mixture 
PPARalpha M00242 ACSM3, ACTA2, TXNIP Decreased 0.001 
PAX M00808 CYP2D6, OAS1, PAQR5, SLC5A3 Increased 0.002 
HNF-1 M00132 ACSM3, TXNIP Decreased 0.006 
UF1H3BETA M01068 CYP2D6, GFPT2, NFKBIA, PAQR5, SLC5A3 Increased 0.006 
TBX5 M01020 NFKBIA, PAQR5, SLC5A3 Increased 0.006 
SRF M00186 ACTA2 Decreased 0.007 
NF-Y M00287 ACSM3, TXNIP Decreased 0.009 
GATA-1 M00127 ACSM3, ACTA2 Decreased 0.015 
MZF1 M00083 CYP2D6, SLC5A3 Increased 0.017 
Oct-1 M00137 ACSM3, TXNIP Decreased 0.027 
Hmx3 M00433 ACTA2, TXNIP Decreased 0.029 
RREB-1 M00257 CYP2D6, GFPT2, NFKBIA, OAS1 Increased 0.029 
Evi-1 M00078 TXNIP Decreased 0.035 
HNF-4 M00134 CYP2D6, OAS1, SLC5A3 Increased 0.036 
COUPTF M01036 CYP2D6, GFPT2, SLC5A3 Increased 0.041 
FOXO4 M00472 ACTA2, TXNIP Decreased 0.043 
Freac-3 M00291 TXNIP Decreased 0.045 
(B) PCA Pollutant Mixture 
FOXO4 M00472 
A1CF, ACTA2, ALPK1, APAF1, APH1B, ARSE, ASPM, BCL2L11, 
BCMO1, BDH2, BNIP3L, C4orf18, CCDC28A, CCDC34, CCDC80, 
CCPG1, CDC25C, CDCA7L, CENPF, CFHR3, CFI, CIR1, CORO2A, CRBN, 
CTDSP2, CTNND1, CTTNBP2, DEPDC4, DIAPH2, EFNA1, EIF2C4, 
ELOVL6, EPHX2, FBXO32, FGB, FRK, GATM, HSD17B11, ID1, IFT81, 
IQGAP2, KIAA1370, KIF20A, MANSC1, MARCKS, MCCC1, MGAM, 
MUT, NAP1L2, NCOA2, NDRG1, NR0B1, NRG4, OSBPL9, PAIP2B, 
PBLD, PCMTD1, PDCD4, PDE3A, PDZK1, POF1B, RBKS, RND1, 
RPS6KA5, SESN3, SKAP2, SLC2A12, SLC35D2, SPTLC3, ST8SIA4, 
SYCP2L, TFDP2, TGFB2, TLR3, TMEM140, TMEM37, TNFSF10, 
TXNDC16, TXNIP, VCAN, VRK2, WEE1, WWP1, ZBTB20, ZNF608, 
ZNF654 
Decreased 
9.45E-
09 
HNF-1 M00132 
A1CF, ABCA12, ABCG2, ACSM3, ADH6, ALPK1, ANG, ANKRA2, 
ANKS4B, ANXA13, APOH, ARSE, C4orf18, C5, C7orf68, CASP4, 
CEACAM1, CEP152, CFHR3, CFI, CPB2, CYB5A, DAB2, ELMO1, 
FAM38B, FGA, FGB, FGG, FRK, GLTSCR2, HABP2, HAO1, HIST2H2BA, 
HNF4A, HOOK3, IP6K2, MANSC1, MARCKS, MGAM, MIA2, 
MTMR11, NAP1L2, NEB, NIPAL3, NIPSNAP3A, NNT, NR5A2, NRM, 
OPHN1, PLCH1, RPS6KA5, SAMD9, SEMA3E, SERPINA6, SLC25A27, 
SLC41A2, SLC7A2, SPATA7, STEAP2, TBC1D5, THG1L, TLR1, TLR3, 
TM4SF20, TMEM136, TMEM144, TMEM37, TXNIP, VPS13C, VRK2, 
WSB1, YPEL2, ZNF654, ZNF704 
Decreased 
6.23E-
06 
TEF M00672 
ABCA12, ADHFE1, AKAP9, AR, ARID5B, ASPM, BCAS3, BTBD11, 
BTN3A1, C1RL, C1S, C4orf34, C5, C5orf42, CCDC28A, CCNG2, 
CCPG1, CENPF, CFH, CFHR1, CFHR3, CRBN, DAB2, DMXL2, DNAJB4, 
DZIP3, ELOVL6, FAM149A, FAM38B, FGB, FLOT1, GRIP1, GSTM4, 
Decreased 
1.18E-
05 
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HIST2H2AA3, HIST2H4A, HSD17B6, ING4, KIAA0922, KIAA1377, 
KIF13B, MANSC1, MIA2, NAP1L2, NEB, NFKBIZ, NIPAL3, NIPSNAP3A, 
NR0B1, NRG4, NRM, P2RX4, PBLD, PLCD4, RFX5, SEMA3E, SESN3, 
SFRS18, SLC16A7, SPTLC3, SYCP2L, TBC1D8B, TIGD2, TLR1, TLR3, 
TRIM31, TSKU, TTC28, UGT2B15, UNC119B, VPS13C, ZC3H6, 
ZNF292, ZNF594, ZNF654, ZSCAN16 
NF-Y M00287 
ABCA5, ABCB6, ACSM3, ADHFE1, ALDH6A1, ARFGAP2, ARHGAP1, 
ARID4A, ARID4B, ASPM, ATF6B, BAMBI, BLMH, BTBD11, BTN3A1, 
C4orf18, C6orf130, CABYR, CCBL2, CCDC28A, CCDC34, CCNG1, 
CCNG2, CDC14B, CDH1, CDK5RAP3, CENPF, CEP152, CFI, CIRBP, 
CNNM2, CPB2, CTDSP2, CYFIP2, CYP4F12, DAPK1, DCDC2, DHCR24, 
ECE1, EHHADH, ELP4, FAM105A, FAM55C, FARP2, FNIP1, GCA, GK, 
HBP1, HFE, HIST1H2AB, HIST1H2AC, HIST2H2AA3, HIST2H2BA, 
HMGB2, HOOK1, HP1BP3, ID1, ITPR2, KCNT2, KDM3A, KIAA1377, 
KIF20A, KIF20B, KLHL24, LARGE, LETMD1, LRBA, LRIG1, MAOA, 
MARCKS, MBOAT1, MLEC, NCALD, NCAPD2, NDRG2, NEB, NEDD4L, 
NRIP1, NUSAP1, PAIP2B, PAN2, PCDH9, PDCD4, PDK2, PDZK1, PER2, 
PGAP2, PIGN, PLEKHH2, RFX5, RND1, RPS6KA5, SAMD9, SCD, 
SERPINA6, SESN3, SHMT1, SKAP2, SLC25A27, SLC46A3, SLC9A3R1, 
ST8SIA4, TFDP2, TMEM50B, TP53, TPCN1, TSPAN15, TXNDC16, 
TXNIP, WEE1, XBP1, YPEL2, YPEL5, ZBTB20, ZNF287, ZNF594, 
ZSCAN16 
Decreased 
2.31E-
05 
LEF1 M00805 
A1CF, ABCA1, ABCA12, ABCA5, ACAD10, ACAD11, ACSS2, ACTA2, 
ADD3, ADH1C, ALDH5A1, ANG, ANXA9, APOBEC3C, APOH, AR, 
ARHGAP1, ARMCX3, ARSD, ARSE, BCAS3, BCL2L11, BDH2, BDKRB1, 
BDKRB2, BLMH, BTN3A1, BTN3A3, C14orf106, C20orf74, C5, 
C6orf130, C9orf3, CABYR, CCDC28A, CCDC34, CCDC80, CCNG1, 
CCPG1, CD99L2, CDC25C, CDK5RAP3, CEACAM1, CFHR1, CFHR3, 
CIR1, CNNM2, CPB2, CPN1, CTNND1, CTTNBP2, CYBRD1, CYP4F11, 
DAB2, DEPDC4, DET1, DHRS3, DIAPH2, DMXL2, DNAJB4, EFHC1, 
EFNA1, ELF3, ELMO1, ELOVL6, ELP4, EPHX2, ERAP1, ERBB2, 
FAM111A, FAM149A, FAM55C, FGA, FGB, FKBP5, FNIP1, FRK, FZD7, 
GABARAPL1, GATSL1, GCA, GK, GLTSCR2, HABP2, HAO1, 
HIST1H2AB, HIST1H2AG, HIST2H2AA3, HOXA2, HSD17B11, ID1, 
KCNT2, KDM3A, KIAA0922, KIAA1377, KIF13B, KIF20A, KLHDC2, 
KLHL24, LETMD1, LRBA, LRIG1, LRP1, LXN, LYRM5, MANBA, 
MANSC1, MARCKS, MATN2, MCCC1, MIA2, MLEC, MR1, MRAP2, 
MSI2, MTMR11, NAP1L2, NCALD, NEB, NEDD4L, NFIA, NIPAL3, 
NIPSNAP3A, NOTCH2, NOTCH2NL, NPY1R, NR1D2, NR5A2, NRIP1, 
NUDT7, NUSAP1, PAIP2B, PAN2, PARP14, PARP9, PBLD, PDCD4, 
PDE3A, PDGFC, PDGFRL, PDK2, PFKFB3, PLCD4, PLCH1, POF1B, 
PRKCD, RAP1GAP, RARB, RBKS, RHOBTB1, RNF213, SAMD9, 
SCAPER, SELENBP1, SERPINB1, SESN3, SFRS18, SH3BGRL2, SLC16A7, 
SLC19A3, SLC23A2, SLC25A27, SLC29A3, SLC2A12, SLC40A1, 
SLC41A2, SLC44A2, SPATA7, ST8SIA4, STEAP2, STX17, SVEP1, 
SYCP2L, SYNE2, TBC1D8B, TBCK, TC2N, TFDP2, TGFB2, TLR3, 
TM4SF20, TMEM136, TMEM37, TNFSF10, TRIM31, TTC39B, TTLL6, 
USP3, VCAN, VPS13C, VRK2, WEE1, WSB1, YPEL5, ZFP14, ZKSCAN1, 
ZNF224, ZNF287, ZNF594, ZNF608, ZNF654, ZNF704, ZSCAN16 
Decreased 
4.37E-
04 
PLZF M01075 
A1CF, ACAD11, ACSM3, ADHFE1, ANO5, APH1B, AR, ASPM, BCAS3, 
BCL2L15, C1S, C4orf18, C4orf34, C5orf42, CCDC34, CDK5RAP3, 
CENPF, CFH, CFI, CLMN, CPB2, CRBN, CYB5A, DAB2, DAPK1, ELP4, 
FAM149B1, GABARAPL1, GCA, GSTA4, HAO1, HIST2H4A, HMGB2, 
HOOK3, IFIT1, KDM3A, KIAA0922, KIAA1370, KIAA1632, KIF13B, 
KLHDC2, KLHL24, LYRM5, MCCC1, MGAM, MIA2, NBEAL1, NCALD, 
Decreased 
4.58E-
04 
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NEB, NFIA, NFKBIZ, NIPSNAP3A, NUDT7, NUSAP1, PAIP2B, PBLD, 
PCMTD1, RHOBTB3, SEMA3E, SESN3, SH3BGRL2, SLC16A7, 
SLC41A2, SSBP2, TBC1D5, TIGD2, TM4SF20, TMEM136, ZNF292, 
ZNF608, ZNF654 
Oct-1 M00161 
ABCB6, ACSM3, ADH6, ADHFE1, ANXA13, ARFGAP2, ASPM, 
C4orf18, CASP4, CCDC34, CEACAM1, CEP70, CFHR1, CORO2A, CRBN, 
DAB2, DNAJB4, ELF3, ENTPD5, FAM105A, FGFR4, FOXN3, 
GABARAPL1, GATM, HABP2, HIST1H2AC, HIST2H2AA3, HIST2H2BA, 
KCNT2, KIAA1109, LHX8, LYRM5, MARCKS, MBOAT1, MGAM, 
MTMR11, NBEAL1, NEB, OSBPL9, PARP9, PDZK1, PLCD4, POF1B, 
RHOBTB1, RHOBTB3, SCD, SCNN1A, SEMA3E, SLC19A3, STAT4, 
TBC1D5, TBC1D8B, TLR1, TSPAN15, WSB1, WWP1, YPEL5, ZNF292 
Decreased 
6.30E-
04 
HOXA4 M00640 
ANKRD1, CALB1, CCBE1, CLDN1, CXCL5, EREG, FBXO40, ITGA3, 
ITGBL1, LMO7, SERPINB8 
Increased 
8.03E-
04 
HNF-1 M00206 
A1CF, ABCA12, ADH6, ALPK1, ANG, ANKS4B, ANXA13, BAMBI, 
BDKRB1, C4orf18, C5orf42, CALCOCO1, CCNG2, CTNND1, DAB2, 
DIAPH2, DYNC2H1, FGA, FRK, HIST2H4A, HP1BP3, HSD17B11, ING4, 
IQGAP2, LXN, LYRM5, MIA2, NAP1L2, NEB, NIPAL3, NNT, NRM, 
PCCA, PLCH1, RARB, SAMD9, SLC19A3, SLC23A1, SLC2A12, 
SLC35D2, SPATA18, SPTLC3, STRA6, THG1L, TLR3, TM4SF20, 
TMEM37, UGT2B15, VPS13C, YPEL2, ZNF654 
Decreased 0.001 
CDX M00991 
A1CF, ABCA5, ACAD11, ACSM3, ALDH6A1, ANG, ARID4B, ARID5B, 
ARMCX3, ASPM, BBS9, BCMO1, BDH2, BTN3A3, C5orf42, CCDC28A, 
CENPF, CFH, CFHR1, CFHR3, CRBN, DEPDC6, DIAPH2, DNAJB4, 
DPYD, DYNC2H1, ENTPD5, FAM149B1, FAM175A, FGB, HBP1, HFE, 
HIST1H2AC, HIST2H4A, HNF4G, HOOK3, HOXA2, KCNK5, LYRM5, 
MARCKS, MCCC1, MIA2, NAP1L2, NBEAL1, NCALD, NRG4, PCMTD1, 
POF1B, SESN3, SHMT1, SKAP2, SLC16A7, SLC19A3, SLC41A2, 
SPATA18, SPP1, ST8SIA4, TBC1D5, TLR1, TLR3, TMEM136, TXNIP, 
UGT2B15, WWP1, XBP1, ZBTB20, ZC3H6, ZNF224, ZNF287, ZNF292, 
ZNF608, ZNF654, ZSCAN16 
Decreased 0.001 
SRY M00148 
A1CF, ABCA1, ABCG2, ADH1C, ANG, ANKRA2, ANXA13, APH1B, 
APOH, ARFGAP2, ARID5B, ARSD, ARSE, AS3MT, ASPM, BAMBI, 
BBS9, BCMO1, BDH2, BLMH, BMPR2, BNIP3L, BTN3A1, BTN3A3, 
C1orf63, C1S, C5, C7orf68, CCDC28A, CCNG2, CDC14B, CDC25C, 
CDCA7L, CEP152, CFHR3, CIR1, CORO2A, CRBN, CTTNBP2, DNAJB4, 
EFHC1, EFNA1, EIF4B, ELMO1, ELOVL6, EPHX2, ERAP1, FAM111A, 
FAM149B1, FAM38B, FBXO32, FGB, FGG, FOXN3, FRK, FZD7, 
GABARAPL1, GATM, GATSL1, GK, HABP2, HBP1, HFE, HIST1H2AC, 
HIST2H4A, HP1BP3, IFIT1, IFT81, INADL, ING4, IP6K2, IQGAP2, 
KIAA1632, LITAF, LYRM5, MARCKS, MCCC1, MGAM, MR1, NAP1L2, 
NCALD, NDRG1, NFIA, NPY1R, NRG4, NUDT7, PAIP2B, PBLD, 
PCMTD1, PDCD4, PPFIBP2, PTPLAD2, RFX5, RND1, RNF213, SAMD9, 
SASH1, SERPINA6, SFRP4, SFRS18, SH3BGRL2, SKAP2, SLC16A7, 
SLC2A12, SLC35D2, SLC7A2, SMPD1, SPATA18, SPATA7, SPP1, 
SPTLC3, STAT6, STX17, SYCP2L, SYNE2, TBC1D8B, TFDP2, THG1L, 
TLR1, TLR3, TM4SF20, TMEM136, TMEM144, TMEM37, TMEM50B, 
TPCN1, TRIM31, TST, TXNIP, UNC13B, VPS13C, VRK2, ZBTB20, 
ZNF287, ZNF704 
Decreased 0.002 
Bach2 M00490 
CCDC99, CEACAM5, COTL1, CST1, DCLK1, FHL1, FLI1, IL11, IL8, 
KRT80, LAMC2, NID2, NR4A1, OR4C6, PSG8, RAB3B, RNF182, 
SEMA3C, SERPINB8, SNRPN, TFPI2, TMEM171 
Increased 0.003 
S8 M00099 
A1CF, ACAD10, ADH1C, ANKS4B, ASPM, BAMBI, C1S, C5, C5orf42, 
CACNA1D, CALCOCO1, CDCA7L, CENPF, CYFIP2, DAB2, DCDC2, 
DIAPH2, DMXL2, DNAJB4, ELMO1, ELP4, FAM55C, FNIP1, HAO1, 
Decreased 0.003 
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HERC6, HFE, HIST1H2AC, IFIT1, KCNT2, KIF13B, LYRM5, MARCKS, 
MGAM, NAP1L2, NBEAL1, NCALD, NCAPD2, NIPSNAP3A, NRG4, 
PDZK1, PECR, PIR, PLCH1, RHOBTB3, SAMD9, SASH1, SEMA3E, 
SH3BGRL2, SLC16A7, TIGD2, TLR1, TMEM60, TTLL6, YPEL2, ZC3H6, 
ZFYVE1, ZNF704 
C/EBPgamma M00622 
ADH1C, ADH6, ALPK1, ANXA13, APOH, ARSD, BCMO1, C9orf3, 
CABYR, CACNA1D, CALCOCO1, CASP4, CCDC28A, CDC14B, CEP70, 
CFHR1, CRBN, CYBRD1, DAB2, DCDC2, DMXL2, DZIP3, FAM111A, 
FGB, IQGAP2, KIAA0922, KIAA1377, KIF13B, LHX8, MCCC1, MEIS2, 
NEK11, NRG4, PAN2, PBLD, PCMTD2, PDCD4, PECR, PLCH1, 
PLEKHH2, PTGR2, RPS6KA5, SEMA3E, SLC2A12, SLC41A2, SPG11, 
SPP1, STAT4, SYCP2L, TMEM140, UGT2B15, VPS13C, ZNF292 
Decreased 0.003 
Nkx6-2 M00489 
ADH1C, ADH6, ANG, ANKS4B, ASPM, BBS9, C5, C5orf42, CALCOCO1, 
CCDC34, CEACAM1, CEP152, CYB5A, DMXL2, ELMO1, ENTPD5, 
EPHX2, FAM38B, FAM55C, FGB, FGG, FLOT1, FNIP1, FRK, HFE, 
HIST2H4A, HNF4G, KIAA1109, KIAA1370, KIAA1712, LHX8, LYRM5, 
MANSC1, MARCKS, MCCC1, MIA2, NAP1L2, NFIA, NIPAL3, 
NIPSNAP3A, NNT, NR0B1, PAN2, PDCD4, PLCH1, RPS6KA5, SCAPER, 
SESN3, SH3BGRL2, SHMT1, SORL1, TBC1D5, TMEM136, TNFSF10, 
TXNIP, UGT2B15, ZC3H6, ZKSCAN1, ZNF292 
Decreased 0.005 
FOXJ2 M00423 
A1CF, ABCG2, ADH1C, ANXA13, ARID5B, ARMCX3, ASPM, BLMH, 
BTN3A3, C4orf18, C4orf34, C5orf42, CCDC28A, CCDC80, CFHR3, CFI, 
CPB2, DPYD, DTX3L, DYNC2H1, DZIP3, FGB, FGG, FNIP1, HSD17B11, 
KIAA1370, KIF20A, MANSC1, MARCKS, MGAM, MUT, NAP1L2, 
NBEAL1, NFIA, NFKBIZ, NIPSNAP3A, NRG4, NUDT7, PBLD, PCCA, 
POF1B, SHMT1, SKAP2, SLC16A7, SORL1, SPP1, SYCP2L, TBC1D5, 
TM4SF20, YPEL5, ZMYM3, ZNF292, ZNF654 
Decreased 0.005 
C/EBPalpha M00116 
ADH1C, ADHFE1, ALPK1, ARMCX3, C9orf3, CCNG2, CFH, CFHR1, 
CPB2, DEPDC4, DHRS3, DMXL2, ELP4, ENTPD5, FAM38B, FGA, GCA, 
HIST1H2AB, HNF4G, INADL, ING4, KIAA0922, LHX8, LRBA, LXN, 
MANBA, MANSC1, MR1, MUT, NBEAL1, NDRG2, NEK11, PBLD, 
PCMTD2, PFKFB3, SLC7A2, ST8SIA4, STEAP2, TIGD2, TLR3, TSKU, 
ZC3H6, ZNF292, ZNF608, ZNF654, ZSCAN16 
Decreased 0.006 
STAT5A M00499 
ANKRD1, ANXA10, C6orf191, CCL2, CLDN1, CPA4, FSTL5, GABRA5, 
GPRC5A, HBEGF, ITGA3, ITGBL1, KRT38, OR4C6, OR51B4, OXTR, 
SAMD7, SERPINE2, SLC5A3, SPRR2B, TFPI2, WDR69 
Increased 0.007 
NF-AT M00302 
ABCA1, ACSS2, ADHFE1, ALS2CR8, BTN3A1, C20orf74, C5orf42, 
CCBL2, CCDC80, CEP152, CFHR3, CYB5A, DIAPH2, EIF2C4, ELOVL6, 
ELP4, FAM105A, FAM55C, FGFR4, HOXA2, HP1BP3, LIMA1, LRBA, 
MARCKS, NFKBIZ, NR5A2, PAIP2B, PER2, SFRP4, SLC25A27, 
SLC29A3, STAT4, STX17, SYNE2, TBC1D5, TGFB2, TLR1, TM4SF20, 
TMEM144, TNFSF10, TP53INP1, TTC39B, UGT2B15, ZNF287, 
ZNF654 
Decreased 0.009 
NF-AT M00935 
ABCA5, ARID4B, ARRB1, C4orf18, CEP152, CEP70, CYP4F3, DMXL2, 
FBXO32, HFE, HIST2H2BA, KIAA1377, LRBA, MARCKS, NIPSNAP3A, 
NNT, NUSAP1, OPHN1, PBLD, PDGFRL, RARB, SEMA3E, SLC16A7, 
SYNE2, TBC1D5, TCP11L2, TMEM144, TP53, TTC39B, YPEL2, ZNF654 
Decreased 0.009 
Freac-4 M00292 
AMPD1, ANKRD1, ANXA10, CCL2, CD55, DHRS9, DUSP4, EMP1, 
GDF15, HAS2, LMO7, NAV3, NMNAT2, OXTR, PHLDA1, RNF182, 
SNRPN, SPRR2B 
Increased 0.010 
TFIIA M00707 
AKAP12, ASAM, AXL, CLDN1, CXCL5, DGCR6, DHX37, ITGA3, 
KIAA1199, ODC1, PMEPA1, STAMBPL1, TGFA, XCL1 
Increased 0.011 
PLZF M01075 
AKAP12, ANKRD22, ANXA10, CCBE1, CPA4, DHX37, DUSP1, EMP1, 
FBXO40, FSHB, GPRC5A, HTR3D, IL11, IL8, ITGBL1, KRT38, OR4C6, 
Increased 0.013 
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OR51B4, OXTR, POU1F1, SAMD7, SOCS2 
HFH-1 M00129 
A1CF, ACTA2, ADHFE1, APH1B, APOH, ARID4B, ARID5B, BDH2, 
BDKRB2, C14orf106, C4orf18, CASP4, CCDC28A, CLMN, CRBN, 
DAB2, DEPDC6, DMXL2, DNAJB4, DYNC2H1, ENTPD5, ERAP1, 
FAM105A, FAM175A, FGB, FGG, FNIP1, HAO1, HIST1H2AC, 
HIST2H2AA3, HSD17B11, IFT81, ITPR2, LITAF, LXN, MGAM, MSI2, 
NAP1L2, NCOA2, NIPSNAP3A, NR5A2, NRG4, NUDT7, PARP9, PBLD, 
PCMTD1, RHOBTB1, RHOBTB3, SASH1, SEMA3E, SKAP2, SLC16A7, 
SLC19A3, SLC2A12, SLC7A2, SORL1, SPTLC3, SYCP2L, SYNE2, 
TBC1D8B, TM4SF20, TMEM136, TMEM140, UNC119B, VRK2, 
WWP1, ZMYM3, ZNF654 
Decreased 0.013 
TBP M00471 
AMPD1, ANKRD22, ANXA10, CALB1, CCBE1, CPA4, DHRS9, DPT, 
FBXO40, FLI1, ITGBL1, NR4A1, OR4C6, OR51B4, POU1F1, SPRR2B, 
SSFA2, STAMBPL1, TFPI2 
Increased 0.014 
ZID M00085 
AP1S3, CDCP1, CEACAM5, CPZ, CTPS, DND1, FSTL5, GFPT2, ITGB8, 
ITGBL1, LRRFIP1, LYAR, MICAL2, NMNAT2, PTRF, RAB3B, SLCO4A1, 
SOCS2, TMEM171, TMEM74, XDH 
Increased 0.014 
HMGIY M01010 
ABCG2, ACTA2, ANKS4B, ANXA4, ARFGAP2, BCL2L11, BDKRB1, 
BTN3A1, CCBL2, CCNG1, CFH, CPB2, DHRS3, DYNC2H1, ELOVL6, 
ELP4, FGB, HIST2H2BA, IQGAP2, KCNT2, KDM3A, KIAA0922, 
KIAA1377, KIF20A, LHX8, LYRM5, MCCC1, NFIA, NPY1R, NR5A2, 
NUDT7, PAIP2B, PLCH1, SAMD9, SFRS18, SLC35D2, SLC41A2, 
SYCP2L, TBC1D8B, TIGD2, TLR3, TM4SF20, TPCN1, WEE1, XBP1, 
ZNF608 
Decreased 0.014 
TATA M00252 
AMPD1, DPT, FGFBP1, GDF15, GLIPR1, IL8, JUN, KIAA1199, NR4A1, 
SERPINB8, SNRPN, STAMBPL1, STC1 , 
Increased 0.015 
SOX M01014 
C6orf191, CALB1, CCBE1, DUSP4, FGFBP1, FLI1, FRMD3, ITGB8, 
ITGBL1, NAV3, NMNAT2, NRG1, OAS1, SOCS2, TNFRSF12A 
Increased 0.015 
NF-E2 M00037 
ANKRD22, AQP3, CCDC99, COTL1, CPZ, DGCR6, FGFBP1, GLIPR1, 
HAS2, HTR3D, IL11, KIAA1199, KRT80, NAV3, OR51B4, RAB3B, 
SERPINB8, TNS4 
Increased 0.017 
DEC M00997 
AKAP12, ASAM, C10orf114, CD55, CEACAM5, CSRP1, DND1, FHL1, 
IER3, ITGA6, MYEOV, SERPINE2, SLCO4A1, SSFA2, THBD, TNS4 
Increased 0.018 
GATA-1 M00346 
CXCL5, FGFBP1, FSTL5, GPRC5A, GREM2, HAS2, HSPH1, LAMC2, 
POU1F1, SERPINE2, TGFA, WDR69 
Increased 0.018 
FAC1 M00456 
A1CF, ACSM3, ALS2CR8, APOH, ARID5B, BCMO1, C14orf106, 
C1orf63, C20orf19, CALCOCO1, CCDC34, CCNG2, CDCA7L, CFHR1, 
CLMN, CRBN, CYB5A, DAB2, DIAPH2, EFNA1, EML4, ENTPD5, 
ERAP1, FAM111A, FAM38B, GABARAPL1, GATSL1, GLTSCR2, HBP1, 
HFE, HIST1H2AG, HNF4G, IFIT1, LITAF, MUT, NCAPD2, NEDD4L, 
NR5A2, NRG4, NRIP1, PDCD4, PECR, POF1B, SFRP4, SFRS18, 
SH3BGRL2, SKAP2, SLC23A2, SLC7A2, SPP1, SPTLC3, STEAP2, STX17, 
SYCP2L, SYNE2, TBC1D5, TBC1D8B, TGFB2, TLR1, TMC7, TMEM144, 
TMEM50B, VCAN, VPS13C, YPEL5, ZFYVE1, ZNF287, ZNF608 
Decreased 0.018 
SREBP-1 M00221 
AMPD1, AQP3, CEACAM5, EREG, FGFBP1, GABRA5, GPRC5A, IL8, 
ITGBL1, JUN, LRRFIP1, PMEPA1, PSG8, SLCO4A1, TFPI2, THBD, 
TMEM171, XCL1 
Increased 0.021 
HNF4 M01032 
ABCA1, ACSM3, AHCYL1, AKAP9, ALS2CR8, ANKRA2, ANKS4B, 
ANXA4, ANXA9, APOBEC3C, APOH, ARID4B, ARID5B, BCAS3, 
BCL2L15, BDKRB1, BDKRB2, C1RL, C4orf18, C4orf34, C5, C6orf130, 
CABYR, CASP4, CCDC34, CD99L2, CDH1, CEP70, CFHR1, CFHR3, CFI, 
CIR1, CLMN, CYHR1, CYP4F11, CYP4F12, CYP4F3, DAB2, DEPDC4, 
DHCR24, DNAJB4, DPYD, EFHC1, ELF3, ELP4, EPB41L4A, FAM111A, 
FAM55C, FGG, FKBP5, GATM, GCA, GIP, GRIP1, HAO1, HBP1, 
Decreased 0.023 
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Targets' 
Expression 
Direction 
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HERC6, HFE, HIST1H2AG, HMGB2, HSD17B11, ID1, IFI35, IFIT1, 
IFT81, KCNT2, KIAA1161, KIAA1370, KIF20A, KLHDC2, KLHL24, LHX8, 
LIMD1, LXN, MARCKS, MATN2, MCCC1, MEIS2, MLEC, MRAP2, 
MUT, NAP1L2, NBEA, NCAPD2, NDRG1, NEB, NEDD4L, NOTCH2, 
NOTCH2NL, NPY1R, NRG4, P2RX4, PAN2, PARP14, PARP9, PBLD, 
PCMTD1, PDGFC, PECR, PER2, PTGR2, RAP1GAP, RARB, RFX5, 
RHOBTB1, RND1, RNF213, SCNN1A, SEMA3E, SERPINB1, SESN3, 
SFRS18, SH3BGRL2, SLC23A2, SLC29A3, SLC35D2, SLC40A1, 
SLC41A2, SOAT1, SPATA7, SPP1, SPTLC3, STAT6, STRA6, SYCP2L, 
TBC1D5, TGFB2, TM4SF20, TMEM140, TMEM37, TMEM50B, TPCN1, 
TRIM31, TSKU, TTC28, TTLL6, USP3, VCAN, VPS13C, ZFYVE1, 
ZKSCAN1, ZNF277, ZNF287, ZNF292, ZNF608, ZNF704 
Pax-4 M00377 
ACAD11, ADH6, ARMCX3, BCAS3, BTN3A1, C20orf19, C5, CACNA1D, 
CCDC34, CCPG1, CEACAM1, DCDC2, DEPDC6, DET1, DMXL2, 
ENTPD5, ERBB3, FAM105A, FNIP1, HIST1H2AG, HIST2H2BA, 
KIAA1712, LHX8, MIA2, NBEAL1, NR0B1, PFKFB3, PLCH1, POF1B, 
SASH1, SFRP4, SLC2A12, SPP1, STEAP2, TBC1D5, TFDP2, UGT2B15, 
WEE1, YPEL2, ZNF292, ZNF704 
Decreased 0.023 
GATA-1 M00128 
ACSS2, ADH1C, ADH6, APOBEC3C, AR, BCL2L15, BDKRB2, C5, CASP4, 
CCDC80, CCNG1, CDCA7L, CYFIP2, CYP4F11, CYP4F12, CYP4F3, 
DPYD, EFHC1, ELP4, FRK, GIP, HNF4G, KIAA1109, KIF20A, LYRM5, 
MYO1A, NAGA, RHOBTB3, SLC40A1, STAT6, TBC1D8B, TIGD2, 
TNFSF10, ZNF292 
Decreased 0.023 
Ncx M00484 
ABCA1, ACTA2, APAF1, C20orf194, CASP4, CDCA7L, CENPF, CEP152, 
CNNM2, CYB5A, CYP4F11, DIAPH2, DTX3L, EFHC1, GPRC5B, GSTA4, 
HBP1, ITPR2, KIAA1712, LIMA1, MANBA, NNT, NPY1R, NRG4, 
OSBPL9, PGAP2, PIGN, RHOBTB3, RNF213, SFRS18, SLC25A27, 
STEAP2, SVEP1, TMEM60, USP3, WWP1, YPEL2, ZBTB20, ZKSCAN1, 
ZNF704 
Decreased 0.023 
FOXP1 M00987 
ABCA1, ABCA12, ADH1C, ADH6, ALPK1, ANKRA2, ANXA13, APH1B, 
AR, ARFGAP2, ARID5B, ARMCX3, ASPM, BBS9, BDH2, BNIP3L, 
BTN3A3, C1S, C4orf18, C5orf42, CACNA1D, CCDC28A, CCPG1, 
CEP152, CFH, CFI, CRBN, CTNND1, DAB2, DEPDC6, DYNC2H1, 
EFNA1, ELP4, EML4, ENTPD5, ERAP1, ERBB3, FAM111A, FAM149B1, 
FGG, FNBP1L, FNIP1, GABARAPL1, GRIP1, HAO1, HIST1H2AC, 
HIST2H4A, HOOK3, HSD17B11, HSD17B6, IFIT1, IFT81, INADL, ING4, 
ITPR2, KCNK5, KIAA1370, KIAA1632, LIMD1, LITAF, LYRM5, 
MANSC1, MARCKS, MCCC1, MIA2, MR1, NAP1L2, NBEA, NBEAL1, 
NCALD, NPY1R, NR5A2, NRG4, OSBPL9, PBLD, PCMTD1, PDCD4, 
PECR, PLCH1, POF1B, PTGR2, PTPLAD2, SASH1, SKAP2, SLC16A7, 
SLC25A27, SLC35D2, SLC41A2, SOAT1, SPATA18, SPP1, SPTLC3, 
STEAP2, SYCP2L, SYNE2, TBC1D5, TBC1D8B, TGFB2, THG1L, TIGD2, 
TLR1, TLR3, TM4SF20, TMC7, TMEM144, TMEM37, TMEM50B, 
TXNIP, UGT2B15, WEE1, WWP1, YPEL2, ZNF224, ZNF287, ZNF292, 
ZNF608, ZNF654 
Decreased 0.023 
ELF-1 M00746 
ABCA12, ADH1C, AHCYL1, ARHGAP1, ARID4B, ARRB1, BCL2L15, 
BNIP3L, C1RL, C20orf74, C5orf42, CABYR, CCBL2, CCNG1, CFH, 
CFHR1, CTNND1, DAB2, DHCR24, DMXL2, DZIP3, EHHADH, ELMO1, 
ELOVL6, FGA, FRK, IQGAP2, LARGE, MARCKS, MCCC1, MR1, MUT, 
NAP1L2, NEK11, NR0B1, NUDT7, OPHN1, PAN2, PDK2, PGAP2, 
PLCD4, PLCH1, RHOBTB1, SAMD9, SESN3, SFRP4, SLC35D2, SOAT1, 
STAT6, TBC1D5, TGFB2, TLR1, TM4SF20, TTLL6, ZBTB20, ZNF608 
Decreased 0.026 
HNF-6 M00639 
ABCA12, ABCG2, ADHFE1, ALDH5A1, ANO5, APOH, ARID4B, 
ARID5B, BLMH, BTN3A3, CACNA1D, CCBL2, CFH, DAB2, DEPDC6, 
DET1, DYNC2H1, EFHC1, ENTPD5, FGB, FGG, GCA, HABP2, HBP1, 
Decreased 0.027 
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HIST1H2AC, HNF4A, HNF4G, KCNK5, KIAA0922, KIAA1377, 
KIAA1712, MARCKS, MCCC1, MTMR11, NAP1L2, NCALD, NEB, NNT, 
NRG4, PDZK1, PLCH1, POF1B, RFX5, SLC16A7, SLC25A27, SLC41A2, 
SSBP2, STX17, UGT2B15, ZNF292 
Alx-4 M00619 
ADH1C, BTBD11, CEP152, FGFR4, FNBP1L, HIST2H2AA3, HMGB2, 
HOOK3, MARCKS, NR1D2, PDCD4, PIGN, PLEKHH2, ZNF654 
Decreased 0.029 
RP58 M00532 
AQP3, CCL2, CSRP1, DHX37, DPT, GREM2, IL8, ITGA3, ITGA6, 
ITGBL1, KRT38, SMOX, SNRPN, XDH 
Increased 0.034 
Lyf-1 M00141 
ABCB6, APOH, ARSE, ATG2B, BLMH, CCBL2, CDCA7L, ERBB2, 
FAM111A, FAM38B, FGG, FRAS1, GRIP1, HNF4A, KIAA0922, LYRM5, 
MYO1A, NBEA, NRG4, PBLD, PGAP2, PLD1, PTGR2, SLC25A27, 
SLC40A1, SULT2B1, SYNE2, TC2N, TJP2, TSPAN15, ZKSCAN1, 
ZMYM3, ZNF608 
Decreased 0.036 
En-1 M00396 
ABCA1, ACSM3, ALPK1, C1S, C20orf194, CASP4, CDCA7L, CEP152, 
CRBN, DIAPH2, DTX3L, EHHADH, ELOVL6, FAM105A, FAM38B, 
FMO5, GCA, HABP2, HIST2H4A, INADL, MANBA, MUT, NPY1R, 
PAIP2B, PARP14, SH3BGRL2, SLC25A27, SPTLC3, SVEP1, SYCP2L, 
TMEM60, UGT2B15, YPEL2, ZKSCAN1 
Decreased 0.038 
ER M00191 
AQP3, CLDN1, FBXO40, GABRA5, GFPT2, GLS, GPRC5A, LAMC2, 
LRRFIP1, P2RY4, PAQR5, PHLDA1, SEMA3C, SLCO4A1, WDR69, XDH 
Increased 0.039 
AFP1 M00616 
ALDH5A1, ASPM, BTN3A1, C10orf57, C6orf130, CACNA1D, 
CALCOCO1, CCNG1, CORO2A, CTNND1, EHHADH, FGB, FOXN3, 
FRAS1, ID1, KCNT2, KIAA1712, KIF13B, LIMA1, LYRM5, MARCKS, 
MLEC, NAP1L2, NIPAL3, NIPSNAP3A, NUDT7, PBLD, PFKFB3, PLCH1, 
POF1B, RARB, RFX5, SFRP4, SFRS18, SLC16A7, SLC41A2, TIGD2, 
TLR1, TMEM144, TXNIP, UGT2B15, ZC3H6, ZMYM3, ZNF292, 
ZNF654 
Decreased 0.041 
Evi-1 M00082 
ABCG2, ADH1C, ADH6, ALS2CR8, ANG, ANXA13, APOH, ASPM, 
BDKRB2, BNIP3L, C1orf63, C5orf42, CCNG2, CEP152, DYNC2H1, 
FAM55C, HIST2H2AA3, HIST2H2BA, KIAA1632, LYRM5, MANSC1, 
MBOAT1, MCCC1, MR1, MSI2, MYO1A, NCALD, NEB, NRG4, PIGN, 
PLCH1, RFX5, SAMD9, SLC41A2, SLC7A2, STAT6, TM4SF20, 
TMEM144, TXNDC16, TXNIP, WWP1, ZNF292, ZNF608 
Decreased 0.042 
Gfi-1 M00250 
ACSS2, AS3MT, BCL2L11, BDH2, BLMH, CABYR, CDK5RAP3, CEP152, 
CTNND1, CTTNBP2, DIAPH2, ERBB3, FARP2, FGB, FGFR4, GCA, 
GRIP1, HBP1, HIST2H4A, HNF4A, INADL, KDM3A, KIAA1377, LIMD1, 
LRP1, LXN, NNT, NRG4, PAIP2B, PECR, PLCD4, POF1B, RHOBTB3, 
SASH1, SCAPER, SH3BGRL2, SKAP2, SLC2A12, STEAP2, TMC7, 
VPS39, YPEL5, ZBTB20, ZNF292 
Decreased 0.042 
LEF1 M00805 
AKAP12, AKR1B1, ANKRD1, ANXA10, AQP3, C10orf114, CD55, 
CLDN1, CPA4, CPZ, CST1, CTPS, DND1, DUSP5, EMP1, EPHA2, EREG, 
FGFBP1, FRMD3, FSHB, FSTL5, GABRA5, GDF15, GFPT2, GLIPR1, 
GPRC5A, HAS2, HBEGF, HTR3D, IL8, ITGA3, ITGBL1, KIAA1199, 
KRT38, KRT80, LAMC2, NAV3, NOSTRIN, NRG1, ODC1, PMEPA1, 
POU1F1, PSG8, RAB3B, S100A3, SAMD7, SEMA3C, SERPINB8, 
SLCO4A1, SOCS2, SPRR2B, STC1, THBD, TNS4, UBASH3B, XCL1, XDH 
Increased 0.043 
OTX M01117 
ANKRA2, C14orf106, CASP6, CRBN, CTNND1, CTTNBP2, DIAPH2, 
ELF3, FAM149B1, FGB, HIST1H2AG, HIST2H4A, IP6K2, KDM3A, 
KLHDC2, MARCKS, NFKBIZ, NIPSNAP3A, NUDT7, PCDH9, PCMTD1, 
PECR, PLCD4, SESN3, TBCK, TSPAN15, WEE1, ZNF292 
Decreased 0.047 
CDP M00102 
ABCA1, ACAD11, ALPK1, ALS2CR8, APOH, ARFGAP2, ARID5B, 
ARMCX3, BAMBI, BCMO1, BNIP3L, BTN3A3, C4orf34, CCBL2, DAB2, 
DEPDC6, DET1, DYNC2H1, DZIP3, EFHC1, FGB, FGG, HIST1H2AG, 
HIST2H4A, HNF4A, HNF4G, HOXA2, INADL, KIAA1109, MARCKS, 
Decreased 0.047 
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MCCC1, MTMR11, NIPSNAP3A, NRG4, NUSAP1, PDGFC, PDZK1, 
PIGN, SASH1, SEMA3E, SERPINA6, SFRS18, SLC16A7, SLC41A2, 
STEAP2, STX17, TBC1D5, TBCK, TLR3, TM4SF20, TMEM136, 
TXNDC16, UGT2B15, ZNF654 
c-Ets-1 M00339 
ANXA3, CALB1, CD55, CSRP1, CXCL5, DUSP1, LAMC2, LMO7, NCEH1, 
NMNAT2, NOSTRIN, NR4A1, NRG1, PHLDA1, PLEK2, PSG8, S100A3, 
SOCS2, SSFA2, TGFA, THBD, TMEM171, TNS4 
Increased 0.049 
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Additional File 5: miRNAs significantly (p-value < 0.005, FDR < 0.005) changed ≥ 1.5-fold 
due to formaldehyde exposure 
--------------------------------------------------------------------------------------------------------------------------  
 
miRNA Formaldehyde/Control Ratio 
miR-33 -5.48 
miR-450 -3.57 
miR-330 -2.43 
miR-181a -2.11 
miR-10b -2.11 
miR-422b -2.02 
miR-532 -1.84 
miR-501 -1.82 
miR-487b -1.80 
miR-20a -1.80 
miR-34a -1.73 
miR-93 -1.72 
miR-106b -1.71 
miR-137 -1.71 
miR-103 -1.70 
miR-301 -1.70 
miR-10a -1.70 
miR-126 -1.70 
miR-17-5p -1.69 
miR-107 -1.69 
miR-454-3p -1.69 
miR-140 -1.68 
miR-101 -1.68 
miR-130a -1.68 
miR-19a -1.67 
miR-26a -1.67 
miR-19b -1.67 
miR-106a -1.66 
miR-99a -1.66 
miR-18a -1.66 
miR-424 -1.65 
let-7a -1.65 
miR-20b -1.65 
miR-25 -1.64 
miR-590 -1.64 
miR-15b -1.64 
let-7b -1.63 
miR-660 -1.63 
miR-27b -1.63 
miR-194 -1.62 
miR-361 -1.62 
miR-192 -1.62 
miR-215 -1.62 
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miRNA Formaldehyde/Control Ratio 
miR-374 -1.62 
miR-15a -1.62 
let-7c -1.61 
miR-148b -1.60 
miR-181b -1.60 
miR-425-5p -1.60 
miR-23b -1.60 
let-7d -1.59 
miR-28 -1.58 
miR-125a -1.58 
miR-181d -1.58 
miR-130b -1.58 
miR-185 -1.58 
miR-324-5p -1.58 
miR-9* -1.57 
miR-452 -1.57 
miR-565 -1.57 
miR-26b -1.57 
miR-152 -1.57 
miR-16 -1.57 
miR-650 -1.56 
miR-21 -1.56 
miR-9 -1.56 
miR-186 -1.56 
miR-151 -1.56 
miR-582 -1.55 
let-7e -1.55 
let-7g -1.55 
miR-98 -1.55 
miR-224 -1.55 
miR-23a -1.54 
miR-27a -1.54 
miR-362 -1.54 
let-7f -1.54 
miR-17-3p -1.53 
miR-550 -1.53 
miR-29b -1.53 
miR-182 -1.53 
miR-100 -1.51 
miR-509 -1.51 
miR-652 -1.51 
miR-331 -1.51 
miR-34b -1.51 
miR-189 -1.51 
let-7i -1.51 
miR-24 -1.50 
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Additional File 6: Predicted miRNA targets for miR-33, miR-330, miR-181a, and miR-10b 
-------------------------------------------------------------------------------------------------------------------------- 
 
Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
1. miR-33 
ABCA1 NM_005502 19 miR-330 
ABCE1 NM_001040876 6059 
 
APPBP2 NM_006380 10513 
 
ARID5B NM_032199 84159 
 
ASAP1 NM_018482 50807 
 
B3GALT2 NM_003783 8707 
 
C11ORF41 NM_012194 25758 
 
CACNA1C NM_001129834 775 
 
CDC42BPA NM_003607 8476 
 
CDK6 NM_001259 1021 
 
CLSPN NM_022111 63967 
 
CROT NM_021151 54677 
 
CSNK1D NM_001893 1453 
 
DPY19L1 NM_015283 23333 
 
DSC3 NM_001941 1825 miR-181a 
DYRK3 NM_001004023 8444 
 
EBF1 NM_024007 1879 
 
EEA1 NM_003566 8411 
 
EN2 NM_001427 2020 
 
ESCO1 NM_052911 114799 
 
FAM46C NM_017709 54855 
 
FGA NM_000508 2243 
 
FUT9 NM_006581 10690 miR-181a 
GLCCI1 NM_138426 113263 
 
GOPC NM_020399 57120 
 
GRIA3 NM_007325 2892 miR-330 
HADHB NM_000183 3032 
 
HBS1L NM_006620 10767 
 
HIPK2 NM_001113239 28996 
 
HMGA2 NM_003483 8091 
 
ING3 NM_019071 54556 
 
KCNMA1 NM_001014797 3778 
 
KIAA2018 NM_001009899 205717 
 
KIF3C NM_002254 3797 
 
LCA5 NM_181714 167691 miR-10b 
LIPI NM_198996 149998 
 
LOC152742 XM_001128848 152742 
 
LPP NM_005578 4026 
 
MMP16 NM_005941 4325 
 
MSR1 NM_138715 4481 
 
NAP1L2 NM_021963 4674 
 
NARG1 NM_057175 80155 
 
NAT8 NM_003960 9027 
 
NAT12 NM_001011713 122830 miR-330 
PIM1 NM_002648 5292 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
PNMA1 NM_006029 9240 
 
PRDM2 NM_001007257 7799 
 
PTPN13 NM_080685 5783 
 
RCAN1 NM_203417 1827 miR-330 
RIMBP2 NM_015347 23504 
 
SATB2 NM_015265 23314 
 
SCN8A NM_014191 6334 
 
SEC24C NM_004922 9632 miR-181a 
SIX4 NM_017420 51804 
 
SLC25A25 NM_001006642 114789 
 
SLC26A7 NM_052832 115111 
 
SLC39A14 NM_015359 23516 
 
SLITRK3 NM_014926 22865 
 
SLU7 NM_006425 10569 
 
SPAST NM_199436 6683 
 
ST18 NM_014682 9705 
 
TNFRSF9 NM_001561 3604 
 
UBE2V2 NM_003350 7336 
 
ZNF140 NM_003440 7699 
 
ZNF148 NM_021964 7707 miR-330 
ZNF281 NM_012482 23528 
 
ZNF300 NM_052860 91975 
 
2. miR-330 
ABCA1 NM_005502 19 miR-33 
ACVR1 NM_001105 90 
 
ADAMTS5 NM_007038 11096 
 
AFF2 NM_002025 2334 
 
AFF4 NM_014423 27125 
 
AGTR2 NM_000686 186 
 
AK7 NM_152327 122481 
 
ANGEL2 NM_144567 90806 
 
ANKH NM_054027 56172 
 
AP2M1 NM_004068 1173 
 
API5 NM_006595 8539 
 
APPL1 NM_012096 26060 
 
ARFGEF2 NM_006420 10564 
 
ARHGAP12 NM_018287 94134 
 
ARHGAP20 NM_020809 57569 
 
ARL17P1 NM_001113738 51326 
 
ATL2 NM_022374 64225 
 
ATP2B1 NM_001001323 490 miR-181a 
ATP2C1 NM_014382 27032 
 
AZIN1 NM_148174 51582 
 
BCL9 NM_004326 607 
 
BCL11B NM_022898 64919 
 
BFSP1 NM_001195 631 
 
BMPR2 NM_001204 659 
 
BTRC NM_033637 8945 
 
C10ORF10 NM_007021 11067 
 
C14ORF129 NM_016472 51527 miR-181a 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
C2CD2 NM_015500 25966 
 
C5ORF15 NM_020199 56951 
 
C5ORF23 NM_024563 79614 
 
C9ORF5 NM_032012 23731 
 
C9ORF64 NM_032307 84267 
 
CALCR NM_001742 799 
 
CAPZA1 NM_006135 829 
 
CBX5 NM_012117 23468 
 
CCND3 NM_001760 896 
 
CD247 NM_000734 919 
 
CDR2 NM_001802 1039 
 
CHP NM_007236 11261 
 
CLCN5 NM_001127899 1184 
 
CLDN8 NM_199328 9073 miR-181a 
CLDN18 NM_016369 51208 
 
CMPK1 NM_016308 51727 
 
CNBP NM_001127195 7555 
 
CRLS1 NM_019095 54675 
 
CSNK1G3 NM_001044722 1456 
 
CYP7A1 NM_000780 1581 
 
D4S234E NM_014392 27065 
 
DAG1 NM_004393 1605 
 
DCAF7 NM_005828 10238 
 
DICER1 NM_030621 23405 
 
DLX1 NM_001038493 1745 
 
DNM3 NM_015569 26052 
 
DNM1L NM_005690 10059 
 
DOCK5 NM_024940 80005 
 
DPP10 NM_001004360 57628 
 
EDEM1 NM_014674 9695 
 
EEF1A1 NM_001402 1915 
 
EFHC1 NM_018100 114327 
 
EIF5 NM_183004 1983 
 
EIF4E NM_001968 1977 
 
EPM2A NM_005670 7957 
 
ERAP1 NM_016442 51752 
 
ERBB4 NM_005235 2066 
 
ERC1 NM_178039 23085 
 
ERLIN2 NM_001003791 11160 
 
EXOC8 NM_175876 149371 
 
FAM107B NM_031453 83641 
 
FAM72D NM_207418 728833 
 
FGFR1 NM_023107 2260 
 
FMO2 NM_001460 2327 
 
FOXK1 NM_001037165 221937 miR-181a 
FRK NM_002031 2444 
 
GJC1 NM_005497 10052 
 
GNRHR NM_001012763 2798 
 
GPRASP1 NM_014710 9737 
 
GRB10 NM_001001550 2887 miR-181a 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
GRIA3 NM_007325 2892 miR-33 
HELZ NM_014877 9931 
 
HIVEP2 NM_006734 3097 
 
HNRNPU NM_031844 3192 
 
HSF2 NM_004506 3298 
 
HSPH1 NM_006644 10808 
 
ID2 NM_002166 3398 
 
IMPACT NM_018439 55364 
 
INO80D NM_017759 54891 miR-181a 
INSL5 NM_005478 10022 
 
ITM2C NM_030926 81618 
 
JPH1 NM_020647 56704 
 
KANK2 NM_015493 25959 
 
KAT2B NM_003884 8850 
 
KDM4C NM_015061 23081 
 
KDSR NM_002035 2531 
 
KIAA1012 NM_014939 22878 
 
KLF10 NM_005655 7071 
 
KLHL24 NM_017644 54800 
 
LAPTM4B NM_018407 55353 
 
LNX2 NM_153371 222484 
 
LRPPRC NM_133259 10128 
 
MARK1 NM_018650 4139 miR-181a 
MAT2A NM_005911 4144 
 
MBNL2 NM_144778 10150 
 
MECOM NM_001105078 2122 
 
METAP2 NM_006838 10988 miR-181a 
MMD NM_012329 23531 
 
MOBKL1A NM_173468 92597 
 
MRPS6 NM_032476 64968 
 
MYEF2 NM_016132 50804 
 
MYPN NM_032578 84665 
 
NAT12 NM_001011713 122830 miR-33 
NEFL NM_006158 4747 
 
ONECUT2 NM_004852 9480 miR-181a 
OTUD3 NM_015207 23252 
 
PAFAH1B1 NM_000430 5048 
 
PCDHA1 NM_018900 56147 miR-181a 
PCDHA2 NM_018905 56146 miR-181a 
PCDHA3 NM_018906 56145 miR-181a 
PCDHA4 NM_018907 56144 miR-181a 
PCDHA5 NM_018908 56143 miR-181a 
PCDHA6 NM_031849 56142 miR-181a 
PCDHA7 NM_018910 56141 miR-181a 
PCDHA8 NM_018911 56140 miR-181a 
PCDHA9 NM_031857 9752 miR-181a 
PCDHA10 NM_018901 56139 miR-181a 
PCDHA11 NM_018902 56138 miR-181a 
PCDHA12 NM_018903 56137 miR-181a 
PCDHAC1 NM_018898 56135 miR-181a 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
PCDHAC2 NM_018899 56134 miR-181a 
PCK1 NM_002591 5105 
 
PCMT1 NM_005389 5110 
 
PCTP NM_001102402 58488 
 
PHAX NM_032177 51808 
 
PLSCR1 NM_021105 5359 
 
PLSCR4 NM_001128304 57088 
 
PLXNA2 NM_025179 5362 
 
PQLC1 NM_025078 80148 
 
PRKAB2 NM_005399 5565 
 
PRKCB NM_002738 5579 
 
PSD3 NM_015310 23362 
 
PTBP2 NM_021190 58155 
 
RAI2 NM_021785 10742 
 
RAP2A NM_021033 5911 
 
RAVER2 NM_018211 55225 
 
RBM12 NM_152838 10137 
 
RCAN1 NM_203417 1827 miR-33 
RGS10 NM_002925 6001 
 
RND3 NM_005168 390 
 
RNF212 NM_194439 285498 
 
RNF144B NM_182757 255488 
 
RUFY2 NM_001042417 55680 
 
SAMD12 NM_001101676 401474 miR-181a 
SCG3 NM_013243 29106 
 
SCP2 NM_001007100 6342 
 
SELI NM_033505 85465 
 
SEMA4D NM_006378 10507 
 
SEP15 NM_203341 9403 
 
SERINC3 NM_006811 10955 
 
SFRS1 NM_006924 6426 
 
SH3TC2 NM_024577 79628 miR-181a 
SIN3A NM_015477 25942 
 
SLAIN1 NM_001040153 122060 
 
SLC2A2 NM_000340 6514 
 
SLC5A3 NM_006933 6526 
 
SMG7 NM_173156 9887 
 
SMNDC1 NM_005871 10285 
 
SNAP23 NM_130798 8773 
 
SNX2 NM_003100 6643 
 
SORL1 NM_003105 6653 
 
SOSTDC1 NM_015464 25928 
 
STAU1 NM_001037328 6780 
 
STEAP4 NM_024636 79689 
 
STK3 NM_006281 6788 
 
SUDS3 NM_022491 64426 
 
SUMF1 NM_182760 285362 
 
TAPT1 NM_153365 202018 
 
TBL1XR1 NM_024665 79718 miR-181a 
TBX5 NM_080717 6910 miR-10b 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
TEAD1 NM_021961 7003 
 
TGFBR3 NM_003243 7049 
 
THBS1 NM_003246 7057 
 
TJP1 NM_003257 7082 
 
TMEM59 NM_004872 9528 
 
TNKS NM_003747 8658 
 
TNRC6B NM_001024843 23112 
 
TNS1 NM_022648 7145 
 
TOX NM_014729 9760 miR-181a 
TRA2A NM_013293 29896 
 
TRIM2 NM_015271 23321 miR-181a 
TRIM37 NM_015294 4591 
 
TRIP12 NM_004238 9320 
 
TROVE2 NM_004600 6738 
 
TSFM NM_005726 10102 
 
TSHR NM_000369 7253 
 
UBE2Q1 NM_017582 55585 
 
UBTD2 NM_152277 92181 
 
UBXN4 NM_014607 23190 
 
USP15 NM_006313 9958 
 
USP37 NM_020935 57695 
 
VAPA NM_003574 9218 
 
VASH2 NM_024749 79805 
 
VGLL3 NM_016206 389136 
 
VPS54 NM_016516 51542 
 
WDR37 NM_014023 22884 
 
XK NM_021083 7504 
 
YIPF5 NM_001024947 81555 
 
YTHDC1 NM_133370 91746 
 
ZBTB34 NM_001099270 403341 miR-181a 
ZC3HAV1 NM_020119 56829 
 
ZCCHC24 NM_153367 219654 
 
ZFC3H1 NM_144982 196441 
 
ZFR NM_016107 51663 
 
ZNF148 NM_021964 7707 miR-33 
ZNF410 NM_021188 57862 
 
ZNF423 NM_015069 23090 
 
ZNF490 NM_020714 57474 
 
ZNF706 NM_016096 51123 
 
ZNF280D NM_001002843 54816 
 
3. miR-181a 
ACSL1 NM_001995 2180 
 
ACVR2A NM_001616 92 
 
ACVR2B NM_001106 93 
 
ACYP1 NM_001107 97 
 
ADAM28 NM_014265 10863 
 
ADAMTSL1 NM_001040272 92949 
 
ADRBK1 NM_001619 156 
 
AFTPH NM_203437 54812 
 
AHCTF1 NM_015446 25909 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
AKAP5 NM_004857 9495 
 
AKAP6 NM_004274 9472 
 
AKAP7 NM_004842 9465 
 
ARHGAP26 NM_015071 23092 
 
ARHGEF3 NM_001128615 50650 
 
ARSJ NM_024590 79642 miR-10b 
ATG5 NM_004849 9474 
 
ATM NM_138292 472 
 
ATP11C NM_173694 286410 
 
ATP2A2 NM_170665 488 
 
ATP2B1 NM_001001323 490 miR-330 
ATXN3 NM_001127696 4287 
 
BAG2 NM_004282 9532 
 
BAG4 NM_004874 9530 
 
BAI3 NM_001704 577 
 
BAZ2B NM_013450 29994 
 
BBS7 NM_018190 55212 
 
BEND3 NM_001080450 57673 
 
BHLHE40 NM_003670 8553 
 
BIRC6 NM_016252 57448 
 
BOLL NM_197970 66037 
 
BRAP NM_006768 8315 
 
BRD1 NM_014577 23774 
 
BRWD1 NM_033656 54014 
 
BTBD3 NM_014962 22903 
 
C10ORF104 NM_173473 119504 
 
C14ORF129 NM_016472 51527 miR-330 
C15ORF29 NM_024713 79768 
 
C16ORF87 NM_001001436 388272 
 
C19ORF12 NM_031448 83636 
 
C20ORF12 NM_001099407 55184 
 
C21ORF66 NM_016631 94104 
 
C2ORF69 NM_153689 205327 
 
C5ORF41 NM_153607 153222 
 
C5ORF47 XM_376444 133491 
 
C6ORF89 NM_152734 221477 
 
CABC1 NM_020247 56997 
 
CALB1 NM_004929 793 
 
CALM1 NM_006888 801 
 
CAMK2D NM_172128 817 
 
CAPRIN1 NM_005898 4076 miR-10b 
CARD8 NM_014959 22900 
 
CBX7 NM_175709 23492 
 
CCAR1 NM_018237 55749 
 
CCDC14 NM_022757 64770 
 
CCDC117 NM_173510 150275 
 
CCNB1 NM_031966 891 
 
CCNJ NM_019084 54619 
 
CCNL2 NM_001039577 81669 
 
CD302 NM_014880 9936 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
CDON NM_016952 50937 
 
CHMP2B NM_014043 25978 
 
CLASP1 NM_015282 23332 
 
CLDN8 NM_199328 9073 miR-330 
CLIP1 NM_002956 6249 
 
CLVS1 NM_173519 157807 
 
CNTN4 NM_175612 152330 
 
CPNE2 NM_152727 221184 
 
CPOX NM_000097 1371 
 
CREB5 NM_004904 9586 
 
CSF2RB NM_000395 1439 
 
CTDSPL NM_005808 10217 
 
CTTNBP2NL NM_018704 55917 
 
CUL3 NM_003590 8452 
 
DARS NM_001349 1615 
 
DCN NM_133504 1634 
 
DDX52 NM_007010 11056 
 
DDX3X NM_001356 1654 
 
DDX3 NM_004660 8653 
 
DEPDC6 NM_022783 64798 
 
DIRAS3 NM_004675 9077 
 
DLGAP2 NM_004745 9228 
 
DNAJC13 NM_015268 23317 
 
DNAL1 NM_031427 83544 
 
DOCK10 NM_014689 55619 
 
DSC3 NM_001941 1825 miR-33 
DYNC1LI2 NM_006141 1783 
 
E2F5 NM_001951 1875 
 
E2F7 NM_203394 144455 
 
EIF4A2 NM_001967 1974 
 
ENPP1 NM_006208 5167 
 
EPC2 NM_015630 26122 
 
ETV6 NM_001987 2120 
 
EXD1 NM_152596 161829 
 
FAM13B NM_001101801 51306 
 
FAM160A2 NM_032127 84067 
 
FBXO33 NM_203301 254170 
 
FBXO34 NM_017943 55030 
 
FIGN NM_018086 55137 miR-10b 
FKBP1A NM_000801 2280 
 
FMNL2 NM_052905 114793 
 
FNDC3B NM_022763 64778 
 
FOXK1 NM_001037165 221937 miR-330 
FOXP1 NM_032682 27086 
 
FUCA1 NM_000147 2517 
 
FUT9 NM_006581 10690 miR-33 
G3BP2 NM_012297 9908 
 
GABRA1 NM_001127648 2554 
 
GAPVD1 NM_015635 26130 
 
GATA6 NM_005257 2627 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
GATM NM_001482 2628 
 
GCC2 NM_181453 9648 
 
GHITM NM_014394 27069 
 
GPD2 NM_000408 2820 
 
GPD1L NM_015141 23171 
 
GPRIN3 NM_198281 285513 
 
GPX8 NM_001008397 493869 
 
GRB10 NM_001001555 2887 miR-330 
HEY2 NM_012259 23493 
 
HIC2 NM_015094 23119 
 
HOOK1 NM_015888 51361 
 
HOXB4 NM_024015 3214 
 
HOXC8 NM_022658 3224 
 
HOXD1 NM_024501 3231 
 
HRH1 NM_001098212 3269 
 
HSPC159 NM_014181 29094 
 
IL2 NM_000586 3558 
 
INO80D NM_017759 54891 miR-330 
IPO8 NM_006390 10526 
 
ITGA2 NM_002203 3673 
 
ITSN1 NM_001001132 6453 
 
KANK1 NM_015158 23189 
 
KCNH8 NM_144633 131096 
 
KCTD3 NM_016121 51133 
 
KDM5A NM_005056 5927 
 
KIAA0528 NM_014802 9847 
 
KIAA1219 NM_020336 57148 
 
KIAA1239 XM_940885 57495 
 
KIAA2022 NM_001008537 340533 
 
KIF3A NM_007054 11127 
 
KLHL2 NM_007246 11275 
 
KLHL5 NM_199039 51088 
 
KRAS NM_033360 3845 
 
LAMP2 NM_001122606 3920 
 
LARP4 NM_199190 113251 
 
LCLAT1 NM_182551 253558 
 
LHFPL3 NM_199000 375612 
 
LIFR NM_002310 3977 
 
LMO3 NM_001001395 55885 
 
LOC161527 XM_929030 161527 
 
LONRF2 NM_198461 164832 
 
LRRC8D NM_018103 55144 
 
MAP1B NM_005909 4131 
 
MAPK1 NM_002745 5594 
 
MARK1 NM_018650 4139 miR-330 
MATN3 NM_002381 4148 
 
MBOAT2 NM_138799 129642 
 
MED8 NM_201542 112950 
 
MEGF9 NM_001080497 1955 
 
METAP1 NM_015143 23173 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
METAP2 NM_006838 10988 miR-330 
MINA NM_032778 84864 
 
MKLN1 NM_013255 4289 
 
MORC3 NM_015358 23515 
 
MPP5 NM_022474 64398 
 
MTF2 NM_007358 22823 
 
MTMR12 NM_001040446 54545 
 
MTMR15 NM_014967 22909 
 
MTX3 NM_001010891 345778 
 
MUC7 NM_152291 4589 
 
NCOA2 NM_006540 10499 
 
NFAT5 NM_001113178 10725 
 
NLN NM_020726 57486 
 
NOTCH4 NM_004557 4855 
 
NOVA1 NM_002515 4857 
 
NR3C1 NM_001018076 2908 
 
NR6A1 NM_033334 2649 
 
NRAS NM_002524 4893 
 
NTS NM_006183 4922 
 
NUDT12 NM_031438 83594 
 
ONECUT2 NM_004852 9480 miR-330 
OSBPL3 NM_145320 26031 
 
OSBPL8 NM_001003712 114882 
 
OTUD4 NM_001102653 54726 
 
PAM NM_138822 5066 
 
PAPD5 NM_001040285 64282 
 
PAPOLG NM_022894 64895 
 
PARK2 NM_013987 5071 
 
PARP11 NM_020367 57097 
 
PAWR NM_002583 5074 
 
PAX9 NM_006194 5083 
 
PCDHA1 NM_031411 56147 miR-330 
PCDHA2 NM_018905 56146 miR-330 
PCDHA3 NM_018906 56145 miR-330 
PCDHA4 NM_018907 56144 miR-330 
PCDHA5 NM_018908 56143 miR-330 
PCDHA6 NM_031849 56142 miR-330 
PCDHA7 NM_018910 56141 miR-330 
PCDHA8 NM_018911 56140 miR-330 
PCDHA9 NM_031857 9752 miR-330 
PCDHA10 NM_018901 56139 miR-330 
PCDHA11 NM_018902 56138 miR-330 
PCDHA12 NM_018903 56137 miR-330 
PCDHAC1 NM_018898 56135 miR-330 
PCDHAC2 NM_018899 56134 miR-330 
PCNP NM_020357 57092 
 
PDE5A NM_001083 8654 
 
PER3 NM_016831 8863 
 
PGAP1 NM_024989 80055 
 
PHC3 NM_024947 80012 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
PHLPP2 NM_015020 23035 
 
PHTF2 NM_001127358 57157 
 
PI4K2B NM_018323 55300 
 
PITPNB NM_012399 23760 
 
PKNOX2 NM_022062 63876 
 
PLAC1L NM_173801 219990 
 
PLEKHA3 NM_019091 65977 
 
PNRC2 NM_017761 55629 
 
POLQ NM_199420 10721 
 
POLR3G NM_006467 10622 
 
POM121 NM_172020 9883 
 
POM121C NM_001099415 100101267 
 
PPP1R12B NM_002481 4660 
 
PPP1R9A NM_017650 55607 
 
PPP2R5E NM_006246 5529 
 
PRDM4 NM_012406 11108 
 
PRDX3 NM_006793 10935 
 
PRH2 NM_001110213 5555 
 
PRKCD NM_006254 5580 
 
PRTG NM_173814 283659 
 
PSG5 NM_002781 5673 
 
PSRC1 NM_001032291 84722 
 
PTGER3 NM_198715 5733 
 
RAB3IP NM_022456 117177 
 
RAD21 NM_006265 5885 
 
RAN NM_006325 5901 
 
RAP1B NM_001010942 5908 
 
RASSF2 NM_014737 9770 
 
RBM26 NM_022118 64062 
 
RBM25 NM_021239 58517 
 
REPS2 NM_001080975 9185 
 
RFC1 NM_002913 5981 
 
RIN2 NM_018993 54453 
 
RLF NM_012421 6018 
 
RNF8 NM_183078 9025 
 
RNF34 NM_025126 80196 
 
ROD1 NM_005156 9991 
 
RP5-1022P6.2 NM_019593 56261 
 
RPAP2 NM_024813 79871 
 
RPE65 NM_000329 6121 
 
RPS6KB1 NM_003161 6198 
 
RRP15 NM_016052 51018 
 
S1PR1 NM_001400 1901 
 
SAMD12 NM_207506 401474 miR-330 
SCD NM_005063 6319 
 
SCOC NM_032547 60592 
 
SEC24C NM_004922 9632 miR-33 
SEMA3C NM_006379 10512 
 
SEMA4G NM_017893 57715 
 
SFRS7 NM_001031684 6432 
 
82 
 
Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
SH3TC2 NM_024577 79628 miR-330 
SIPA1L2 NM_020808 57568 
 
SIRT1 NM_012238 23411 
 
SLC19A2 NM_006996 10560 
 
SLC24A1 NM_004727 9187 
 
SLC25A24 NM_213651 29957 
 
SLC7A11 NM_014331 23657 
 
SLITRK1 NM_052910 114798 
 
SPIN1 NM_006717 10927 
 
SPOCK1 NM_004598 6695 
 
SPP1 NM_001040058 6696 
 
SPRY4 NM_030964 81848 
 
SRPK2 NM_182692 6733 
 
ST8SIA4 NM_005668 7903 
 
STX7 NM_003569 8417 
 
SUCLG2 NM_003848 8801 
 
SYNE1 NM_133650 23345 
 
TADA2B NM_152293 93624 
 
TBC1D1 NM_015173 23216 
 
TBC1D4 NM_014832 9882 
 
TBL1X NM_005647 6907 
 
TBL1XR1 NM_024665 79718 miR-330 
TBPL1 NM_004865 9519 
 
TCERG1 NM_006706 10915 
 
TET2 NM_017628 54790 
 
TFEC NM_012252 22797 
 
TFRC NM_003234 7037 
 
TGFBR1 NM_004612 7046 
 
TGFBRAP1 NM_004257 9392 
 
TIFA NM_052864 92610 
 
TIMP3 NM_000362 7078 
 
TLL1 NM_012464 7092 
 
TMEM26 NM_178505 219623 
 
TMEM27 NM_020665 57393 
 
TMEM131 NM_015348 23505 
 
TMEM165 NM_018475 55858 
 
TMF1 NM_007114 7110 
 
TNF NM_000594 7124 
 
TNFRSF11B NM_002546 4982 
 
TNFSF4 NM_003326 7292 
 
TNPO1 NM_153188 3842 
 
TOM1L1 NM_005486 10040 
 
TOR1AIP2 NM_145034 163590 
 
TOX NM_014729 9760 miR-330 
TRDMT1 NM_176081 1787 
 
TRIM2 NM_015271 23321 miR-330 
TSPAN8 NM_004616 7103 
 
TSPYL4 NM_021648 23270 
 
UBE2A NM_003336 7319 
 
UBE2D1 NM_003338 7321 
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Symbol GenBank Entrez Gene ID miRNAs with Overlapping Targets 
UBP1 NM_001128160 7342 
 
USP42 NM_032172 84132 
 
VBP1 NM_003372 7411 
 
VCAN NM_001126336 1462 
 
WHSC2 NM_005663 7469 
 
WNK1 NM_018979 65125 
 
XRN1 NM_019001 54464 
 
ZBTB34 NM_001099270 403341 miR-330 
ZBTB44 NM_014155 29068 
 
ZFAND6 NM_019006 54469 
 
ZFP36L1 NM_004926 677 
 
ZFP36L2 NM_006887 678 
 
ZIC3 NM_003413 7547 
 
ZNF83 NM_001105549 55769 
 
ZNF124 NM_003431 7678 
 
ZNF439 NM_152262 90594 
 
ZNF440 NM_152357 126070 
 
ZNF441 NM_152355 126068 
 
ZNF454 NM_182594 285676 
 
ZNF468 NM_001008801 90333 
 
ZNF559 NM_032497 84527 
 
ZNF594 NM_032530 84622 
 
ZNF655 NM_138494 79027 
 
ZNF673 NM_001129898 55634 
 
ZSCAN23 NM_001012455 222696 
 
4. miR-10b 
ARG2 NM_001172 384 
 
ARSJ NM_024590 79642 miR-181a 
BDNF NM_170731 627 
 
C1ORF71 XM_001717264 163882 
 
CAPRIN1 NM_005898 4076 miR-181a 
CLCC1 NM_001048210 23155 
 
EBF2 NM_022659 64641 
 
FIGN NM_018086 55137 miR-181a 
FNBP1L NM_001024948 54874 
 
GALNT1 NM_020474 2589 
 
HOXA3 NM_153631 3200 
 
HOXB3 NM_002146 3213 
 
KLF11 NM_003597 8462 
 
LCA5 NM_001122769 167691 miR-33 
MAP3K7 NM_003188 6885 
 
NONO NM_007363 4841 
 
RB1CC1 NM_014781 9821 
 
RBM27 NM_018989 54439 
 
RNF7 NM_183237 9616 
 
SNX18 NM_001102575 112574 
 
TBX5 NM_181486 6910 miR-330 
TFAP2C NM_003222 7022 
 
TRNT1 NM_182916 51095 
 
USP46 NM_022832 64854 
 
WDR26 NM_001115113 80232 
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Additional File 7: 40 networks significantly associated with the predicted targets of miR-33, 
miR-330, miR-181a, and miR-10b 
-------------------------------------------------------------------------------------------------------------------------- 
 
Network 
No. 
p-value 
No. of Predicted 
Transcripts 
Molecules in Network 
1. miR-33 
1 1E-34 16 
ABCA1,ACAA2,Alcohol group acceptor phosphotransferase,CACNA1C, 
CACNA1D, CACNA1H,CDK6,CROT,CSNK1D,GLO1,HADHB,HMGA2,KCNMA1, 
LDL,LIMK2,MIR124, MMP16,MSR1,NARG1,NEK2,NFkB (complex),PDGF 
BB,PGRMC2,PIM1,Pka, PLEKHA1,PPP1R13L,PTPN13,RCAN1,RYR1 (includes 
EG:114207),SERPINB6,ST18, SUCLG2,TNFRSF9,Trypsin 
2 1E-27 14 
AHSG,ARD1A,BAT1,CHMP1B,CLSPN,CP110,CPB2,CTNNB1,DSC3,FBXW11,FG
B,FH,GLCCI1,GOT1,Groucho,HBS1L,HNF1A,HNF4A,HPX,ING3,LIN7C,MIR9-1 
(includes EG:407046),NAT8,NFYB,PCBD1,PLK1,PNMA1,PTPN13,PZP, 
RIMBP2,SLC26A7, SLITRK3,SPAST,ZNF281,ZNF300 
3 1E-26 13 
ABCE1,ANP32A,ARID5B,ATXN1,B3GALT2,BACE1,BAT2,BECN1,C11ORF41,CC
DC85B,CFL1,CHI3L1,CSF1R,DAZAP2 (includes EG:9802),DZIP3,EEA1, 
FAM46C(includes EG:54855),FGA,KIAA2018,KIF3C,KRT18,LPA,MIR17 
(includes EG:406952),MIR212 (includes EG:406994),MIR29A (includes 
EG:407021),MIR29B1,MIR29B2,NAT12,NEDD4L,SATB2,SLC39A14, 
SLU7,TARDBP,TGFB1,TRIP6 
4 1E-21 11 
ASAP1,CADM1,CCL9,CDC42,CDC42BPA,CDC42BPB,CXCL12,EBF1,EFS,ERK,FC
GR2B,FUT9,FZD5,GOPC,IL1B,ITSN2,LIMK2,LPP,MATK,PALLD,POSTN,progest
erone,PRRX1,PTK2,RRS1,SEC23A,SEC24C (includes EG:9632),SHPRH,SIX4, 
SLC25A25,SLC6A4, SSTR3,UBE2V2,VIM,ZNF140 
5 1E-13 8 
amino acids,APLP2,APP,APPBP2,beta-estradiol,CA2,CXCL5,DYRK3,EN2, 
EPB41L3,EPO,FLOT1,FSTL1,GRI,GRIA3,GRIA4,GRIP2,HIPK2,HIST4H4 
(includes EG:121504), HSP90B1,KISS1,MLLT3,nitric oxide,NSF,PARD6B, 
PPP3R1,PRDM2,PRKCA,PRKG1, PTPN13,SLC6A4,SYT11,WNT5B,ZNF148, 
ZNRF1 
2. miR-330 
1 1E-40 23 
ACVR1,AGTR2,Ap1,APPL1,ATP2B1,BMPR2,C5ORF23,CAPZA1,CCND3,CD247,
ERK,Estrogen Receptor,FGFR1,FSH,GNRH,GNRHR,hCG,HSF2,HSPH1,Insulin, 
KLF10,Lh, MAT2A,MRPS6 (includes EG:64968),PDGF BB,PP2A,RAP2A,RND3, 
SFRS1,Shc, SMG7,SNAP23,Tgf beta,THBS1,TRA2A 
2 1E-37 24 
ABCA1,ARFGEF2,BCL11B,BTRC,Calcineurin protein(s),CALCR,CBX5,CHP, 
cldn,CLDN8,CLDN18,Creb,CYP7A1,GJC1,HELZ,HNRNPU,LDL,N-cor,Nfat 
(family),NFkB (complex),PCK1,PRKAC,PRKCB,RCAN1,RNA polymerase II, 
Rxr,SEP15,SLC2A2, STAU1,TBL1XR1,TEAD1,TGFBR3,TJP1,TSHR,Vegf 
3 1E-33 20 
Akt,BCL9,Caspase,Ck2,EEF1A1,EIF5,EIF4E,ERBB4,ERK1/2,F Actin,FRK, 
GRB10, Histone h3,Histone h4,ID2,Jnk,KAT2B,KDM4C,MAGED2,Mapk, 
MECOM,MYEF2, NRG2 (includes EG:381149),P38 MAPK,PAFAH1B1, 
PCDHA4,PCDHA11,PI3K,Pkc(s), Rb,SIN3A,STK3,SUDS3,TNS1,XK 
4 1E-26 17 
AFF2,C10ORF10,CBLC,CD19,CD82,CNTFR,CRK,DAB1,EDEM1,EFEMP2,ERBB,F
CGR1A/2A/3A,INPPL1,KHDRBS1,KRTAP4-12,LYN,NEDD9,PCDHA1,PCDHA2, 
PCDHA3, PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10,PCDHA12, 
PLSCR1,PLSCR4,RBM12,SSR1,STX18,XBP1,YIPF5 
5 1E-25 16 
ADIPOR1,ANGEL2,APOC3,ARL17P1,C9ORF5,C9ORF64,CIAO1,CNBP,EEF2K,FA
M107B,FOXA2,glycogen,HNF1B,HNF4A,HNRNPR,KIAA1012,LRP5,MAGOH,M
ETAP2,MLXIPL,NCBP1,ONECUT2,PCK1,PEPCK,PRKAB2,RAI2,RPL31,SLC2A2,S
YTL4,TADA3L,TMEM59 (includes EG:9528),TOE1,TROVE2,TTR,USP15 
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6 1E-25 16 
BMP2,C14ORF129,C2CD2,C5ORF15,CRADD,D4S234E,DNM1L,EPM2A 
(includes EG:7957),FRK,GSK3B,HNRNPA3,HOXA13,ITM2C,KLF10,MIR17 
(includes EG:406952),MIR27B (includes EG:407019),MIRN330,MNT,MYPN, 
NAT12,PAX8, PLXNA2,PPP1CA,PPP1R3C,RBL2,SERPINB2,SFRP1,SFRS5, 
SMYD2,SOSTDC1,TBX2,TNF,ZBTB34,ZNF410,ZNF423 
7 1E-23 15 
ATL2,BCL2,BCLAF1,CGN,CMPK1,DCAF7,DERL1,DHX15,DPP10,E2F4,EFHC1,HI
ST2H2BE,IFNA2,KIF1B,LAPTM4B,MARK1,MIR122,MYCBP2,NDE1,NEFL,OFD1
,PTPN3,SCG3,TBC1D4,TP53BP2,TRIM2,TSFM (includes EG:10102),UBXN4, 
USP18,USP37 (includes EG:57695),VCP,VPS54,YWHAG,YWHAZ,ZC3HAV1 
8 1E-23 15 
ABL1,AFF4,amino acids,APEX2,ARHGAP12,CSNK1G3,DLGAP5,DNM3,DYRK2, 
ERLIN2,EWSR1,GNS,hydrogen peroxide,MBNL2,MERTK,MIR133A,MIR133A-
1, MIR133A-2,MIRN140,MOBKL1A,NBEA (includes EG:26960),PCDHAC2, 
PCMT1, PTBP2,RIPK4,SELI,SMNDC1,SNX2,SRF,STK38L (includes EG:23012), 
TCEB3B,TGFB1, TRAF2,TRIM37,UBTD2 
9 1E-22 15 
AGT,ANKH,AZIN1,BOK,CLNS1A,DICER1,DOCK5,EIF5,EIF2C2,FMR1,GRIA3,HSF
2,LNX2,MIRLET7B (includes EG:406884),MIRN346,NR3C1,OTUD3,PIWIL4, 
PPP1R3C, PPP2CA,PRKRA,RNF144B,SERINC3,STXBP5,TARBP2,TBX2,TBX5, 
TNRC6B,UBE2A,UBE2I,UBE2L6,UBE2Q1,UBE2T,UGCG,WDR37 
10 1E-21 14 
AGR2,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSI,ARSJ,BFSP1,BMX,CDKN2A,D4
S234E,DAG1,DLX1,ERBB2,ERC1,KANK2,MMD,PLXNB2,PQLC1,PTRF,RASA3,R
UFY2,SCP2,SLCO1A1,STEAP4,SULF1,SULF2,SUMF1,TLN1,TNF,VIM,ZFR,ZNF1
48 
11 1E-19 13 
ASS1,ATP2C1,BTRC,CCDC85B,CDKN1A,CDR2,CLCN5,Cofilin,ERAP1,EXOC7,EX
OC8,GCN1L1,HIVEP2,HOXB4,IGF2BP1,IMPACT,KRT20,LRPPRC,MAZ,MBIP,M
CM10,MIRLET7A1,MYC,PKN1,PNN,POLR1B,POLR2L (includes EG:5441), 
PRC1,RFX1,TADA2L, TRIP12,UXT,VASH2,YTHDC1,ZFC3H1 
12 1E-19 13 
ADAMTS5,AP1S2,API5,DHX15,DRD2,FMO,FMO2,FOXK1,GH1,GPRASP1,HTT,
KCNK3,KLF16,MIR103-1 (includes EG:406895),MLH1,PCTP,PSD3,PTPN22, 
RALB,retinoic acid,RPL6,RPS19,SATB1,SFRS2IP,SLAIN1,SLC5A3,TOX,UBA7, 
VAMP1,VAPA,VAPB,VGLL3,YWHAB,ZNF133,ZNF706 
13 1E-13 10 
ACTR5,ACTR8,AP2M1,APEX2,ARHGAP29,ATP6V0E1,ERVK6,FGD1,FIGF,FURI
N,GATS,HEBP2,INO80,INO80B,INO80D,INO80E,INS1,ITGB1,JPH1,KATNA1,KL
HL24,LDLRAP1,MIR124,MIR124-1,phosphatidylinositol-3,4,5-triphosphate, 
PREX1,Rac,RAVER2, RGS10,SEMA4D,SLC16A1,SORL1,SURF4,TNKS,ZCCHC24 
3. miR-181a 
1 1E-43 26 
BAG4,BIRC6,CALB1,CAMK2D,DLGAP2,E2F7,ENPP1,FUCA1,HEY2,HRH1,Ifn,MI
R1,MTMR12,MUC7,NFkB (complex),NFkB (family),NOTCH4,NTS,PARK2, 
PAWR, POM121C,PRDX3,PRH2,Proteasome,SPHINGOMYELINASE,TFRC, 
TIMP3,Tnf receptor,TOM1L1,TRIM2,UBE2,UBE2A,UBE2D1,Ubiquitin, 
ZFAND6 
2 1E-41 25 
ACVR2A,ACVR2B,Alcohol group acceptor phosphotransferase,ATM, 
BHLHE40, DDX3X,EIF4A2,FBXO33,FBXO34,FKBP1A,GABRA1,Histone H1,IFN 
Beta,Importin beta,IPO8,KLHL2,MAPK1,p70 S6k,PDE5A,POLQ,PP1,PP1-
C,PPP1R9A,PPP2R5E, PRKCD,RAN,REPS2,Smad,SPRY4,Tgf beta,TGFBR, 
TGFBR1,TGFBRAP1,TNFRSF11B, TNPO1 
3 1E-34 22 
Akt,Ap1,ATXN3,BAG2,BRWD1,CABC1,Cbp/p300,CBX7,CCAR1,E2F5,Estrogen 
Receptor,ETV6,GRB10,Growth hormone,Histone h4,HOXB4,HOXC8,Hsp90, 
ITSN1, KDM5A,N-cor,NCOA2,NR3C1,Pias,RAD21,Rxr,SPP1,SRPK2,STAT5a/b, 
TBC1D4, TBL1X,TBL1XR1,TET2,tyrosine kinase,VitaminD3-VDR-RXR 
4 1E-32 21 
ACSL1,AKAP,AKAP5,AKAP6,AKAP7,AMPK,ATG5 (includes EG:9474),ATP2A2, 
CaMKII,Caspase,CCNL2,CDON,Creb,CREB5,Cytochrome c,DNAJC13, 
DYNC1LI2, FSH,GATA6,hCG,Histone h3,Hsp70,Mmp,P38 MAPK,PCDHA4, 
Pka,RFC1,RNA polymerase II,SCD,SFRS7,SIRT1,TBPL1,TCERG1,ZBTB44, 
ZNF83 
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5 1E-21 16 
ADAM11,ADAM28,C2ORF69,C5ORF41,CCNJ,CD40LG,CTDSPL,FBXO33,FRK,IL
K,KCNH8,MEGF9,MIR140 (includes EG:406932),MIR153-1,MIR153-2, 
MIR181B1, MIR181B2,MIR21 (includes EG:406991),MIR217 (includes 
EG:406999),MT1G, NEFH,NFIB,OTUD4,PAPOLA,PAPOLG,PAX8,PCDHAC2, 
PHLPP2,RAB9A,RB1,SEMA4G,SLITRK1,SPIN1,TERT,ZIC3 
6 1E-20 17 
14-3-3,Angiotensin II receptor type 1,Calcineurin A,Calcineurin protein(s), 
CARD8, CD3,CLASP1,CLIP1,DOCK10,DSC3,Eotaxin,Fcer1,GPD2,Ifn gamma, 
IKK (complex), Importin alpha,LRRC8D,MAP2K1/2,MEF2,MHC Class 
II,MKLN1,NFAT5,NFAT (complex),Nfat (family),NR6A1,PLEKHA3,Ptger, 
PTGER3,SEMA3C,TCR,TIFA,TNF, TNFSF4,VAV,ZFP36L1 
7 1E-20 15 
ADRBK1,CRK,EFNA1,ENG,ERBB4,FLNA,GNB2L1,INHBA,KAT2B,MIR34A 
(includes EG:407040),MMP13,MTF2,NEDD9,NFYC,NKX2-1,PCDHA1, 
PCDHA2,PCDHA3, PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10, 
PCDHA11,PCDHA12,PDPK1,PRDM4,SMAD3,sphingosine-1-phosphate, 
TMEM165,TP53BP2,WEE1,ZEB2 
8 1E-20 15 
ACTR5,ACTR8,ALDOB,BBS7,BEND3,CD302,CDCA7L,CHMP2B,ERVK6,FOXA2,
GATS,HNF1A,HOXD1,INO80B,INO80D,INO80E,KANK1,METAP1,MIR124,MIR
124-1, ONECUT2,OSBPL8,PCNP,POLR3G,POU2F1,retinoic acid,RPE65, 
RUVBL1,SUCLG1, SUCLG2,SUMO1,TMEM109,TNFRSF21,TWIST2,ZNF673 
9 1E-19 15 
ACTB,AFTPH,ANKH,APBB1,beta-estradiol,C19ORF12,CPNE2,EIF3M,ENC1, 
FUT9, GH1,Glutathione peroxidase,GPX8,GSTM3 (includes EG:2947),GSTT1, 
hydrogen peroxide,MGST2,PARP,PARP4,PARP11,PER3,PNRC2 (includes 
EG:55629), progesterone,PSG5,PTGER3,PTP4A2,ROD1,SLC7A11,SMARCA4, 
SMPDL3A,SPOCK1,SRD5A2,TOR1AIP2,TOX,TSC22D1 
10 1E-18 14 
ATYPICAL PROTEIN KINASE C,BCR,C1q,Collagen type I,Collagen(s),DCN,ERK, 
Focal adhesion kinase,Ige,IgG,Igm,Integrin,ITGA2,KIF3A,Laminin,LAMP2, 
LIFR,Mek,NRAS, Pdgf,PDGF BB,PLA2,Pld,PP2A,RAB3IP,Rac,Rap1,Ras, 
RASSF2,RIN2,RPS6KB1,S1PR1, TLL1,TSPAN8,VCAN 
11 1E-18 14 
AP3B2,ARRB1,ATP11C,BRD1,BRF1,cldn,CLDN4,CLDN6,CLDN8,CNTN4,CSDA,
DNAJB6,FIGN,FOXK1,GAPVD1,HNRNPAB,KCTD3,LOC161527,MIR31 
(includes EG:407035),MIRN341,MTX3,NFYB,OGG1,OSBPL3,PLEC1,RAB8B, 
RBM26,SON,SSTR3,ST8SIA4,TJP1,VIM,VPS39,YWHAB,ZNF468 
12 1E-18 14 
AHCTF1,ARHGEF3,BTBD3,CDC2L1 (includes EG:984),COBRA1,DDX52, 
FAM13B, HEATR1,IPO7,KIAA1239,KIAA2022,KPNB1,MED8,MED25,MED26, 
MED28,MED29,MIR195,MIR373,MIR181C (includes EG:406957),MIR199A1, 
MLH1,MTMR15,MYC, NUP133,PAPD5,PHTF2,POLR2C,POLR2D,RDBP,Rfc, 
RPAP2,SR140,WHSC2,XRN1 
13 1E-16 13 
BRAP,C15ORF29,C20ORF12,CDC14A,CDK5,CTSB,DNAL1,FAM160A2,GFI1B,G
HITM,GOLGA2,GPS2,HIC2,HLA-B,HNF4A,LARP4,MINA,MIRN336,MYST2, 
NDRG1, ONECUT1,PDK2,PPARGC1A,PPP1CA,PPP1R12B,PRDM5,PRKCE, 
RAB33B,RABAC1,ROCK1,SEC23A,SEC24C (includes EG:9632),SLC6A4,TMF1, 
ZNF594 
14 1E-16 13 
ADAMTS4,ADAMTS5,ARF4,C21ORF33,CAPRIN1,CASP14,CCDC14,CCDC85B,C
OMP,DNAJB4,FNDC3B,GCC2,MATN3,MATN4,NNMT,PARVA,PAX3,PHGDH,PI
4K2B,RAB18,RBM25 (includes EG:58517),RNF8,RNH1,SDPR,SF3A3, 
SLC2A4,STOML2,STX7, TBC1D1,TGFB1,TSPYL4,VPS11,WBP4,WNK1,ZFP36L2 
15 1E-16 13 
ADAMTSL1,AHSG,ALP,ALPI,ATP2A1,B4GALNT1,BMYO,C16ORF87,CD274,CD
1A,CSF1,DBT,DDX3Y (includes EG:8653),DGKA,EPC2,GATM,GRB2,HMGN3, 
HSPC159,IL4,L-triiodothyronine,LIF,MIRN328,PAX9,RP5-1022P6.2,SHH, 
SLC24A1,SLC29A1,ST5, TFEC,TMEM131,VEGFA,ZBTB34,ZFP36,ZNF124 
16 1E-15 13 
ACADVL,AIMP2,ALB,BAI3,BAZ2B,BBC3,C10ORF104,CBX4,CPOX,CTBP2,DENR 
(includes EG:8562),EEF2K,EIF4A3 (includes EG:9775),GPRIN3,HIPK2,HP, 
ITGA2, LMO3,METAP2,MORC3,MTA1,PAX5,PCGF2,PDE4B,PEG3,PHC2,PHC3, 
PSRC1,RBBP6 (includes EG:5930),S100A4,SERPING1,SLC19A2,SUPT3H 
(includes EG:8464), TADA2B,TP53 
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17 1E-15 12 
ACYP1,APOBEC3B,C14ORF129,CDC5L,CHIC2,CMBL,CRB3,CYP2D9,DISC1,ETN
K2,EXOSC4,G3BP2,GSK3B,HNF4A,HOOK1,Hydrolase,KIF3C,LTA4H,MDFI 
(includes EG:4188),MPP1,MPP5,NLN,NPDC1,PARP4,PRCC,PTPN7,REXO2, 
SCOC,SFI1,SYNE1,UBP1,VPS29,ZNF439,ZNF440,ZNF559 
18 1E-14 12 
ADCY,ADRBK1,ARHGAP26,ATP2B1,CCNB1,Cdc2,CSF2RB,CUL3,Cyclin A, 
Cyclin B,Cyclin E,DARS,DIRAS3,ERK1/2,G protein beta gamma,Gpcr,IL1,IL2, 
Insulin, Interferon alpha,Jnk,KRAS,LDL,Lh,Mapk,PI3K,PITPNB,Pkc(s), 
PLC,RAP1B,Ras homolog,Sapk,Shc,STAT,Vegf 
19 1E-11 10 
amino acids,ASPH,C7ORF16,CDKL1,CTTNBP2NL,DAPK2 (includes EG:23604), 
DEPDC6 (includes EG:64798),EEF1A1,FMNL2 (includes EG:114793),FNBP4, 
FOXP1,HAT1,HTT,IL12 (complex),MARK1,MBOAT2,MLST8,MTOR,NXN, 
PDK1,PGGT1B, PPP2CA,PQBP1,PRPF40A,PTPN7,RIPK4,RLF,RNF34,RP6-
213H19.1,STAT4,STRADA, TPP2,TRDMT1,TRIM30,ZNF655 
20 1E-11 10 
Actin,AFAP1,AKAP5,Alpha tubulin,APLNR,ARPP-21,C21ORF66,CALM1, 
Calmodulin,CAMK2N2,Ck2,CYB5R3,F Actin,FGD4,GABRR1,GRIN1,KCNQ2, 
KCNQ3,KIAA1219, MAP1B,NOVA1,PAM,PCP4,PFDN4,PFDN6,POM121, 
PPEF2,sodium chloride,SRC, TMEM27,TRIM13,Tubulin,UNC13A,USP6,VBP1 
4. miR-10b 
1 1E-23 10 
ACT1,ANKRD1,ARPP-21,ASB2,BDNF,CALB2,CNGA2,EBF2,EDARADD,FASLG, 
FIGN, FNBP1L,GRIN2B,GRIN2C,HTT,IP6K2,KLF11,LCA5,MAP3K7,MBTPS1, 
MIR124-1,NAPB,NEUN,NFkB (complex),PELI1,PELI3,RBM27,RNF7,SGSM2, 
SNX18,TPH1, UBC,UBE2V1,WDR34,YY1 
2 1E-22 10 
AGT,ANKRD1,ARG2,Arginase,beta-estradiol,CAPRIN1,CREB1,G3BP1, 
GALNT1, GRIN2C,GRM3,HOXA2,HOXA3 (includes EG:3200),HOXB3,HOXD3, 
LOR,MAFB, MYLPF,NR3C1,PBX1,PPP3R1,RB1CC1,RPS6KA5,SLC19A1,STAT3, 
TBX2,TBX3,TBX5,TFAP2C,TGFB1,TP53,TRNT1,WDR26,WWOX,WWTR1 
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Additional File 8: Canonical pathways involving at least three molecules present in top 
networks significantly associated with predicted targets of miR-33, miR-330, miR-181a, and 
miR-10b 
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Canonical Pathways 
Present in 
miR-33 
Network? 
Present in 
miR-330 
Network? 
Present in 
miR-181a 
Network? 
Present in 
miR-10b 
Network? 
Total miRNA 
Networks with 
Canonical Pathway 
Molecular Mechanisms of Cancer Yes Yes Yes Yes 4 
Acute Phase Response Signaling Yes Yes Yes No 3 
Colorectal Cancer Metastasis Signaling Yes Yes Yes No 3 
Glucocorticoid Receptor Signaling Yes Yes Yes No 3 
GNRH Signaling Yes Yes Yes No 3 
G-Protein Coupled Receptor Signaling Yes Yes Yes No 3 
Hepatic Cholestasis Yes Yes Yes No 3 
NF-kB Signaling Yes No Yes Yes 3 
PPAR Signaling Yes Yes Yes No 3 
Production of Nitric Oxide and Reactive Oxygen 
Species in Macrophages 
Yes Yes Yes No 3 
Role of Macrophages, Fibroblasts and 
Endothelial Cells in Rheumatoid Arthritis 
Yes Yes Yes No 3 
Tight Junction Signaling Yes Yes Yes No 3 
Type I Diabetes Mellitus Signaling No Yes Yes Yes 3 
Actin Cytoskeleton Signaling Yes Yes No No 2 
Androgen Signaling Yes Yes No No 2 
Aryl Hydrocarbon Receptor Signaling Yes Yes No No 2 
Axonal Guidance Signaling Yes Yes No No 2 
B Cell Receptor Signaling No Yes Yes No 2 
BMP signaling pathway Yes Yes No No 2 
Breast Cancer Regulation by Stathmin1 Yes Yes No No 2 
Calcium Signaling Yes Yes No No 2 
Cardiac Hypertrophy Signaling Yes Yes No No 2 
Ceramide Signaling No Yes Yes No 2 
Ephrin Receptor Signaling Yes Yes No No 2 
Glioblastoma Multiforme Signaling Yes Yes No No 2 
Glioma Signaling Yes Yes No No 2 
Hepatic Fibrosis / Hepatic Stellate Cell 
Activation 
No Yes Yes No 2 
HMGB1 Signaling No Yes Yes No 2 
Huntington's Disease Signaling No Yes No Yes 2 
iCOS-iCOSL Signaling in T Helper Cells Yes No Yes No 2 
IL-12 Signaling and Production in Macrophages Yes Yes No No 2 
IL-6 Signaling No Yes Yes No 2 
IL-8 Signaling Yes Yes No No 2 
ILK Signaling No Yes Yes No 2 
LXR/RXR Activation Yes No Yes No 2 
PAK Signaling Yes Yes No No 2 
PPARalpha/RXRalpha Activation Yes Yes No No 2 
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Canonical Pathway 
Protein Kinase A Signaling Yes No Yes No 2 
PTEN Signaling No Yes Yes No 2 
RAR Activation Yes Yes No No 2 
Renin-Angiotensin Signaling Yes Yes No No 2 
Role of NFAT in Cardiac Hypertrophy Yes Yes No No 2 
Role of NFAT in Regulation of the Immune 
Response 
Yes Yes No No 2 
Role of Osteoblasts, Osteoclasts and 
Chondrocytes in Rheumatoid Arthritis 
No Yes Yes No 2 
Thrombin Signaling No Yes Yes No 2 
Type II Diabetes Mellitus Signaling Yes No Yes No 2 
4-1BB Signaling in T Lymphocytes Yes No No No 1 
Acute Myeloid Leukemia Signaling Yes No No No 1 
AMPK Signaling No Yes No No 1 
Amyloid Processing Yes No No No 1 
Amyotrophic Lateral Sclerosis Signaling Yes No No No 1 
Apoptosis Signaling No No Yes No 1 
Atherosclerosis Signaling Yes No No No 1 
Autoimmune Thyroid Disease Signaling No Yes No No 1 
Cardiac B-adrenergic Signaling Yes No No No 1 
CCR5 Signaling in Macrophages No Yes No No 1 
CD28 Signaling in T Helper Cells No Yes No No 1 
CD40 Signaling No No No Yes 1 
Cdc42 Signaling No Yes No No 1 
Cellular Effects of Sildenafil (Viagra) Yes No No No 1 
Cholecystokinin/Gastrin-mediated Signaling No Yes No No 1 
Chronic Myeloid Leukemia Signaling Yes No No No 1 
Crosstalk between Dendritic Cells and Natural 
Killer Cells 
No No Yes No 1 
CXCR4 Signaling No Yes No No 1 
Death Receptor Signaling No No Yes No 1 
Dendritic Cell Maturation No No Yes No 1 
EGF Signaling No Yes No No 1 
EIF2 Signaling No Yes No No 1 
Endothelin-1 Signaling No Yes No No 1 
ERK/MAPK Signaling No Yes No No 1 
Erythropoietin Signaling No Yes No No 1 
Estrogen Receptor Signaling No Yes No No 1 
Estrogen-Dependent Breast Cancer Signaling No Yes No No 1 
Factors Promoting Cardiogenesis in Vertebrates No Yes No No 1 
Germ Cell-Sertoli Cell Junction Signaling No Yes No No 1 
Human Embryonic Stem Cell Pluripotency No Yes No No 1 
Hypoxia Signaling in the Cardiovascular System No No Yes No 1 
IGF-1 Signaling No Yes No No 1 
IL-1 Signaling Yes No No No 1 
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IL-2 Signaling No Yes No No 1 
IL-3 Signaling No Yes No No 1 
Induction of Apoptosis by HIV1 No No Yes No 1 
Inositol Phosphate Metabolism Yes No No No 1 
Insulin Receptor Signaling No Yes No No 1 
Integrin Signaling No Yes No No 1 
mTOR Signaling No Yes No No 1 
Natural Killer Cell Signaling No Yes No No 1 
Neuropathic Pain Signaling in Dorsal Horn 
Neurons 
No No No Yes 1 
Neurotrophin/TRK Signaling No Yes No No 1 
Nicotinate and Nicotinamide Metabolism Yes No No No 1 
Nitric Oxide Signaling in the Cardiovascular 
System 
Yes No No No 1 
Ovarian Cancer Signaling No Yes No No 1 
P13K/AKT Signaling No Yes No No 1 
p70S6K Signaling No Yes No No 1 
PDGF Signaling No Yes No No 1 
Phospholipase C Signaling No Yes No No 1 
Prolactin Signaling No Yes No No 1 
Protein Ubiquitination Pathway No No Yes No 1 
PXR/RXR Activation Yes No No No 1 
Rac Signaling Yes No No No 1 
Regulation of eIF4 and p70S6K Signaling No Yes No No 1 
Regulation of IL-2 Expression in Activated and 
Anergic T Lymphocytes 
No Yes No No 1 
Relaxin Signaling Yes No No No 1 
Renal Cell Carcinoma No Yes No No 1 
Role of NANOG in Mammalian Embryonic 
Stem Cell Pluripotency 
No Yes No No 1 
Role of PKR in Interferon Induction and 
Antiviral Response 
No No Yes No 1 
SAPK/JNK Signaling No Yes No No 1 
Small Cell Lung Cancer Signaling Yes No No No 1 
Sphingosine-1-phosphate Signaling No Yes No No 1 
Synaptic Long Term Potentiation Yes No No No 1 
Systemic Lupus Erythematosus Signaling No Yes No No 1 
T Cell Receptor Signaling No Yes No No 1 
TGF-B Signaling No Yes No No 1 
Thrombopoietin Signaling No Yes No No 1 
VDR/RXR Activation Yes No No No 1 
Wnt/B-catenin Signaling No Yes No No 1 
Xenobiotic Metabolism Signaling No No Yes No 1 
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Additional File 9: Biological functions significantly (p-value < 0.005) associated with 
predicted miRNA targets of miR-33, miR-330, miR-181a, and miR-10b 
---------------------------------------------------------------------------------------------------------------- 
 
Functions p-value 
1. miR-33 
Amino Acid Metabolism 0.0034 
Behavior 0.0001 
Cancer 0.0041 
Carbohydrate Metabolism 0.0041 
Cardiovascular Disease 0.0046 
Cell Cycle 0.0009 
Cell Death 0.0041 
Cell Morphology 0.0003 
Cell-mediated Immune Response 0.0041 
Cell-To-Cell Signaling and Interaction 0.0036 
Cellular Assembly and Organization 0.0036 
Cellular Compromise 0.0041 
Cellular Development 0.0003 
Cellular Function and Maintenance 0.0041 
Cellular Growth and Proliferation 0.0041 
Cellular Movement 0.0041 
Connective Tissue Development and Function 0.0041 
Drug Metabolism 0.0041 
Embryonic Development 0.0003 
Endocrine System Development and Function 0.0041 
Gene Expression 0.0041 
Genetic Disorder 0.0002 
Hair and Skin Development and Function 0.0017 
Hematological Disease 0.0041 
Hematological System Development and Function 0.0041 
Hematopoiesis 0.0041 
Immunological Disease 0.0041 
Inflammatory Response 0.0041 
Lipid Metabolism 0.0041 
Metabolic Disease 0.0041 
Molecular Transport 0.0041 
Nervous System Development and Function 0.0041 
Neurological Disease 0.0002 
Organ Development 0.0041 
Organ Morphology 0.0041 
Organismal Injury and Abnormalities 0.0041 
Post-Translational Modification 0.0034 
Protein Synthesis 0.0025 
Psychological Disorders 0.0002 
Renal and Urological System Development and Function 0.0009 
Reproductive System Development and Function 0.0041 
Skeletal and Muscular Disorders 0.0014 
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Functions p-value 
Skeletal and Muscular System Development and Function 0.0040 
Small Molecule Biochemistry 0.0034 
Tissue Development 0.0040 
Vitamin and Mineral Metabolism 0.0041 
2. miR-330 
 
Carbohydrate Metabolism 0.0006 
Cell Cycle 0.0043 
Cell Morphology 0.0038 
Cell-mediated Immune Response 0.0038 
Cell-To-Cell Signaling and Interaction 0.0011 
Cellular Development 0.0028 
Cellular Function and Maintenance 0.0002 
Cellular Growth and Proliferation 0.0028 
Cellular Movement 0.0002 
Embryonic Development 0.0019 
Endocrine System Development and Function 0.0028 
Gene Expression 0.0028 
Hematological System Development and Function 0.0038 
Immune Cell Trafficking 0.0038 
Inflammatory Response 0.0019 
Lipid Metabolism 0.0006 
Molecular Transport 0.0018 
Nervous System Development and Function 0.0004 
Organismal Development 0.0013 
RNA Trafficking 0.0028 
Small Molecule Biochemistry 0.0006 
Tissue Development 0.0019 
3. miR-181a 
 
Cancer 0.0012 
Carbohydrate Metabolism 0.0032 
Cardiovascular Disease 0.0000 
Cell Cycle 0.0001 
Cell Death 0.0001 
Cell Morphology 0.0012 
Cell-mediated Immune Response 0.0038 
Cell-To-Cell Signaling and Interaction 0.0004 
Cellular Assembly and Organization 0.0015 
Cellular Development 0.0012 
Cellular Function and Maintenance 0.0012 
Cellular Growth and Proliferation 0.0004 
Cellular Movement 0.0012 
Connective Tissue Development and Function 0.0012 
Connective Tissue Disorders 0.0012 
Dermatological Diseases and Conditions 0.0012 
DNA Replication, Recombination, and Repair 0.0038 
Drug Metabolism 0.0036 
Endocrine System Development and Function 0.0002 
Endocrine System Disorders 0.0020 
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Functions p-value 
Gastrointestinal Disease 0.0005 
Gene Expression 0.0001 
Genetic Disorder 0.0003 
Hair and Skin Development and Function 0.0012 
Hematological Disease 0.0012 
Hematological System Development and Function 0.0038 
Hematopoiesis 0.0038 
Immune Cell Trafficking 0.0038 
Immunological Disease 0.0012 
Infection Mechanism 0.0010 
Inflammatory Disease 0.0005 
Inflammatory Response 0.0012 
Lipid Metabolism 0.0023 
Metabolic Disease 0.0020 
Molecular Transport 0.0012 
Nervous System Development and Function 0.0003 
Neurological Disease 0.0005 
Nucleic Acid Metabolism 0.0012 
Organ Development 0.0017 
Organismal Development 0.0030 
Organismal Functions 0.0023 
Organismal Injury and Abnormalities 0.0019 
Organismal Survival 0.0020 
Respiratory Disease 0.0023 
Respiratory System Development and Function 0.0004 
Skeletal and Muscular Disorders 0.0012 
Skeletal and Muscular System Development and Function 0.0002 
Small Molecule Biochemistry 0.0004 
Tissue Development 0.0002 
Tissue Morphology 0.0004 
Tumor Morphology 0.0012 
4. miR-10b 
Amino Acid Metabolism 0.0015 
Auditory and Vestibular System Development and Function 0.0046 
Behavior 0.0030 
Cardiovascular Disease 0.0015 
Cardiovascular System Development and Function 0.0001 
Cell Death 0.0015 
Cell Morphology 0.0015 
Cell-To-Cell Signaling and Interaction 0.0015 
Cellular Assembly and Organization 0.0015 
Cellular Compromise 0.0017 
Cellular Development 0.0000 
Cellular Function and Maintenance 0.0015 
Cellular Growth and Proliferation 0.0013 
Cellular Movement 0.0015 
Connective Tissue Development and Function 0.0016 
Connective Tissue Disorders 0.0030 
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Functions p-value 
Developmental Disorder 0.0046 
Digestive System Development and Function 0.0015 
Embryonic Development 0.0010 
Endocrine System Development and Function 0.0002 
Endocrine System Disorders 0.0046 
Gastrointestinal Disease 0.0046 
Gene Expression 0.0003 
Genetic Disorder 0.0046 
Hair and Skin Development and Function 0.0030 
Hematological Disease 0.0015 
Hematological System Development and Function 0.0015 
Hematopoiesis 0.0015 
Humoral Immune Response 0.0015 
Immune Cell Trafficking 0.0046 
Immunological Disease 0.0046 
Inflammatory Disease 0.0030 
Inflammatory Response 0.0046 
Lymphoid Tissue Structure and Development 0.0030 
Nervous System Development and Function 0.0015 
Neurological Disease 0.0002 
Organ Development 0.0002 
Organ Morphology 0.0015 
Organismal Development 0.0002 
Organismal Functions 0.0015 
Organismal Injury and Abnormalities 0.0015 
Reproductive System Development and Function 0.0046 
RNA Post-Transcriptional Modification 0.0030 
Skeletal and Muscular Disorders 0.0030 
Skeletal and Muscular System Development and Function 0.0016 
Small Molecule Biochemistry 0.0015 
Tissue Development 0.0010 
Tissue Morphology 0.0001 
Visual System Development and Function 0.0015 
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Additional File 10: Biological functions significantly (p-value < 0.005) associated with 
formaldehyde-responsive genes, as identified through pathway analysis of  the Li et. al. 
(2007) genomic database 
---------------------------------------------------------------------------------------------------------------- 
 
Functions p-value 
Cell Death 1.65E-22 
Cellular Growth and Proliferation 1.17E-19 
Cancer 1.87E-19 
Gene Expression 4.40E-16 
Cell Cycle 1.51E-15 
Cellular Development 6.49E-13 
Developmental Disorder 7.45E-12 
Reproductive System Disease 2.93E-11 
Cardiovascular System Development and Function 2.38E-10 
Organismal Development 2.38E-10 
Organismal Survival 3.94E-10 
Hematological System Development and Function 1.93E-09 
Hematopoiesis 1.93E-09 
Tissue Development 5.73E-09 
Cell-mediated Immune Response 1.09E-08 
Cellular Function and Maintenance 1.09E-08 
Connective Tissue Disorders 1.10E-08 
Immunological Disease 1.10E-08 
Inflammatory Disease 1.10E-08 
Skeletal and Muscular Disorders 1.10E-08 
Tissue Morphology 5.86E-08 
Gastrointestinal Disease 5.86E-08 
Skeletal and Muscular System Development and Function 7.68E-08 
DNA Replication, Recombination, and Repair 1.47E-07 
Cardiovascular Disease 3.01E-07 
Organ Development 4.23E-07 
Genetic Disorder 4.39E-07 
Neurological Disease 4.39E-07 
Embryonic Development 4.92E-07 
Reproductive System Development and Function 4.92E-07 
Connective Tissue Development and Function 7.51E-07 
Cellular Compromise 9.51E-07 
Cellular Movement 9.84E-07 
Cell Morphology 1.74E-06 
Hematological Disease 4.32E-06 
Infection Mechanism 5.28E-06 
Nervous System Development and Function 5.28E-06 
Hair and Skin Development and Function 1.06E-05 
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Functions p-value 
Molecular Transport 1.53E-05 
Protein Synthesis 1.53E-05 
Post-Translational Modification 2.79E-05 
Protein Folding 2.79E-05 
Cell Signaling 5.05E-05 
Small Molecule Biochemistry 5.05E-05 
Digestive System Development and Function 8.26E-05 
Hepatic System Development and Function 8.26E-05 
Cell-To-Cell Signaling and Interaction 1.31E-04 
Behavior 1.40E-04 
Organ Morphology 1.40E-04 
Organismal Injury and Abnormalities 1.47E-04 
Cellular Assembly and Organization 1.59E-04 
Lymphoid Tissue Structure and Development 2.00E-04 
Respiratory Disease 2.03E-04 
Metabolic Disease 2.40E-04 
Tumor Morphology 2.84E-04 
Endocrine System Disorders 3.15E-04 
Dermatological Diseases and Conditions 3.39E-04 
Lipid Metabolism 6.94E-04 
RNA Trafficking 6.94E-04 
Renal and Urological Disease 6.94E-04 
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